Word           ||True ||Pred
==============================
short-interfering: O     O
rna-mediated   : O     O
depletion      : O     O
of             : O     O
p53            : O     O
increased      : O     O
endogenous     : O     O
cxcr4          : O     O
expression     : O     O
in             : O     O
mcf-7          : O     O
breast         : O     O
cancer         : O     O
cells          : O     O
that           : O     O
contain        : O     O
wild-type      : O     O
p53.           : O     O
Word           ||True ||Pred
==============================
furthermore,   : O     O
we             : O     O
established    : O     O
a              : O     O
small          : O     O
amplicon       : O     O
genotyping     : O     O
(sag)          : O     O
method         : O     O
for            : O     O
detecting      : O     O
three          : O     O
high           : O     O
frequency      : O     O
coding-region  : O     O
snps           : O     O
(rs1800255:g>a,: O     O
rs1801184:t>c, : O     O
and            : O     O
rs2271683:a>g) : O     O
in             : O     O
col3a1         : O     O
to             : O     O
differentiate  : O     O
mutations      : O     O
before         : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
we             : O     O
aimed          : O     O
to             : O     O
evaluate       : O     O
whether        : O     O
there          : O     O
are            : O     O
bard1          : O     O
genetic        : O     O
variants       : O     O
that           : O     O
contribute     : O     O
to             : O     O
breast         : O     O
cancer         : O     O
risk           : O     O
by             : O     O
screening      : O     O
the            : O     O
gene           : O     O
for            : O     O
germline       : O     O
alterations    : O     O
in             : O     O
45             : O     O
finnish        : O     O
familial       : O     O
breast         : O     O
cancer         : O     O
patients       : O     O
and            : O     O
in             : O     O
seven          : O     O
patients       : O     O
with           : O     O
both           : O     O
breast         : O     O
and            : O     O
ovarian        : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
evolvement     : O     O
and            : O     O
progression    : O     O
of             : O     O
cardiovascular : O     O
diseases       : O     O
affecting      : O     O
the            : O     O
venous         : O     O
and            : O     O
arterial       : O     O
system         : O     O
are            : O     O
influenced     : O     O
by             : O     O
a              : O     O
multitude      : O     O
of             : O     O
environmental  : O     O
and            : O     O
hereditary     : O     O
factors.       : O     O
Word           ||True ||Pred
==============================
most           : O     O
col3a1         : O     O
mutations      : O     O
are            : O     O
detected       : O     O
by             : O     O
using          : O     O
total          : O     O
rna            : O     O
from           : O     O
patient-derived: O     O
fibroblasts,   : O     O
which          : O     O
requires       : O     O
an             : O     O
invasive       : O     O
skin           : O     O
biopsy.        : O     O
Word           ||True ||Pred
==============================
novel          : O     O
creld1         : O     O
gene           : O     O
mutations      : O     O
in             : O     O
patients       : O     O
with           : O     O
atrioventricular: O     O
septal         : O     O
defect.        : O     O
Word           ||True ||Pred
==============================
methods-results:: O     O
compared       : O     O
with           : O     O
the            : O     O
wild-type      : O     O
hgralpha,      : O     O
the            : O     O
mutant         : O     O
receptor       : O     O
hgralphad401h  : O     O
demonstrated   : O     O
a              : O     O
2.4-fold       : O     O
increase       : O     O
in             : O     O
its            : O     O
ability        : O     O
to             : O     O
transactivate  : O     O
the            : O     O
glucocorticoid-inducible: O     O
mouse          : O     O
mammary        : O     O
tumor          : O     O
virus          : O     O
promoter       : O     O
in             : O     O
response       : O     O
to             : O     O
dexamethasone  : O     O
but            : O     O
had            : O     O
similar        : O     O
affinity       : O     O
for            : O     O
the            : O     O
ligand         : O     O
(dissociation  : O     O
constant       : O     O
=              : O     O
6.2            : O     O
+/-            : O     O
0.6            : O     O
vs.            : O     O
Word           ||True ||Pred
==============================
in             : O     O
an             : O     O
australian     : O     O
clinic         : O     O
population     : O     O
rpgr           : O     O
orf15          : O     O
mutations      : O     O
cause          : O     O
xlcord         : O     O
in             : O     O
addition       : O     O
to             : O     O
xlrp..         : O     O
Word           ||True ||Pred
==============================
moreover,      : O     O
a              : O     O
dominant       : O     O
inhibition     : O     O
of             : O     O
the            : O     O
wild-type      : O     O
trbeta         : O     O
counterpart    : O     O
transactivation: O     O
function       : O     O
was            : O     O
observed       : O     O
on             : O     O
both           : O     O
a              : O     O
positive       : O     O
(f2-tre)       : O     O
and            : O     O
a              : O     O
negative       : O     O
(tshalpha)     : O     O
promoter.      : O     O
Word           ||True ||Pred
==============================
polymerase     : O     O
chain          : O     O
reaction       : O     O
was            : O     O
carried        : O     O
out            : O     O
and            : O     O
single         : O     O
nucleotide     : O     O
polymorphisms  : O     O
of             : O     O
fgfr4          : O     O
were           : O     O
identified     : O     O
by             : O     O
restriction    : O     O
enzyme         : O     O
digestion.     : O     O
Word           ||True ||Pred
==============================
our            : O     O
study          : O     O
implies        : O     O
that           : O     O
the            : O     O
g/c            : O     O
polymorphism   : O     O
of             : O     O
the            : O     O
rad51          : O     O
gene           : O     O
may            : O     O
not            : O     O
be             : O     O
directly       : O     O
involved       : O     O
in             : O     O
the            : O     O
development    : O     O
and/or         : O     O
progression    : O     O
of             : O     O
breast         : O     O
cancer         : O     O
and            : O     O
so             : O     O
it             : O     O
may            : O     O
not            : O     O
be             : O     O
useful         : O     O
as             : O     O
an             : O     O
independent    : O     O
marker         : O     O
in             : O     O
this           : O     O
disease..      : O     O
Word           ||True ||Pred
==============================
nonetheless,   : O     O
nbs1           : O     O
gene           : O     O
heterozygosity : O     O
is             : O     O
not            : O     O
a              : O     O
major          : O     O
risk           : O     O
factor         : O     O
for            : O     O
lymphoid       : O     O
malignancies   : O     O
in             : O     O
childhood      : O     O
and            : O     O
adolescence..  : O     O
Word           ||True ||Pred
==============================
we             : O     O
detected       : O     O
a              : O     O
novel,         : O     O
single,        : O     O
heterozygous   : O     O
nucleotide     : O     O
(g             : O     O
-->            : O     O
c)             : O     O
substitution   : O     O
at             : O     O
position       : O     O
1201           : O     O
(exon          : O     O
2)             : O     O
of             : O     O
the            : O     O
hgr            : O     O
gene,          : O     O
which          : O     O
resulted       : O     O
in             : O     O
aspartic       : O     O
acid           : O     O
to             : O     O
histidine      : O     O
substitution   : O     O
at             : O     O
amino          : O     O
acid           : O     O
position       : O     O
401            : O     O
in             : O     O
the            : O     O
amino-terminal : O     O
domain         : O     O
of             : O     O
the            : O     O
hgralpha.      : O     O
Word           ||True ||Pred
==============================
congenital     : O     O
hypothyroidism : O     O
due            : O     O
to             : O     O
a              : O     O
new            : O     O
deletion       : O     O
in             : O     O
the            : O     O
sodium/iodide  : O     O
symporter      : O     O
protein.       : O     O
Word           ||True ||Pred
==============================
most           : O     O
patients       : O     O
with           : O     O
ho-fhbl        : O     O
have           : O     O
mutations      : O     O
in             : O     O
apob           : O     O
gene           : O     O
resulting      : O     O
in             : O     O
truncated      : O     O
apobs.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
only           : O     O
non-neural     : O     O
neoplasm       : O     O
was            : O     O
an             : O     O
adrenocortical : O     O
carcinoma      : O     O
in             : O     O
a              : O     O
boy            : O     O
aged           : O     O
4              : O     O
years          : O     O
who            : O     O
developed      : O     O
an             : O     O
anaplastic     : O     O
choroid        : O     O
plexus         : O     O
papilloma      : O     O
2              : O     O
years          : O     O
later.         : O     O
Word           ||True ||Pred
==============================
conclusion:    : O     O
these          : O     O
results        : O     O
provide        : O     O
further        : O     O
evidence       : O     O
that           : O     O
bard1          : O     O
cys557ser      : O     O
confers        : O     O
a              : O     O
slightly       : O     O
increased      : O     O
risk           : O     O
of             : O     O
breast         : O     O
cancer         : O     O
in             : O     O
women..        : O     O
Word           ||True ||Pred
==============================
lenticular     : O     O
phenotyping    : O     O
and            : O     O
genotyping     : O     O
were           : O     O
performed      : O     O
independently  : O     O
with           : O     O
short          : O     O
tandem         : O     O
repeat         : O     O
polymorphism.  : O     O
Word           ||True ||Pred
==============================
we             : O     O
found          : O     O
a              : O     O
single         : O     O
nucleotide     : O     O
deletion       : O     O
c.342dela,     : O     O
located        : O     O
in             : O     O
exon           : O     O
3,             : O     O
which          : O     O
resulted       : O     O
in             : O     O
a              : O     O
frameshift     : O     O
at             : O     O
amino          : O     O
acid           : O     O
position       : O     O
58             : O     O
(p.arg58fs     : O     O
or             : O     O
p.r58fs).      : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
four           : O     O
patients       : O     O
with           : O     O
cns2,          : O     O
63             : O     O
patients       : O     O
with           : O     O
gs,            : O     O
and            : O     O
71             : O     O
healthy        : O     O
subjects       : O     O
were           : O     O
enrolled       : O     O
in             : O     O
the            : O     O
study.         : O     O
Word           ||True ||Pred
==============================
given          : O     O
the            : O     O
absence        : O     O
of             : O     O
clear          : O     O
d(n)/d(s)      : O     O
differences    : O     O
between        : O     O
patient        : O     O
groups,        : O     O
delayed        : O     O
onset          : O     O
of             : O     O
aids           : O     O
symptoms       : O     O
appears        : O     O
to             : O     O
be             : O     O
solely         : O     O
associated     : O     O
with           : O     O
lower          : O     O
viral          : O     O
replication    : O     O
rates          : O     O
rather         : O     O
than           : O     O
with           : O     O
differences    : O     O
in             : O     O
selection      : O     O
on             : O     O
amino          : O     O
acid           : O     O
fixation..     : O     O
Word           ||True ||Pred
==============================
results:       : O     O
the            : O     O
frequencies    : O     O
of             : O     O
the            : O     O
asp/glu        : O     O
and            : O     O
glu/glu        : O     O
were           : O     O
significantly  : O     O
increased      : O     O
in             : O     O
diabetic       : O     O
subjects       : O     O
with           : O     O
detectable     : O     O
ia-2           : O     O
antibodies     : O     O
(p             : O     O
<              : O     O
0.01).         : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
we             : O     O
resequenced    : O     O
the            : O     O
positional     : O     O
candidate      : O     O
gene           : O     O
rnasel         : O     O
in             : O     O
48             : O     O
prostate       : O     O
cancer         : O     O
cases          : O     O
and            : O     O
genotyped      : O     O
the            : O     O
previously     : O     O
reported       : O     O
r462q          : O     O
and            : O     O
d541e          : O     O
polymorphisms  : O     O
in             : O     O
230            : O     O
prostate       : O     O
cancer         : O     O
cases          : O     O
and            : O     O
458            : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
polymorphisms  : O     O
of             : O     O
the            : O     O
dna            : O     O
mismatch       : O     O
repair         : O     O
gene           : O     O
hmsh2          : O     O
in             : O     O
breast         : O     O
cancer         : O     O
occurence      : O     O
and            : O     O
progression.   : O     O
Word           ||True ||Pred
==============================
understanding  : O     O
of             : O     O
biological     : O     O
significance   : O     O
of             : O     O
these          : O     O
mutations      : O     O
should         : O     O
help           : O     O
in             : O     O
genetic        : O     O
counselling    : O     O
to             : O     O
carriers       : O     O
and            : O     O
their          : O     O
families.      : O     O
Word           ||True ||Pred
==============================
expanding      : O     O
clinical       : O     O
spectrum       : O     O
of             : O     O
non-autoimmune : O     O
hyperthyroidism: O     O
due            : O     O
to             : O     O
an             : O     O
activating     : O     O
germline       : O     O
mutation,      : O     O
p.m453t,       : O     O
in             : O     O
the            : O     O
thyrotropin    : O     O
receptor       : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
this           : O     O
observation    : O     O
prompted       : O     O
us             : O     O
to             : O     O
investigate    : O     O
the            : O     O
putative       : O     O
somatic        : O     O
mosaicism      : O     O
in             : O     O
the            : O     O
patient        : O     O
consisting     : O     O
of             : O     O
normal         : O     O
cells          : O     O
and            : O     O
cells          : O     O
heterozygous   : O     O
for            : O     O
the            : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
conclusion:    : O     O
these          : O     O
data           : O     O
highlight      : O     O
the            : O     O
need           : O     O
for            : O     O
a              : O     O
range          : O     O
of             : O     O
functional     : O     O
studies        : O     O
to             : O     O
be             : O     O
performed      : O     O
in             : O     O
order          : O     O
to             : O     O
identify       : O     O
variants       : O     O
with           : O     O
partially      : O     O
compromised    : O     O
function.      : O     O
Word           ||True ||Pred
==============================
markers        : O     O
rs2073163      : Mut   O
and            : O     O
rs1155794      : Mut   O
from           : O     O
haploblock     : O     O
2              : O     O
were           : O     O
associated     : O     O
with           : O     O
2-hour         : O     O
plasma         : O     O
glucose        : O     O
levels         : O     O
in             : O     O
men            : O     O
during         : O     O
the            : O     O
3-year         : O     O
follow-up.     : O     O
Word           ||True ||Pred
==============================
the            : O     O
exon           : O     O
3              : O     O
polymorphism   : O     O
of             : O     O
the            : O     O
meh            : O     O
gene           : O     O
was            : O     O
associated     : O     O
with           : O     O
a              : O     O
significantly  : O     O
decreased      : O     O
risk           : O     O
of             : O     O
lung           : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
consequently,  : O     O
the            : O     O
d/h            : O     O
and            : O     O
g/e            : O     O
mutants,       : O     O
unlike         : O     O
the            : O     O
wild-type      : O     O
adam12,        : O     O
are            : O     O
not            : O     O
capable        : O     O
of             : O     O
shedding       : O     O
delta-like     : O     O
l,             : O     O
a              : O     O
ligand         : O     O
for            : O     O
notch          : O     O
receptor,      : O     O
at             : O     O
the            : O     O
cell           : O     O
surface,       : O     O
or             : O     O
of             : O     O
stimulating    : O     O
cell           : O     O
migration.     : O     O
Word           ||True ||Pred
==============================
primary        : O     O
glucocorticoid : O     O
resistance     : O     O
(omim          : O     O
138040)        : O     O
is             : O     O
a              : O     O
rare           : O     O
hereditary     : O     O
disease        : O     O
that           : O     O
causes         : O     O
a              : O     O
generalized    : O     O
partial        : O     O
insensitivity  : O     O
to             : O     O
glucocorticoid : O     O
action,        : O     O
due            : O     O
to             : O     O
genetic        : O     O
alterations    : O     O
of             : O     O
the            : O     O
glucocorticoid : O     O
receptor       : O     O
(gr).          : O     O
Word           ||True ||Pred
==============================
subgroup       : O     O
analysis       : O     O
shows          : O     O
a              : O     O
higher         : O     O
incidence      : O     O
of             : O     O
the            : O     O
heterozygous   : O     O
arggly         : O     O
genotype       : O     O
in             : O     O
cancer         : O     O
cases          : O     O
than           : O     O
in             : O     O
the            : O     O
combined       : O     O
group          : O     O
of             : O     O
bph            : O     O
and            : O     O
controls       : O     O
(p<0.05);      : O     O
this           : O     O
difference     : O     O
is             : O     O
statistically  : O     O
significant    : O     O
between        : O     O
cancer         : O     O
and            : O     O
bph            : O     O
patients       : O     O
but            : O     O
not            : O     O
between        : O     O
cancer         : O     O
cases          : O     O
and            : O     O
community      : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
number         : O     O
of             : O     O
reports        : O     O
investigating  : O     O
disease        : O     O
susceptibility : O     O
based          : O     O
on             : O     O
the            : O     O
carriage       : O     O
of             : O     O
low-penetrance,: O     O
high-frequency : O     O
polymorphisms  : O     O
has            : O     O
steadily       : O     O
increased      : O     O
over           : O     O
the            : O     O
last           : O     O
years.         : O     O
Word           ||True ||Pred
==============================
tandem         : O     O
brct           : O     O
motifs,        : O     O
including      : O     O
those          : O     O
found          : O     O
at             : O     O
the            : O     O
c              : O     O
terminus       : O     O
of             : O     O
bard1,         : O     O
are            : O     O
known          : O     O
to             : O     O
form           : O     O
a              : O     O
phosphoprotein : O     O
recognition    : O     O
module.        : O     O
Word           ||True ||Pred
==============================
results:       : O     O
homozygous     : O     O
y486d          : O     O
was            : O     O
observed       : O     O
in             : O     O
all            : O     O
four           : O     O
patients       : O     O
with           : O     O
cns2.          : O     O
Word           ||True ||Pred
==============================
we             : O     O
did            : O     O
not            : O     O
detect         : O     O
inactivating   : O     O
mutations      : O     O
in             : O     O
exons          : O     O
11,            : O     O
16,            : O     O
and            : O     O
21             : O     O
of             : O     O
the            : O     O
thox2          : O     O
gene           : O     O
where          : O     O
mutations      : O     O
have           : O     O
been           : O     O
previously     : O     O
described.     : O     O
Word           ||True ||Pred
==============================
histamine-n-methyl: O     O
transferase    : O     O
polymorphism   : O     O
and            : O     O
risk           : O     O
for            : O     O
migraine.      : O     O
Word           ||True ||Pred
==============================
objectives:    : O     O
a              : O     O
molecular      : O     O
genetic        : O     O
approach       : O     O
was            : O     O
used           : O     O
to             : O     O
determine      : O     O
the            : O     O
molecular      : O     O
basis          : O     O
of             : O     O
prothrombin    : O     O
deficiency     : O     O
within         : O     O
the            : O     O
family.        : O     O
Word           ||True ||Pred
==============================
in             : O     O
the            : O     O
current        : O     O
study,         : O     O
the            : O     O
haplotype      : O     O
structure      : O     O
of             : O     O
the            : O     O
ptpn22         : O     O
region         : O     O
was            : O     O
determined,    : O     O
and            : O     O
individual     : O     O
haplotypes     : O     O
were           : O     O
tested         : O     O
for            : O     O
association    : O     O
with           : O     O
type           : O     O
1              : O     O
diabetes       : O     O
in             : O     O
family-based   : O     O
tests.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
result         : O     O
of             : O     O
pcr            : O     O
associated     : O     O
with           : O     O
restriction    : O     O
fragment       : O     O
length         : O     O
polymorphism   : O     O
analysis       : O     O
also           : O     O
suggested      : O     O
that           : O     O
this           : O     O
mutation       : O     O
is             : O     O
heterozygous.  : O     O
Word           ||True ||Pred
==============================
we             : O     O
performed      : O     O
2              : O     O
sets           : O     O
of             : O     O
case-control   : O     O
comparisons    : O     O
using          : O     O
japanese       : O     O
subjects       : O     O
(first         : O     O
set:           : O     O
830            : O     O
patients       : O     O
with           : O     O
ra             : O     O
and            : O     O
658            : O     O
controls;      : O     O
second         : O     O
set:           : O     O
1112           : O     O
patients       : O     O
with           : O     O
ra             : O     O
and            : O     O
940            : O     O
controls),     : O     O
and            : O     O
then           : O     O
performed      : O     O
a              : O     O
stratified     : O     O
analysis       : O     O
using          : O     O
human          : O     O
leukocyte      : O     O
antigen        : O     O
(hla)-drb1     : O     O
shared         : O     O
epitope        : O     O
(se)           : O     O
status.        : O     O
Word           ||True ||Pred
==============================
all            : O     O
novel          : O     O
detected       : O     O
mutations      : O     O
were           : O     O
excluded       : O     O
by             : O     O
their          : O     O
presence       : O     O
in             : O     O
a              : O     O
panel          : O     O
of             : O     O
200            : O     O
chromosomes    : O     O
from           : O     O
normal         : O     O
individuals.   : O     O
Word           ||True ||Pred
==============================
subjects       : O     O
and            : O     O
methods:       : O     O
five           : O     O
members        : O     O
of             : O     O
an             : O     O
iranian        : O     O
family         : O     O
of             : O     O
persian        : O     O
ethnic         : O     O
origin         : O     O
were           : O     O
studied.       : O     O
Word           ||True ||Pred
==============================
the            : O     O
aim            : O     O
of             : O     O
this           : O     O
study          : O     O
was            : O     O
to             : O     O
investigate    : O     O
the            : O     O
spectrum       : O     O
of             : O     O
mutations      : O     O
in             : O     O
this           : O     O
gene           : O     O
in             : O     O
bcd            : O     O
patients       : O     O
from           : O     O
singapore,     : O     O
and            : O     O
to             : O     O
characterize   : O     O
their          : O     O
phenotype.     : O     O
Word           ||True ||Pred
==============================
in             : O     O
contrast       : O     O
to             : O     O
previous       : O     O
reports,       : O     O
our            : O     O
study          : O     O
does           : O     O
not            : O     O
suggest        : O     O
that           : O     O
common         : O     O
variants       : O     O
(i.e.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
two            : O     O
novel          : O     O
mutations      : O     O
in             : O     O
sry            : O     O
gene           : O     O
provided       : O     O
valuable       : O     O
information    : O     O
for            : O     O
understanding  : O     O
the            : O     O
molecular      : O     O
mechanism      : O     O
of             : O     O
the            : O     O
patient        : O     O
with           : O     O
46,xy          : O     O
female         : O     O
sex            : O     O
reversal..     : O     O
Word           ||True ||Pred
==============================
in             : O     O
order          : O     O
to             : O     O
define         : O     O
the            : O     O
cftr           : O     O
genotype       : O     O
a              : O     O
series         : O     O
of             : O     O
1812           : O     O
individuals    : O     O
from           : O     O
central-southern: O     O
italy          : O     O
with           : O     O
and            : O     O
without        : O     O
cf             : O     O
manifestations : O     O
were           : O     O
screened       : O     O
by             : O     O
using          : O     O
the            : O     O
pcr/ola        : O     O
assay.         : O     O
Word           ||True ||Pred
==============================
seven          : O     O
of             : O     O
these          : O     O
were           : O     O
mutations      : O     O
presumed       : O     O
to             : O     O
cause          : O     O
ataxia         : O     O
telangiectasia : O     O
based          : O     O
on             : O     O
their          : O     O
effect         : O     O
on             : O     O
the            : O     O
atm            : O     O
protein,       : O     O
including      : O     O
five           : O     O
that           : O     O
caused         : O     O
a              : O     O
protein        : O     O
truncation     : O     O
and            : O     O
two            : O     O
missense       : O     O
mutations      : O     O
in             : O     O
the            : O     O
catalytic      : O     O
kinase         : O     O
domain         : O     O
of             : O     O
the            : O     O
highly         : O     O
conserved      : O     O
cooh           : O     O
terminus       : O     O
of             : O     O
the            : O     O
protein.       : O     O
Word           ||True ||Pred
==============================
the            : O     O
first          : O     O
was            : O     O
a              : O     O
ctt-->cat      : O     O
substitution,  : O     O
codon          : O     O
607            : O     O
(exon          : O     O
16)            : O     O
changing       : O     O
leucine        : O     O
to             : O     O
histidine.     : O     O
Word           ||True ||Pred
==============================
the            : O     O
mutation       : O     O
produced       : O     O
a              : O     O
stop           : O     O
codon          : O     O
within         : O     O
exon           : O     O
4              : O     O
of             : O     O
the            : O     O
irf6           : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
apolipoprotein : O     O
d              : O     O
(apod)         : O     O
is             : O     O
a              : O     O
lipoprotein-associated: O     O
glycoprotein,  : O     O
structurally   : O     O
unrelated      : O     O
to             : O     O
apoe,          : O     O
that           : O     O
transports     : O     O
small          : O     O
hydrophobic    : O     O
ligands        : O     O
including      : O     O
cholesterol    : O     O
and            : O     O
sterols.       : O     O
Word           ||True ||Pred
==============================
a              : O     O
comparative    : O     O
reevaluation   : O     O
showed         : O     O
that           : O     O
mb-drm         : O     O
and            : O     O
sepn-rm        : O     O
share          : O     O
identical      : O     O
clinical       : O     O
features.      : O     O
Word           ||True ||Pred
==============================
phenotype      : O     O
characterization: O     O
showed         : O     O
clinical       : O     O
heterogeneity, : O     O
and            : O     O
age            : O     O
did            : O     O
not            : O     O
correlate      : O     O
with           : O     O
disease        : O     O
severity..     : O     O
Word           ||True ||Pred
==============================
background:    : O     O
a              : O     O
dengue         : O     O
virus          : O     O
type           : O     O
2              : O     O
(den-2         : O     O
tonga/74)      : O     O
isolated       : O     O
from           : O     O
a              : O     O
1974           : O     O
epidemic       : O     O
was            : O     O
characterized  : O     O
by             : O     O
mild           : O     O
illness        : O     O
and            : O     O
belongs        : O     O
to             : O     O
the            : O     O
american       : O     O
genotype       : O     O
of             : O     O
den-2          : O     O
viruses.       : O     O
Word           ||True ||Pred
==============================
recent         : O     O
studies        : O     O
indicate       : O     O
that           : O     O
genetic        : O     O
ablation       : O     O
of             : O     O
mouse          : O     O
uroplakin      : O     O
(up)           : O     O
iii            : O     O
gene,          : O     O
which          : O     O
encodes        : O     O
a              : O     O
47             : O     O
kd             : O     O
urothelial-specific: O     O
integral       : O     O
membrane       : O     O
protein        : O     O
forming        : O     O
urothelial     : O     O
plaques,       : O     O
causes         : O     O
vur            : O     O
and            : O     O
hydronephrosis.: O     O
Word           ||True ||Pred
==============================
phenotype      : O     O
of             : O     O
the            : O     O
twin           : O     O
girls          : O     O
resembles      : O     O
spondyloepiphyseal: O     O
dysplasia      : O     O
congenita      : O     O
spranger-wiedemann: O     O
(sedc-sw),     : O     O
but            : O     O
shortening     : O     O
of             : O     O
the            : O     O
stature        : O     O
is             : O     O
more           : O     O
severe         : O     O
and            : O     O
the            : O     O
cranioface     : O     O
is             : O     O
normal.        : O     O
Word           ||True ||Pred
==============================
this           : O     O
conservative   : O     O
amino          : O     O
acid           : O     O
change         : O     O
was            : O     O
not            : O     O
within         : O     O
any            : O     O
known          : O     O
functional     : O     O
domains        : O     O
of             : O     O
ep300.         : O     O
Word           ||True ||Pred
==============================
altered        : O     O
ligand         : O     O
binding        : O     O
by             : O     O
insulin-like   : O     O
growth         : O     O
factor         : O     O
ii/mannose     : O     O
6-phosphate    : O     O
receptors      : O     O
bearing        : O     O
missense       : O     O
mutations      : O     O
in             : O     O
human          : O     O
cancers.       : O     O
Word           ||True ||Pred
==============================
sequencing     : O     O
of             : O     O
gli3           : O     O
revealed       : O     O
a              : O     O
two            : O     O
nucleotide     : O     O
deletion       : O     O
in             : O     O
exon           : O     O
15             : O     O
(c.3385_3386deltt): O     O
predicting     : O     O
a              : O     O
frameshift     : O     O
and            : O     O
premature      : O     O
stop           : O     O
at             : O     O
codon          : O     O
1129           : O     O
(p.f1129x)     : O     O
in             : O     O
the            : O     O
children       : O     O
while          : O     O
both           : O     O
parents        : O     O
have           : O     O
wild           : O     O
type           : O     O
alleles.       : O     O
Word           ||True ||Pred
==============================
in             : O     O
the            : O     O
pc-3           : O     O
prostate       : O     O
cancer         : O     O
line,          : O     O
the            : O     O
mutation       : O     O
is             : O     O
either         : O     O
homozygous,    : O     O
or             : O     O
hemizygous     : O     O
accompanied    : O     O
by             : O     O
loss           : O     O
of             : O     O
heterozygosity.: O     O
Word           ||True ||Pred
==============================
seven          : O     O
novel          : O     O
single-nucleotide: O     O
polymorphisms  : O     O
(snps)         : O     O
were           : O     O
also           : O     O
found,         : O     O
of             : O     O
which          : O     O
a              : O     O
change         : O     O
of             : O     O
leucine        : O     O
269            : O     O
to             : O     O
phenylalanine  : O     O
(leu269phe)    : O     O
was            : O     O
found          : O     O
in             : O     O
12             : O     O
of             : O     O
18             : O     O
patients       : O     O
with           : O     O
the            : O     O
arg555trp      : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
effects        : O     O
of             : O     O
mutations      : O     O
on             : O     O
the            : O     O
structure      : O     O
and            : O     O
function       : O     O
of             : O     O
ar             : O     O
were           : O     O
investigated   : O     O
by             : O     O
androgen-binding: O     O
assays         : O     O
and            : O     O
transactivation: O     O
assays,        : O     O
respectively.  : O     O
Word           ||True ||Pred
==============================
molecular      : O     O
analysis       : O     O
of             : O     O
gamma-globin   : O     O
promoters,     : O     O
hs-111         : O     O
and            : O     O
3'hs1,         : O     O
in             : O     O
beta-thalassemia: O     O
intermedia     : O     O
patients       : O     O
associated     : O     O
with           : O     O
high           : O     O
levels         : O     O
of             : O     O
hb             : O     O
f.             : O     O
Word           ||True ||Pred
==============================
background:    : O     O
classic        : O     O
neonatal-onset : O     O
glycine        : O     O
encephalopathy : O     O
(ge)           : O     O
is             : O     O
devastating    : O     O
and            : O     O
life           : O     O
threatening.   : O     O
Word           ||True ||Pred
==============================
cyp1b1         : O     O
is             : O     O
genetically    : O     O
polymorphic,   : O     O
and            : O     O
the            : O     O
variations     : O     O
in             : O     O
the            : O     O
cyp1b1         : O     O
gene           : O     O
may            : O     O
be             : O     O
related        : O     O
to             : O     O
the            : O     O
risk           : O     O
of             : O     O
breast         : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
fibroblast     : O     O
growth         : O     O
factor         : O     O
receptor       : O     O
4              : O     O
(fgfr4),       : O     O
a              : O     O
member         : O     O
of             : O     O
the            : O     O
fibroblast     : O     O
growth         : O     O
receptor       : O     O
family,        : O     O
was            : O     O
recently       : O     O
reported       : O     O
to             : O     O
be             : O     O
more           : O     O
abundantly     : O     O
expressed      : O     O
in             : O     O
malignant      : O     O
than           : O     O
benign         : O     O
prostate       : O     O
cells.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
p53            : O     O
rescue         : O     O
drug           : O     O
prima-1        : O     O
reduced        : O     O
cxcr4          : O     O
mrna           : O     O
and            : O     O
cell           : O     O
surface        : O     O
expression     : O     O
in             : O     O
mda-mb-231     : O     O
cells,         : O     O
which          : O     O
express        : O     O
r280k          : O     O
mutant         : O     O
p53.           : O     O
Word           ||True ||Pred
==============================
the            : O     O
phosphomannosylated: O     O
pseudoglycoprotein: O     O
pentamannose   : O     O
6-phosphate-bsa: O     O
(pmp-bsa)      : O     O
was            : O     O
synthesized    : O     O
as             : O     O
a              : O     O
ligand         : O     O
for            : O     O
the            : O     O
m6p            : O     O
binding        : O     O
site.          : O     O
Word           ||True ||Pred
==============================
biochemical    : O     O
properties     : O     O
of             : O     O
the            : O     O
mutant         : O     O
timp3          : O     O
protein        : O     O
were           : O     O
studied,       : O     O
and            : O     O
phylogenetic   : O     O
and            : O     O
molecular      : O     O
modeling       : O     O
analyses       : O     O
of             : O     O
timp           : O     O
proteins       : O     O
were           : O     O
performed.     : O     O
Word           ||True ||Pred
==============================
in             : O     O
the            : O     O
present        : O     O
study,         : O     O
we             : O     O
found          : O     O
a              : O     O
novel          : O     O
cyp17          : O     O
mutation       : O     O
from           : O     O
the            : O     O
molecular      : O     O
analysis       : O     O
of             : O     O
a              : O     O
korean         : O     O
patient        : O     O
with           : O     O
primary        : O     O
amenorrhea     : O     O
with           : O     O
a              : O     O
46,xx          : O     O
karyotype,     : O     O
and            : O     O
hypokalemic    : O     O
hypertension.  : O     O
Word           ||True ||Pred
==============================
in             : O     O
the            : O     O
opa1           : O     O
gene,          : O     O
heterozygous   : O     O
frameshift     : O     O
mutations      : O     O
from           : O     O
codon          : O     O
903            : O     O
due            : O     O
to             : O     O
a              : O     O
four-base      : O     O
pair           : O     O
deletion       : O     O
in             : O     O
exon           : O     O
27             : O     O
were           : O     O
detected       : O     O
in             : O     O
three          : O     O
patients       : O     O
from           : O     O
one            : O     O
family         : O     O
(c.2708_2711delttag,: O     O
p.v903gfsx905).: O     O
Word           ||True ||Pred
==============================
results:       : O     O
the            : O     O
threonine      : O     O
allele         : O     O
of             : O     O
a49t           : O     O
was            : O     O
not            : O     O
found          : O     O
in             : O     O
our            : O     O
subjects.      : O     O
Word           ||True ||Pred
==============================
sequence       : O     O
analysis       : O     O
of             : O     O
the            : O     O
vwf            : O     O
gene           : O     O
from           : O     O
two            : O     O
unrelated      : O     O
type           : O     O
2a             : O     O
vwd            : O     O
patients       : O     O
showed         : O     O
an             : O     O
identical,     : O     O
novel,         : O     O
heterozygous   : O     O
t-->g          : O     O
transversion   : O     O
at             : O     O
nucleotide     : O     O
4508,          : O     O
resulting      : O     O
in             : O     O
the            : O     O
substitution   : O     O
of             : O     O
l1503r         : O     O
in             : O     O
the            : O     O
vwf            : O     O
a2             : O     O
domain.        : O     O
Word           ||True ||Pred
==============================
conclusions:   : O     O
these          : O     O
findings       : O     O
indicate       : O     O
that           : O     O
the            : O     O
promoter       : O     O
polymorphism   : O     O
of             : O     O
irf5           : O     O
is             : O     O
a              : O     O
genetic        : O     O
factor         : O     O
conferring     : O     O
predisposition : O     O
to             : O     O
ra,            : O     O
and            : O     O
that           : O     O
it             : O     O
contributes    : O     O
considerably   : O     O
to             : O     O
disease        : O     O
pathogenesis   : O     O
in             : O     O
patients       : O     O
that           : O     O
were           : O     O
se             : O     O
negative..     : O     O
Word           ||True ||Pred
==============================
marker         : O     O
haplotypes     : O     O
around         : O     O
the            : O     O
dll3           : O     O
locus          : O     O
contradicted   : O     O
this           : O     O
hypothesis     : O     O
as             : O     O
three          : O     O
different      : O     O
haplotypes     : O     O
were           : O     O
seen           : O     O
in             : O     O
affected       : O     O
individuals,   : O     O
but            : O     O
sequence       : O     O
analysis       : O     O
showed         : O     O
that           : O     O
three          : O     O
unreported     : O     O
dll3           : O     O
mutations      : O     O
were           : O     O
segregating:   : O     O
a              : O     O
duplication    : O     O
of             : O     O
17             : O     O
bp             : O     O
in             : O     O
exon           : O     O
8              : O     O
(c.1285-1301dup),: O     O
a              : O     O
single-nucleotide: O     O
deletion       : O     O
in             : O     O
exon           : O     O
5              : O     O
(c.615delc),   : O     O
and            : O     O
a              : O     O
r238x          : O     O
nonsense       : O     O
mutation       : O     O
in             : O     O
exon           : O     O
6.             : O     O
Word           ||True ||Pred
==============================
tumor          : O     O
necrosis       : O     O
factor         : O     O
receptor-associated: O     O
periodic       : O     O
syndrome       : O     O
(traps),       : O     O
an             : O     O
autosomal      : O     O
disease        : O     O
belonging      : O     O
to             : O     O
human          : O     O
autoinflammatory: O     O
syndromes,     : O     O
is             : O     O
caused         : O     O
by             : O     O
mutations      : O     O
in             : O     O
tumor          : O     O
necrosis       : O     O
factor         : O     O
receptor       : O     O
superfamily    : O     O
member         : O     O
1a             : O     O
(tnfrsf1a)     : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
objectives:    : O     O
to             : O     O
investigate    : O     O
the            : O     O
molecular      : O     O
basis          : O     O
of             : O     O
fdh            : O     O
in             : O     O
a              : O     O
2-year-old     : O     O
thai           : O     O
girl           : O     O
who            : O     O
presented      : O     O
at             : O     O
birth          : O     O
with           : O     O
depressed,     : O     O
pale           : O     O
linear         : O     O
scars          : O     O
on             : O     O
the            : O     O
trunk          : O     O
and            : O     O
limbs,         : O     O
sparse         : O     O
brittle        : O     O
hair,          : O     O
syndactyly     : O     O
of             : O     O
the            : O     O
right          : O     O
middle         : O     O
and            : O     O
ring           : O     O
fingers,       : O     O
dental         : O     O
caries         : O     O
and            : O     O
radiological   : O     O
features       : O     O
of             : O     O
osteopathia    : O     O
striata.       : O     O
Word           ||True ||Pred
==============================
mutations      : O     O
in             : O     O
brca2          : O     O
have           : O     O
been           : O     O
associated     : O     O
with           : O     O
increased      : O     O
prostate       : O     O
cancer         : O     O
risk           : O     O
and            : O     O
account        : O     O
for            : O     O
around         : O     O
2%             : O     O
of             : O     O
young          : O     O
onset          : O     O
(<56           : O     O
years)         : O     O
prostate       : O     O
cancer         : O     O
cases.         : O     O
Word           ||True ||Pred
==============================
our            : O     O
aim            : O     O
was            : O     O
to             : O     O
study          : O     O
the            : O     O
associations   : O     O
of             : O     O
individual     : O     O
single         : O     O
nucleotide     : O     O
polymorphisms  : O     O
and            : O     O
haplotypes     : O     O
with           : O     O
adiposity,     : O     O
glucose        : O     O
metabolism,    : O     O
and            : O     O
the            : O     O
risk           : O     O
of             : O     O
type           : O     O
2              : O     O
diabetes       : O     O
(t2d).         : O     O
Word           ||True ||Pred
==============================
paradoxically, : O     O
studies        : O     O
of             : O     O
sporadic       : O     O
and            : O     O
familial       : O     O
breast         : O     O
cancer         : O     O
have           : O     O
failed         : O     O
to             : O     O
demonstrate    : O     O
an             : O     O
elevated       : O     O
prevalence     : O     O
of             : O     O
mutations      : O     O
among          : O     O
breast         : O     O
cancer         : O     O
cases.         : O     O
Word           ||True ||Pred
==============================
two            : O     O
new            : O     O
beta-globin    : O     O
chain          : O     O
variants:      : O     O
hb             : O     O
tripoli:       : O     O
codon          : O     O
26,            : O     O
gag-->gcg      : O     O
[beta26(b8)glu-->ala]: O     O
and            : O     O
hb             : O     O
tizi-ouzou:    : O     O
codon          : O     O
29,            : O     O
ggc-->agc      : O     O
[beta29(b11)gly-->ser]: O     O
are            : O     O
described      : O     O
on             : O     O
the            : O     O
first          : O     O
exon           : O     O
of             : O     O
the            : O     O
beta-globin    : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
two            : O     O
heterozygous   : O     O
mutations      : O     O
were           : O     O
identified     : O     O
in             : O     O
col17a1:       : O     O
a              : O     O
new            : O     O
3'-acceptor    : O     O
splice-site    : O     O
mutation       : O     O
in             : O     O
intron         : O     O
21             : O     O
(1877-2a-->c), : O     O
and            : O     O
a              : O     O
deletion       : O     O
in             : O     O
exon           : O     O
48             : O     O
(3432delt).    : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
analysis       : O     O
of             : O     O
the            : O     O
met326ile      : O     O
polymorphism   : O     O
was            : O     O
carried        : O     O
out            : O     O
on             : O     O
dna            : O     O
samples        : O     O
from           : O     O
256            : O     O
pcos           : O     O
patients       : O     O
and            : O     O
283            : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
objectives:    : O     O
to             : O     O
compare        : O     O
men            : O     O
with           : O     O
prostate       : O     O
disease        : O     O
with           : O     O
those          : O     O
from           : O     O
the            : O     O
general        : O     O
population     : O     O
regarding      : O     O
polymorphisms  : O     O
in             : O     O
the            : O     O
androgen       : O     O
receptor       : O     O
gene           : O     O
and            : O     O
in             : O     O
the            : O     O
5alpha-reductase: O     O
ii             : O     O
(srd5a2)       : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
eleven         : O     O
genetic        : O     O
changes        : O     O
have           : O     O
been           : O     O
identified     : O     O
in             : O     O
the            : O     O
human          : O     O
crem           : O     O
gene,          : O     O
three          : O     O
novel          : O     O
single-nucleotide: O     O
polymorphisms  : O     O
[within        : O     O
the            : O     O
promoters      : O     O
p1,            : O     O
p3             : O     O
and            : O     O
intervening    : O     O
sequence       : O     O
1              : O     O
(ivs1)],       : O     O
one            : O     O
insertion      : O     O
(ivs2)         : O     O
and            : O     O
one            : O     O
non-sense      : O     O
mutation       : O     O
(exon          : O     O
gamma).        : O     O
Word           ||True ||Pred
==============================
results:       : O     O
allele         : O     O
frequencies    : O     O
were           : O     O
homogeneous    : O     O
over           : O     O
the            : O     O
italian        : O     O
territory,     : O     O
with           : O     O
the            : O     O
relevant       : O     O
exception      : O     O
of             : O     O
the            : O     O
ace            : O     O
i/d,           : O     O
the            : O     O
d              : O     O
allele         : O     O
being          : O     O
significantly  : O     O
less           : O     O
frequent       : O     O
in             : O     O
the            : O     O
northern       : O     O
region         : O     O
(61%)          : O     O
than           : O     O
in             : O     O
the            : O     O
rest           : O     O
of             : O     O
the            : O     O
country        : O     O
(67%;          : O     O
p              : O     O
<              : O     O
0.0001).       : O     O
Word           ||True ||Pred
==============================
rare           : O     O
mutations      : O     O
in             : O     O
gene           : O     O
pcsk1,         : O     O
encoding       : O     O
this           : O     O
enzyme,        : O     O
cause          : O     O
childhood      : O     O
obesity        : O     O
and            : O     O
abnormal       : O     O
glucose        : O     O
homeostasis    : O     O
with           : O     O
elevated       : O     O
proinsulin     : O     O
concentrations.: O     O
Word           ||True ||Pred
==============================
objectives:    : O     O
our            : O     O
objective      : O     O
was            : O     O
to             : O     O
investigate    : O     O
the            : O     O
relationship   : O     O
between        : O     O
6bins          : O     O
and            : O     O
the            : O     O
vascular       : O     O
complication   : O     O
pulmonary      : O     O
arterial       : O     O
hypertension   : O     O
(pah)          : O     O
in             : O     O
ssc            : O     O
in             : O     O
a              : O     O
french         : O     O
caucasian      : O     O
population.    : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
human          : O     O
peripheral     : O     O
blood          : O     O
mononuclear    : O     O
cells          : O     O
(pbmcs)        : O     O
were           : O     O
isolated       : O     O
from           : O     O
a              : O     O
taiwanese      : O     O
mdm            : O     O
family         : O     O
bearing        : O     O
the            : O     O
g              : O     O
to             : O     O
a              : O     O
substitution   : O     O
in             : O     O
nucleotide     : O     O
256            : O     O
in             : O     O
the            : O     O
slurp1         : O     O
gene,          : O     O
corresponding  : O     O
to             : O     O
a              : O     O
glycine        : O     O
to             : O     O
arginine       : O     O
substitution   : O     O
at             : O     O
amino          : O     O
acid           : O     O
86             : O     O
(g86r)         : O     O
in             : O     O
the            : O     O
slurp-1        : O     O
protein.       : O     O
Word           ||True ||Pred
==============================
anticipation   : O     O
in             : O     O
familial       : O     O
lattice        : O     O
corneal        : O     O
dystrophy      : O     O
type           : O     O
i              : O     O
with           : O     O
r124c          : O     O
mutation       : O     O
in             : O     O
the            : O     O
tgfbi          : O     O
(bigh3)        : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
development    : O     O
of             : O     O
evidence       : O     O
based          : O     O
guidelines     : O     O
for            : O     O
cdh1           : O     O
screening      : O     O
for            : O     O
hdgc           : O     O
have           : O     O
been           : O     O
complicated    : O     O
by             : O     O
its            : O     O
rarity,        : O     O
variable       : O     O
penetrance,    : O     O
and            : O     O
lack           : O     O
of             : O     O
founder        : O     O
mutations.     : O     O
Word           ||True ||Pred
==============================
the            : O     O
entire         : O     O
coding         : O     O
regions        : O     O
of             : O     O
the            : O     O
cd18           : O     O
gene           : O     O
were           : O     O
screened       : O     O
with           : O     O
direct         : O     O
sequencing     : O     O
genomic        : O     O
dna.           : O     O
Word           ||True ||Pred
==============================
a              : O     O
higher         : O     O
frequency      : O     O
of             : O     O
the            : O     O
c35322t        : O     O
snp            : O     O
was            : O     O
observed       : O     O
among          : O     O
hypertensive   : O     O
patients       : O     O
than           : O     O
control        : O     O
subjects.      : O     O
Word           ||True ||Pred
==============================
we             : O     O
found          : O     O
no             : O     O
evidence       : O     O
of             : O     O
a              : O     O
significant    : O     O
modification   : O     O
of             : O     O
breast         : O     O
cancer         : O     O
penetrance     : O     O
in             : O     O
brca1          : O     O
mutation       : O     O
carriers       : O     O
by             : O     O
either         : O     O
polymorphism.  : O     O
Word           ||True ||Pred
==============================
because        : O     O
of             : O     O
the            : O     O
variability    : O     O
of             : O     O
the            : O     O
symptoms,      : O     O
diagnosis      : O     O
is             : O     O
often          : O     O
delayed.       : O     O
Word           ||True ||Pred
==============================
site-directed  : O     O
mutagenesis    : O     O
of             : O     O
two            : O     O
sq/tq          : O     O
motif          : O     O
serines        : O     O
(s1143a        : O     O
and            : O     O
s1280a)        : O     O
in             : O     O
the            : O     O
brca1          : O     O
fusion         : O     O
protein        : O     O
reduced,       : O     O
but            : O     O
did            : O     O
not            : O     O
abolish,       : O     O
targeting      : O     O
to             : O     O
mmts-inducible : O     O
foci.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
molecular      : O     O
pathology      : O     O
of             : O     O
fxi            : O     O
deficiency     : O     O
is             : O     O
mutation       : O     O
in             : O     O
the            : O     O
f11            : O     O
gene           : O     O
on             : O     O
the            : O     O
chromosome     : O     O
band           : O     O
4q35.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
missense       : O     O
mutations      : O     O
in             : O     O
the            : O     O
candidate      : O     O
prostate       : O     O
cancer         : O     O
gene           : O     O
elac2          : O     O
do             : O     O
not            : O     O
alter          : O     O
enzymatic      : O     O
properties     : O     O
of             : O     O
its            : O     O
product.       : O     O
Word           ||True ||Pred
==============================
results:       : O     O
we             : O     O
detected       : O     O
three          : O     O
types          : O     O
of             : O     O
opa1           : O     O
mutation       : O     O
but            : O     O
no             : O     O
mtdna          : O     O
mutations.     : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
a              : O     O
dataset        : O     O
comprising     : O     O
13             : O     O
norrie-fevr,   : O     O
one            : O     O
coat's         : O     O
disease,       : O     O
31             : O     O
rop            : O     O
patients       : O     O
and            : O     O
90             : O     O
ex-premature   : O     O
babies         : O     O
of             : O     O
<32            : O     O
weeks'         : O     O
gestation      : O     O
underwent      : O     O
an             : O     O
ophthalmologic : O     O
examination    : O     O
and            : O     O
were           : O     O
screened       : O     O
for            : O     O
mutations      : O     O
within         : O     O
the            : O     O
ndp            : O     O
gene           : O     O
by             : O     O
direct         : O     O
dna            : O     O
sequencing,    : O     O
denaturing     : O     O
high-performance: O     O
liquid         : O     O
chromatography : O     O
or             : O     O
gel            : O     O
electrophoresis.: O     O
Word           ||True ||Pred
==============================
setting:       : O     O
nrampl         : O     O
encoded        : O     O
by             : O     O
the            : O     O
nramp1         : O     O
gene           : O     O
influences     : O     O
the            : O     O
phagolysosomal : O     O
function       : O     O
of             : O     O
alveolar       : O     O
macrophage     : O     O
against        : O     O
mycobacterium  : O     O
tuberculosis.  : O     O
Word           ||True ||Pred
==============================
an             : O     O
analysis       : O     O
according      : O     O
to             : O     O
histological   : O     O
subtypes       : O     O
revealed       : O     O
a              : O     O
statistically  : O     O
significant    : O     O
association    : O     O
for            : O     O
adenocarcinomas;: O     O
the            : O     O
adjusted       : O     O
or             : O     O
for            : O     O
the            : O     O
his113/his113  : O     O
genotype       : O     O
was            : O     O
0.40           : O     O
(95%           : O     O
cl             : O     O
0.17-0.94).    : O     O
Word           ||True ||Pred
==============================
the            : O     O
prevalence     : O     O
of             : O     O
heterozygotes  : O     O
for            : O     O
h3543y         : O     O
in             : O     O
the            : O     O
study          : O     O
population     : O     O
was            : O     O
0.47%          : O     O
compared       : O     O
to             : O     O
0.12%          : O     O
for            : O     O
the            : O     O
known          : O     O
arg            : O     O
3500           : O     O
gln            : O     O
(r3500q)       : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
further        : O     O
studies        : O     O
of             : O     O
ar(l701h)      : O     O
in             : O     O
pc3            : O     O
cells          : O     O
suggested      : O     O
that           : O     O
this           : O     O
mutant         : O     O
is             : O     O
prohibited     : O     O
from           : O     O
hormone-independent: O     O
transactivation: O     O
in             : O     O
mammalian      : O     O
cells.         : O     O
Word           ||True ||Pred
==============================
patient's      : O     O
viruses        : O     O
displayed      : O     O
13             : O     O
common         : O     O
mutations      : O     O
in             : O     O
conserved      : O     O
residues,      : O     O
from           : O     O
the            : O     O
5'             : O     O
ltr            : O     O
to             : O     O
the            : O     O
nef            : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
subsequent     : O     O
studies        : O     O
focused        : O     O
on             : O     O
the            : O     O
dependence     : O     O
of             : O     O
ar(l701h)      : O     O
on             : O     O
molecular      : O     O
chaperones     : O     O
for            : O     O
folding        : O     O
to             : O     O
the            : O     O
active         : O     O
state.         : O     O
Word           ||True ||Pred
==============================
in             : O     O
addition,      : O     O
eight          : O     O
individuals    : O     O
who            : O     O
had            : O     O
both           : O     O
microcoria     : O     O
and            : O     O
glaucoma       : O     O
were           : O     O
screened       : O     O
for            : O     O
glaucoma       : O     O
genes:         : O     O
myocilin       : O     O
(myoc),        : O     O
optineurin     : O     O
(optn)         : O     O
and            : O     O
cyp1b1.        : O     O
Word           ||True ||Pred
==============================
exon           : O     O
4              : O     O
of             : O     O
the            : O     O
transforming   : O     O
growth         : O     O
factor-induced : O     O
gene           : O     O
(tgfbi)        : O     O
was            : O     O
screened       : O     O
for            : O     O
the            : O     O
most           : O     O
frequent       : O     O
mutation,      : O     O
r124c,         : O     O
in             : O     O
the            : O     O
proband        : O     O
by             : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
the            : O     O
distribution   : O     O
of             : O     O
hbv            : O     O
genotypes      : O     O
among          : O     O
these          : O     O
patients       : O     O
was            : O     O
a              : O     O
(n             : O     O
=              : O     O
9;             : O     O
50%),          : O     O
d              : O     O
(n             : O     O
=              : O     O
4;             : O     O
22.2%),        : O     O
g              : O     O
(n             : O     O
=              : O     O
3;             : O     O
16.7%),        : O     O
and            : O     O
f              : O     O
(n             : O     O
=              : O     O
2;             : O     O
11.1%).        : O     O
Word           ||True ||Pred
==============================
to             : O     O
test           : O     O
that           : O     O
slurp-1        : O     O
is             : O     O
essential      : O     O
for            : O     O
t-cell         : O     O
activation.    : O     O
Word           ||True ||Pred
==============================
a              : O     O
life-time      : O     O
exposure       : O     O
to             : O     O
enhanced       : O     O
ar             : O     O
expression,    : O     O
in             : O     O
turn,          : O     O
could          : O     O
potentially    : O     O
predispose     : O     O
to             : O     O
prostate       : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
conclusion:    : O     O
these          : O     O
findings       : O     O
suggest        : O     O
that           : O     O
the            : O     O
ts3'-utr       : O     O
del6           : O     O
polymorphism   : O     O
may            : O     O
play           : O     O
a              : O     O
role           : O     O
in             : O     O
the            : O     O
etiology       : O     O
of             : O     O
breast         : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
to             : O     O
test           : O     O
the            : O     O
hypothesis     : O     O
that           : O     O
these          : O     O
three          : O     O
polymorphisms  : O     O
are            : O     O
associated     : O     O
with           : O     O
risk           : O     O
of             : O     O
breast         : O     O
cancer,        : O     O
a              : O     O
case-control   : O     O
study          : O     O
was            : O     O
conducted      : O     O
with           : O     O
patients       : O     O
of             : O     O
aichi          : O     O
cancer         : O     O
center         : O     O
hospital.      : O     O
Word           ||True ||Pred
==============================
in             : O     O
the            : O     O
cns,           : O     O
histamine      : O     O
is             : O     O
almost         : O     O
exclusively    : O     O
metabolized    : O     O
by             : O     O
the            : O     O
polymorphic    : O     O
enzyme         : O     O
histamine      : O     O
n-methyltransferase: O     O
(hnmt).        : O     O
Word           ||True ||Pred
==============================
no             : O     O
association    : O     O
between        : O     O
p21b(g128t)    : O     O
or             : O     O
p21b(t35c)     : O     O
and            : O     O
response       : O     O
to             : O     O
chemotherapy   : O     O
with           : O     O
an             : O     O
anthracycline-containing: O     O
regimen        : O     O
or             : O     O
paclitaxel     : O     O
was            : O     O
recorded.      : O     O
Word           ||True ||Pred
==============================
we             : O     O
found          : O     O
germline       : O     O
truncating     : O     O
atm            : O     O
mutations      : O     O
to             : O     O
be             : O     O
rare           : O     O
in             : O     O
these          : O     O
young          : O     O
breast         : O     O
cancer         : O     O
patients       : O     O
and            : O     O
therefore      : O     O
they           : O     O
are            : O     O
unlikely       : O     O
to             : O     O
play           : O     O
a              : O     O
role           : O     O
in             : O     O
the            : O     O
etiology       : O     O
of             : O     O
their          : O     O
disease.       : O     O
Word           ||True ||Pred
==============================
we             : O     O
did            : O     O
not            : O     O
find           : O     O
statistically  : O     O
significant    : O     O
differences    : O     O
between        : O     O
groups         : O     O
in             : O     O
the            : O     O
insertion/deletion: O     O
polymorphism   : O     O
of             : O     O
the            : O     O
ace            : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
despite        : O     O
the            : O     O
variety        : O     O
of             : O     O
patients       : O     O
with           : O     O
cfs,           : O     O
disc1          : O     O
ser704cys      : O     O
has            : O     O
an             : O     O
association    : O     O
with           : O     O
cfs,           : O     O
which          : O     O
may            : O     O
also           : O     O
suggest        : O     O
that           : O     O
disc1          : O     O
plays          : O     O
a              : O     O
central        : O     O
role           : O     O
in             : O     O
the            : O     O
induction      : O     O
of             : O     O
various        : O     O
psychiatric    : O     O
diseases..     : O     O
Word           ||True ||Pred
==============================
no             : O     O
allelic,       : O     O
genotypic      : O     O
or             : O     O
haplotypic     : O     O
associations   : O     O
were           : O     O
detected       : O     O
when           : O     O
comparing      : O     O
pm             : O     O
or             : O     O
dm             : O     O
cases          : O     O
to             : O     O
controls,      : O     O
or             : O     O
when           : O     O
pm             : O     O
and            : O     O
dm             : O     O
were           : O     O
compared       : O     O
with           : O     O
each           : O     O
other.         : O     O
Word           ||True ||Pred
==============================
males          : O     O
and            : O     O
females        : O     O
are            : O     O
equally        : O     O
affected       : O     O
and            : O     O
present        : O     O
with           : O     O
a              : O     O
distinct       : O     O
pattern        : O     O
of             : O     O
total          : O     O
hair           : O     O
loss           : O     O
on             : O     O
scalp,         : O     O
axilla         : O     O
and            : O     O
body.          : O     O
Word           ||True ||Pred
==============================
patients       : O     O
harboring      : O     O
wt1            : O     O
mutations      : O     O
seemed         : O     O
to             : O     O
have           : O     O
a              : O     O
younger        : O     O
age            : O     O
(29.5          : O     O
vs             : O     O
45.4           : O     O
years),        : O     O
a              : O     O
higher         : O     O
white          : O     O
blood          : O     O
cell           : O     O
count          : O     O
(120.3         : O     O
vs             : O     O
19.8           : O     O
10(9)/l),      : O     O
and            : O     O
a              : O     O
lower          : O     O
platelet       : O     O
count          : O     O
(54.2          : O     O
vs             : O     O
104.3          : O     O
10(9)/l)       : O     O
as             : O     O
compared       : O     O
to             : O     O
those          : O     O
without        : O     O
the            : O     O
mutations      : O     O
although       : O     O
statistical    : O     O
differences    : O     O
could          : O     O
not            : O     O
be             : O     O
demonstrated.  : O     O
Word           ||True ||Pred
==============================
all            : O     O
eligible       : O     O
patients       : O     O
were           : O     O
asked          : O     O
to             : O     O
take           : O     O
part.          : O     O
Word           ||True ||Pred
==============================
ten            : O     O
primary        : O     O
central        : O     O
nervous        : O     O
system         : O     O
lymphomas      : O     O
(pcnsl,        : O     O
brain          : O     O
lymphomas)     : O     O
were           : O     O
examined       : O     O
for            : O     O
p14            : O     O
gene           : O     O
exon           : O     O
1beta          : O     O
deletion,      : O     O
mutation       : O     O
and            : O     O
methylation    : O     O
by             : O     O
southern       : O     O
blot           : O     O
analysis,      : O     O
nucleotide     : O     O
analysis       : O     O
of             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
clones         : O     O
and            : O     O
southern       : O     O
blot-based     : O     O
methylation    : O     O
assay.         : O     O
Word           ||True ||Pred
==============================
families       : O     O
with           : O     O
identified     : O     O
high-risk      : O     O
factors        : O     O
were           : O     O
recalled.      : O     O
Word           ||True ||Pred
==============================
consequently,  : O     O
there          : O     O
is             : O     O
genetic        : O     O
heterogeneity, : O     O
but            : O     O
until          : O     O
recently,      : O     O
little         : O     O
is             : O     O
known          : O     O
about          : O     O
the            : O     O
genes          : O     O
involving      : O     O
in             : O     O
the            : O     O
pathogenesis   : O     O
of             : O     O
avsd.          : O     O
Word           ||True ||Pred
==============================
exploratory    : O     O
investigation  : O     O
on             : O     O
functional     : O     O
significance   : O     O
of             : O     O
ets2           : O     O
and            : O     O
sim2           : O     O
genes          : O     O
in             : O     O
down           : O     O
syndrome.      : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
a              : O     O
recent         : O     O
study          : O     O
presented      : O     O
first          : O     O
evidence       : O     O
that           : O     O
a              : O     O
single         : O     O
nucleotide     : O     O
polymorphism   : O     O
(snp)          : O     O
at             : O     O
codon          : O     O
388            : O     O
of             : O     O
fibroblast     : O     O
growth         : O     O
factor         : O     O
receptor       : O     O
4              : O     O
(fgfr4)        : O     O
gene,          : O     O
causing        : O     O
a              : O     O
transmembrane  : O     O
domain         : O     O
missense       : O     O
mutation       : O     O
(gly388arg),   : O     O
is             : O     O
associated     : O     O
with           : O     O
disease        : O     O
outcome        : O     O
in             : O     O
node-positive  : O     O
breast         : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
ethnic         : O     O
background     : O     O
was            : O     O
confirmed      : O     O
for            : O     O
all            : O     O
subjects       : O     O
by             : O     O
self-report    : O     O
or             : O     O
interview.     : O     O
Word           ||True ||Pred
==============================
il-10          : O     O
is             : O     O
a              : O     O
multi-functional: O     O
cytokine       : O     O
thought        : O     O
to             : O     O
play           : O     O
a              : O     O
role           : O     O
in             : O     O
the            : O     O
pathogenesis   : O     O
of             : O     O
periodontitis. : O     O
Word           ||True ||Pred
==============================
we             : O     O
previously     : O     O
reported       : O     O
a              : O     O
case           : O     O
of             : O     O
heterozygous   : O     O
beta-thalassaemia: O     O
with           : O     O
ivs1-1g        : O     O
>              : O     O
c              : O     O
substitution   : O     O
in             : O     O
the            : O     O
beta-globin    : O     O
gene           : O     O
and            : O     O
a              : O     O
non-detectable : O     O
level          : O     O
of             : O     O
mutant         : O     O
mrna           : O     O
in             : O     O
the            : O     O
patient's      : O     O
reticulocytes. : O     O
Word           ||True ||Pred
==============================
22             : O     O
out            : O     O
of             : O     O
460;           : O     O
or             : O     O
2.1;           : O     O
95%            : O     O
ci             : O     O
1.2-3.8,       : O     O
p<0.01).       : O     O
Word           ||True ||Pred
==============================
however,       : O     O
it             : O     O
cannot         : O     O
be             : O     O
excluded       : O     O
that           : O     O
the            : O     O
2              : O     O
unique         : O     O
dna            : O     O
sequence       : O     O
alterations    : O     O
could          : O     O
have           : O     O
affected       : O     O
foxf2          : O     O
on             : O     O
the            : O     O
mrna           : O     O
or             : O     O
protein        : O     O
level          : O     O
thus           : O     O
contributing   : O     O
to             : O     O
the            : O     O
observed       : O     O
disturbances   : O     O
in             : O     O
genital        : O     O
and            : O     O
palate         : O     O
development..  : O     O
Word           ||True ||Pred
==============================
it             : O     O
is             : O     O
possible       : O     O
that           : O     O
apoe           : O     O
osaka          : O     O
mutation       : O     O
causes         : O     O
a              : O     O
conformational : O     O
change         : O     O
of             : O     O
apoe           : O     O
protein        : O     O
and            : O     O
affects        : O     O
the            : O     O
interaction    : O     O
between        : O     O
abnormal       : O     O
apoe-containing: O     O
lipoproteins   : O     O
and            : O     O
the            : O     O
endothelial    : O     O
cells          : O     O
of             : O     O
glomerular     : O     O
capillaries.   : O     O
Word           ||True ||Pred
==============================
using          : O     O
two            : O     O
web            : O     O
interfaces     : O     O
(esefinder     : O     O
and            : O     O
rescue-ese),   : O     O
we             : O     O
provide        : O     O
evidence       : O     O
that           : O     O
the            : O     O
double         : O     O
nucleotide     : O     O
change         : O     O
may            : O     O
affect         : O     O
an             : O     O
exonic         : O     O
splicing       : O     O
enhancer       : O     O
(ese),         : O     O
a              : O     O
sequence       : O     O
element        : O     O
distinct       : O     O
from           : O     O
the            : O     O
canonical      : O     O
splice         : O     O
sites          : O     O
that           : O     O
are            : O     O
needed         : O     O
for            : O     O
normal         : O     O
splicing.      : O     O
Word           ||True ||Pred
==============================
this           : O     O
study          : O     O
was            : O     O
aimed          : O     O
at             : O     O
evaluating     : O     O
the            : O     O
potential      : O     O
impact         : O     O
of             : O     O
this           : O     O
gene           : O     O
polymorphism   : O     O
on             : O     O
disease        : O     O
progression    : O     O
and            : O     O
treatment      : O     O
outcome        : O     O
in             : O     O
patients       : O     O
with           : O     O
melanoma.      : O     O
Word           ||True ||Pred
==============================
comparison     : O     O
of             : O     O
polymorphism   : O     O
in             : O     O
the            : O     O
3              : O     O
groups         : O     O
was            : O     O
using          : O     O
the            : O     O
chi-square     : O     O
test.          : O     O
Word           ||True ||Pred
==============================
we             : O     O
applied        : O     O
such           : O     O
approaches     : O     O
to             : O     O
analysis       : O     O
of             : O     O
the            : O     O
cancer-associated: O     O
cell           : O     O
cycle          : O     O
regulator      : O     O
chek2          : O     O
in             : O     O
the            : O     O
ashkenazi      : O     O
jewish         : O     O
population.    : O     O
Word           ||True ||Pred
==============================
on             : O     O
this           : O     O
basis          : O     O
we             : O     O
screened       : O     O
naturally      : O     O
occurring      : O     O
mutants        : O     O
of             : O     O
human          : O     O
ar             : O     O
for            : O     O
hormone-independent: O     O
activity       : O     O
using          : O     O
a              : O     O
yeast          : O     O
model          : O     O
system.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
integrity      : O     O
of             : O     O
the            : O     O
c-terminal,    : O     O
brct           : O     O
repeat         : O     O
region         : O     O
is             : O     O
also           : O     O
critical       : O     O
for            : O     O
brca1          : O     O
tumor          : O     O
suppressor     : O     O
function.      : O     O
Word           ||True ||Pred
==============================
patients/methods:: O     O
serum          : O     O
and            : O     O
dna            : O     O
of             : O     O
patients       : O     O
were           : O     O
analyzed.      : O     O
Word           ||True ||Pred
==============================
as             : O     O
only           : O     O
the            : O     O
two            : O     O
family         : O     O
members        : O     O
homozygous     : O     O
for            : O     O
the            : O     O
mutation       : O     O
showed         : O     O
wfs,           : O     O
these          : O     O
data           : O     O
support        : O     O
the            : O     O
notion         : O     O
that           : O     O
this           : O     O
mutation       : O     O
is             : O     O
the            : O     O
cause          : O     O
of             : O     O
wfs..          : O     O
Word           ||True ||Pred
==============================
glutathione    : O     O
s-transferases : O     O
m1,            : O     O
t1,            : O     O
and            : O     O
p1             : O     O
and            : O     O
breast         : O     O
cancer:        : O     O
a              : O     O
pooled         : O     O
analysis.      : O     O
Word           ||True ||Pred
==============================
fifteen        : O     O
of             : O     O
the            : O     O
180            : O     O
finnish        : O     O
hereditary     : O     O
pca            : O     O
families       : O     O
(8.3%)         : O     O
had            : O     O
one            : O     O
or             : O     O
more           : O     O
gastric        : O     O
cancer         : O     O
cases.         : O     O
Word           ||True ||Pred
==============================
approximately  : O     O
50%            : O     O
of             : O     O
the            : O     O
caucasian      : O     O
population     : O     O
are            : O     O
homozygous     : O     O
for            : O     O
deletions      : O     O
in             : O     O
gstm1          : O     O
and            : O     O
approximately  : O     O
20%            : O     O
are            : O     O
homozygous     : O     O
for            : O     O
deletions      : O     O
in             : O     O
gstt1,         : O     O
resulting      : O     O
in             : O     O
conjugation    : O     O
deficiency     : O     O
of             : O     O
mutagenic      : O     O
electrophiles  : O     O
to             : O     O
glutathione.   : O     O
Word           ||True ||Pred
==============================
lfs            : O     O
predisposes    : O     O
to             : O     O
the            : O     O
development    : O     O
of             : O     O
leukemia,      : O     O
sarcomas,      : O     O
adrenocortical : O     O
and            : O     O
breast         : O     O
carcinomas,    : O     O
brain          : O     O
tumors         : O     O
and,           : O     O
questionably,  : O     O
nb.            : O     O
Word           ||True ||Pred
==============================
the            : O     O
mutation       : O     O
spectrum       : O     O
of             : O     O
pku            : O     O
in             : O     O
chinese        : O     O
is             : O     O
similar        : O     O
to             : O     O
other          : O     O
asian          : O     O
populations    : O     O
but            : O     O
significantly  : O     O
different      : O     O
from           : O     O
european       : O     O
populations.   : O     O
Word           ||True ||Pred
==============================
direct         : O     O
sequence       : O     O
analyses       : O     O
revealed       : O     O
five           : O     O
single-base    : O     O
substitutions, : O     O
one            : O     O
tetranucleotide: O     O
(ttat)         : O     O
insertion,     : O     O
and            : O     O
seven          : O     O
short          : O     O
tandem         : O     O
repeats        : O     O
(strs)         : O     O
in             : O     O
the            : O     O
intron;        : O     O
four           : O     O
of             : O     O
the            : O     O
strs           : O     O
and            : O     O
one            : O     O
single-base    : O     O
substitution   : O     O
had            : O     O
been           : O     O
reported       : O     O
previously.    : O     O
Word           ||True ||Pred
==============================
the            : O     O
period2        : O     O
(per2)         : O     O
gene           : O     O
is             : O     O
a              : O     O
key            : O     O
component      : O     O
of             : O     O
the            : O     O
molecular      : O     O
mechanism      : O     O
that           : O     O
generates      : O     O
circadian      : O     O
rhythms        : O     O
in             : O     O
mammals.       : O     O
Word           ||True ||Pred
==============================
in             : O     O
total,         : O     O
19             : O     O
different      : O     O
heterozygous   : O     O
mutations      : O     O
were           : O     O
identified     : O     O
in             : O     O
41             : O     O
subjects;      : O     O
two            : O     O
were           : O     O
recurrent      : O     O
and            : O     O
17             : O     O
were           : O     O
novel.         : O     O
Word           ||True ||Pred
==============================
however,       : O     O
the            : O     O
commonly       : O     O
reported       : O     O
3              : O     O
bp             : O     O
deletion       : O     O
(904-906delgag): O     O
was            : O     O
not            : O     O
detected.      : O     O
Word           ||True ||Pred
==============================
mutational     : O     O
analysis       : O     O
for            : O     O
the            : O     O
wrn            : O     O
gene           : O     O
revealed       : O     O
a              : O     O
homozygous     : O     O
nucleotide     : O     O
substitution   : O     O
3190c>t        : O     O
in             : O     O
exon           : O     O
24,            : O     O
resulting      : O     O
in             : O     O
a              : O     O
protein        : O     O
product        : O     O
with           : O     O
replacement    : O     O
of             : O     O
an             : O     O
arginine       : O     O
residue        : O     O
at             : O     O
position       : O     O
573            : O     O
by             : O     O
termination    : O     O
codon          : O     O
(arg987ter).   : O     O
Word           ||True ||Pred
==============================
here,          : O     O
we             : O     O
report         : O     O
a              : O     O
novel          : O     O
natural        : O     O
rth            : O     O
mutation       : O     O
(e333d)        : O     O
located        : O     O
in             : O     O
the            : O     O
large          : O     O
carboxy-terminal: O     O
ligand         : O     O
binding        : O     O
domain         : O     O
of             : O     O
trbeta.        : O     O
Word           ||True ||Pred
==============================
cp-31398,      : O     O
another        : O     O
p53            : O     O
rescue         : O     O
drug,          : O     O
similarly      : O     O
reduced        : O     O
cell           : O     O
surface        : O     O
levels         : O     O
of             : O     O
cxcr4.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
frequencies    : O     O
of             : O     O
these          : O     O
genetic        : O     O
alterations    : O     O
were           : O     O
similar        : O     O
to             : O     O
those          : O     O
reported       : O     O
for            : O     O
primary        : O     O
glioblastomas  : O     O
at             : O     O
the            : O     O
population     : O     O
level          : O     O
in             : O     O
switzerland.   : O     O
Word           ||True ||Pred
==============================
genes          : O     O
chromosomes    : O     O
cancer         : O     O
26:286-294,    : O     O
1999..         : O     O
Word           ||True ||Pred
==============================
cap            : O     O
progression    : O     O
was,           : O     O
however,       : O     O
independent    : O     O
of             : O     O
srd5a2         : O     O
variants.      : O     O
Word           ||True ||Pred
==============================
results:       : O     O
immunofluorescence: O     O
microscopy     : O     O
performed      : O     O
on             : O     O
nonlesional    : O     O
skin           : O     O
demonstrated   : O     O
absence        : O     O
of             : O     O
the            : O     O
type           : O     O
xvii           : O     O
collagen       : O     O
endodomain     : O     O
and            : O     O
presence,      : O     O
although       : O     O
reduced,       : O     O
of             : O     O
the            : O     O
shed           : O     O
ectodomain.    : O     O
Word           ||True ||Pred
==============================
conclusions:   : O     O
a              : O     O
novel          : O     O
tacstd2        : O     O
c119y          : O     O
mutation       : O     O
leading        : O     O
to             : O     O
an             : O     O
amino          : O     O
acid           : O     O
substitution   : O     O
was            : O     O
identified     : O     O
in             : O     O
two            : O     O
affected       : O     O
siblings       : O     O
of             : O     O
a              : O     O
family.        : O     O
Word           ||True ||Pred
==============================
we             : O     O
aimed          : O     O
to             : O     O
append         : O     O
to             : O     O
the            : O     O
increasing     : O     O
database       : O     O
of             : O     O
these          : O     O
oncogenic      : O     O
lesions        : O     O
and,           : O     O
therefore,     : O     O
analyzed       : O     O
dna            : O     O
from           : O     O
tumor          : O     O
tissue         : O     O
and            : O     O
constitutive   : O     O
dna            : O     O
from           : O     O
a              : O     O
patient        : O     O
with           : O     O
thyroid        : O     O
carcinoma.     : O     O
Word           ||True ||Pred
==============================
creld1         : O     O
was            : O     O
amplified      : O     O
by             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
(pcr)          : O     O
with           : O     O
specific       : O     O
primers.       : O     O
Word           ||True ||Pred
==============================
testes         : O     O
located        : O     O
in             : O     O
the            : O     O
inguinal       : O     O
canal          : O     O
showed         : O     O
a              : O     O
normal         : O     O
morphology     : O     O
for            : O     O
age.           : O     O
Word           ||True ||Pred
==============================
to             : O     O
identify       : O     O
genetic        : O     O
variants       : O     O
contributing   : O     O
to             : O     O
end-stage      : O     O
renal          : O     O
disease        : O     O
(esrd)         : O     O
in             : O     O
type           : O     O
2              : O     O
diabetes,      : O     O
we             : O     O
performed      : O     O
a              : O     O
genome-wide    : O     O
analysis       : O     O
of             : O     O
115,352        : O     O
single         : O     O
nucleotide     : O     O
polymorphisms  : O     O
(snps)         : O     O
in             : O     O
pools          : O     O
of             : O     O
105            : O     O
unrelated      : O     O
case           : O     O
subjects       : O     O
with           : O     O
esrd           : O     O
and            : O     O
102            : O     O
unrelated      : O     O
control        : O     O
subjects       : O     O
who            : O     O
have           : O     O
had            : O     O
type           : O     O
2              : O     O
diabetes       : O     O
for            : O     O
>              : O     O
or             : O     O
=10            : O     O
years          : O     O
without        : O     O
macroalbuminuria.: O     O
Word           ||True ||Pred
==============================
we             : O     O
screened       : O     O
the            : O     O
apob           : O     O
gene           : O     O
segment        : O     O
of             : O     O
codons         : O     O
3448-3561      : O     O
by             : O     O
denaturing     : O     O
gradient       : O     O
gel            : O     O
electrophoresis: O     O
(dgge)         : O     O
analysis       : O     O
in             : O     O
a              : O     O
total          : O     O
of             : O     O
853            : O     O
consecutively  : O     O
sampled        : O     O
german         : O     O
patients       : O     O
undergoing     : O     O
diagnostic     : O     O
coronary       : O     O
angiography    : O     O
for            : O     O
suspected      : O     O
cad.           : O     O
Word           ||True ||Pred
==============================
two            : O     O
silent         : O     O
mutations,     : O     O
c.1272c>t      : O     O
(ser424ser)    : O     O
and            : O     O
c.1284t>c      : O     O
(tyr428tyr),   : O     O
respectively,  : O     O
occurred       : O     O
in             : O     O
the            : O     O
coding         : O     O
region         : O     O
of             : O     O
exon           : O     O
2,             : O     O
again          : O     O
in             : O     O
both           : O     O
patients       : O     O
and            : O     O
normal         : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
an             : O     O
involvement    : O     O
of             : O     O
m235t          : O     O
polymorphism   : O     O
of             : O     O
the            : O     O
agt            : O     O
gene           : O     O
in             : O     O
renal          : O     O
disease        : O     O
was            : O     O
observed       : O     O
in             : O     O
our            : O     O
study.         : O     O
Word           ||True ||Pred
==============================
one            : O     O
protein        : O     O
truncating     : O     O
variant        : O     O
was            : O     O
found          : O     O
in             : O     O
brip1/bach1,   : O     O
as             : O     O
well           : O     O
as             : O     O
four           : O     O
missense       : O     O
variants,      : O     O
a              : O     O
silent         : O     O
change         : O     O
and            : O     O
a              : O     O
variant        : O     O
in             : O     O
the            : O     O
3'             : O     O
untranslated   : O     O
region.        : O     O
Word           ||True ||Pred
==============================
in             : O     O
vitro          : O     O
analysis       : O     O
demonstrated   : O     O
that           : O     O
jak2v617f      : O     O
is             : O     O
a              : O     O
constitutively : O     O
active         : O     O
tyrosine       : O     O
kinase..       : O     O
Word           ||True ||Pred
==============================
the            : O     O
aim            : O     O
of             : O     O
this           : O     O
study          : O     O
was            : O     O
i)             : O     O
to             : O     O
give           : O     O
a              : O     O
detailed       : O     O
description    : O     O
of             : O     O
the            : O     O
frequencies    : O     O
of             : O     O
factors        : O     O
of             : O     O
hereditary     : O     O
thrombophilia  : O     O
and            : O     O
their          : O     O
combinations   : O     O
in             : O     O
a              : O     O
german         : O     O
population     : O     O
(n             : O     O
=              : O     O
282)           : O     O
and            : O     O
ii)            : O     O
to             : O     O
compare        : O     O
their          : O     O
distributions  : O     O
with           : O     O
those          : O     O
reported       : O     O
for            : O     O
other          : O     O
regions.       : O     O
Word           ||True ||Pred
==============================
nevertheless,  : O     O
studies        : O     O
suggest        : O     O
that           : O     O
they           : O     O
can            : O     O
simply         : O     O
represent      : O     O
phenotypic     : O     O
variations     : O     O
of             : O     O
the            : O     O
same           : O     O
disease        : O     O
spectrum,      : O     O
sharing        : O     O
common         : O     O
genetic        : O     O
mutations..    : O     O
Word           ||True ||Pred
==============================
the            : O     O
purpose        : O     O
of             : O     O
this           : O     O
study          : O     O
is             : O     O
to             : O     O
examine        : O     O
the            : O     O
relative       : O     O
distribution   : O     O
of             : O     O
the            : O     O
primary        : O     O
dystonia       : O     O
subtypes       : O     O
and            : O     O
identify       : O     O
mutation       : O     O
(s)            : O     O
in             : O     O
the            : O     O
dyt1           : O     O
gene           : O     O
in             : O     O
indian         : O     O
patients.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
proband        : O     O
was            : O     O
a              : O     O
55-year-old    : O     O
woman          : O     O
who            : O     O
gave           : O     O
birth          : O     O
to             : O     O
two            : O     O
daughters      : O     O
and            : O     O
one            : O     O
son            : O     O
aged           : O     O
30,            : O     O
29             : O     O
and            : O     O
27,            : O     O
respectively.  : O     O
Word           ||True ||Pred
==============================
in             : O     O
contrast       : O     O
to             : O     O
the            : O     O
previously     : O     O
described      : O     O
mps            : O     O
ix             : O     O
patient,       : O     O
our            : O     O
three          : O     O
patients       : O     O
display        : O     O
a              : O     O
phenotype      : O     O
limited        : O     O
to             : O     O
the            : O     O
joints,        : O     O
suggesting     : O     O
that           : O     O
this           : O     O
is             : O     O
the            : O     O
primary        : O     O
manifestation  : O     O
of             : O     O
hyal1          : O     O
deficiency..   : O     O
Word           ||True ||Pred
==============================
pcr            : O     O
amplification  : O     O
of             : O     O
exon           : O     O
29             : O     O
was            : O     O
followed       : O     O
by             : O     O
dna            : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
the            : O     O
mutant         : O     O
protein        : O     O
appears        : O     O
to             : O     O
be             : O     O
expressed      : O     O
by             : O     O
fibroblasts    : O     O
from           : O     O
an             : O     O
affected       : O     O
family         : O     O
member.        : O     O
Word           ||True ||Pred
==============================
dna            : O     O
typing         : O     O
of             : O     O
dbp            : O     O
locus          : O     O
was            : O     O
performed      : O     O
by             : O     O
the            : O     O
pcr-restriction: O     O
fragment       : O     O
length         : O     O
polymorphism   : O     O
method         : O     O
(rflp).        : O     O
Word           ||True ||Pred
==============================
results:       : O     O
three          : O     O
pathogenic     : O     O
mutations      : O     O
were           : O     O
identified;    : O     O
two            : O     O
mutations,     : O     O
s482x          : O     O
and            : O     O
k386t,         : O     O
were           : O     O
novel          : O     O
and            : O     O
found          : O     O
in             : O     O
three          : O     O
patients.      : O     O
Word           ||True ||Pred
==============================
we             : O     O
hypothesized   : O     O
that           : O     O
germline       : O     O
mutations      : O     O
in             : O     O
ep300          : O     O
may            : O     O
account        : O     O
for            : O     O
some           : O     O
breast         : O     O
cancer         : O     O
families       : O     O
that           : O     O
include        : O     O
cases          : O     O
of             : O     O
gastric,       : O     O
pancreatic     : O     O
and/or         : O     O
colorectal     : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
we             : O     O
also           : O     O
observed       : O     O
a              : O     O
20             : O     O
bp             : O     O
insertion/deletion: O     O
polymorphism   : O     O
1,109          : O     O
bp             : O     O
upstream       : O     O
of             : O     O
the            : O     O
initiation     : O     O
codon,         : O     O
but            : O     O
this           : O     O
variant        : O     O
was            : O     O
not            : O     O
associated     : O     O
with           : O     O
prostate       : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
one            : O     O
of             : O     O
the            : O     O
common         : O     O
functional     : O     O
polymorphisms  : O     O
of             : O     O
gstp1          : O     O
is             : O     O
a              : O     O
>              : O     O
g              : O     O
at             : O     O
nucleotide     : O     O
313,           : O     O
which          : O     O
results        : O     O
in             : O     O
an             : O     O
amino          : O     O
acid           : O     O
substitution   : O     O
(ile105val)    : O     O
at             : O     O
the            : O     O
substrate      : O     O
binding        : O     O
site           : O     O
of             : O     O
gstp1          : O     O
and            : O     O
reduces        : O     O
catalytic      : O     O
activity       : O     O
of             : O     O
gstp1.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
study          : O     O
cohort         : O     O
was            : O     O
divided        : O     O
into           : O     O
three          : O     O
groups         : O     O
based          : O     O
on             : O     O
pathology      : O     O
(viz.          : O     O
Word           ||True ||Pred
==============================
however,       : O     O
standard       : O     O
egfr           : O     O
mutation       : O     O
analysis       : O     O
requires       : O     O
a              : O     O
minimum        : O     O
amount         : O     O
of             : O     O
tumor          : O     O
tissue,        : O     O
which          : O     O
may            : O     O
not            : O     O
be             : O     O
available      : O     O
in             : O     O
certain        : O     O
situations.    : O     O
Word           ||True ||Pred
==============================
case           : O     O
2              : O     O
harbored       : O     O
a              : O     O
novel          : O     O
heterozygous   : O     O
c60s/l244f     : O     O
mutation       : O     O
in             : O     O
exon           : O     O
2,             : O     O
located        : O     O
within         : O     O
a              : O     O
highly         : O     O
conserved      : O     O
lrr            : O     O
1              : O     O
and            : O     O
lrr            : O     O
9,             : O     O
respectively.  : O     O
Word           ||True ||Pred
==============================
the            : O     O
severe         : O     O
phenotype      : O     O
with           : O     O
seriously      : O     O
impaired       : O     O
intellectual   : O     O
development,   : O     O
hyperkinetic   : O     O
behaviour,     : O     O
tachycardia,   : O     O
hearing        : O     O
and            : O     O
visual         : O     O
impairment     : O     O
is             : O     O
probably       : O     O
due            : O     O
to             : O     O
the            : O     O
dominant       : O     O
negative       : O     O
effect         : O     O
of             : O     O
the            : O     O
i280s          : O     O
mutant         : O     O
protein        : O     O
and            : O     O
the            : O     O
absence        : O     O
of             : O     O
any            : O     O
functional     : O     O
tr-beta..      : O     O
Word           ||True ||Pred
==============================
the            : O     O
+              : O     O
allele         : O     O
of             : O     O
xmni           : O     O
also           : O     O
had            : O     O
complete       : O     O
correlation    : O     O
with           : O     O
the            : O     O
a              : O     O
allele         : O     O
of             : O     O
-588           : O     O
variation.     : O     O
Word           ||True ||Pred
==============================
we             : O     O
report         : O     O
a              : O     O
3-month-old    : O     O
taiwanese      : O     O
boy            : O     O
with           : O     O
initial        : O     O
presentation   : O     O
of             : O     O
a              : O     O
lack           : O     O
of             : O     O
subcutaneous   : O     O
fat,           : O     O
prominent      : O     O
musculature,   : O     O
generalized    : O     O
eruptive       : O     O
xanthomas,     : O     O
and            : O     O
extreme        : O     O
hypertriglyceridemia.: O     O
Word           ||True ||Pred
==============================
materials      : O     O
and            : O     O
methods:       : O     O
a              : O     O
cohort         : O     O
of             : O     O
1163           : O     O
unrelated      : O     O
patients       : O     O
with           : O     O
ibd            : O     O
(874           : O     O
crohn's        : O     O
disease,       : O     O
259            : O     O
ulcerative     : O     O
colitis,       : O     O
30             : O     O
indeterminate  : O     O
colitis)       : O     O
and            : O     O
312            : O     O
controls       : O     O
were           : O     O
analysed       : O     O
for            : O     O
anti-saccharomyces: O     O
cerevisiae     : O     O
antibodies     : O     O
(gasca)        : O     O
igg,           : O     O
anti-laminaribioside: O     O
antibodies     : O     O
(alca)         : O     O
igg,           : O     O
anti-chitobioside: O     O
antibodies     : O     O
(acca)         : O     O
iga,           : O     O
anti-mannobioside: O     O
antibodies     : O     O
(amca)         : O     O
igg            : O     O
and            : O     O
outer          : O     O
membrane       : O     O
porin          : O     O
(omp)          : O     O
iga            : O     O
and            : O     O
were           : O     O
genotyped      : O     O
for            : O     O
variants       : O     O
in             : O     O
nod2/card15,   : O     O
tucan/cardinal/card8,: O     O
nod1/card4,    : O     O
tlr4,          : O     O
tlr1,          : O     O
tlr2           : O     O
and            : O     O
tlr6.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
chemokine      : O     O
monocyte       : O     O
chemotactic    : O     O
protein-1      : O     O
(mcp-1)        : O     O
is             : O     O
expressed      : O     O
at             : O     O
sites          : O     O
of             : O     O
the            : O     O
t              : O     O
cell           : O     O
inflammatory   : O     O
response       : O     O
in             : O     O
the            : O     O
iims.          : O     O
Word           ||True ||Pred
==============================
haplotype      : O     O
analysis       : O     O
based          : O     O
on             : O     O
three          : O     O
snps           : O     O
(rs4810424,    : O     O
rs2071197,     : O     O
and            : O     O
rs3818247)     : O     O
representing   : O     O
the            : O     O
linkage        : O     O
disequilibrium : O     O
blocks         : O     O
in             : O     O
our            : O     O
study          : O     O
population     : O     O
indicated      : O     O
that           : O     O
the            : O     O
conversion     : O     O
to             : O     O
type           : O     O
2              : O     O
diabetes       : O     O
mellitus       : O     O
was            : O     O
dependent      : O     O
on             : O     O
the            : O     O
number         : O     O
of             : O     O
risk           : O     O
alleles        : O     O
in             : O     O
different      : O     O
haplotypes     : O     O
in             : O     O
women.         : O     O
Word           ||True ||Pred
==============================
two            : O     O
siblings       : O     O
presented      : O     O
with           : O     O
movement       : O     O
disorders      : O     O
and            : O     O
diabetes.      : O     O
Word           ||True ||Pred
==============================
these          : O     O
findings       : O     O
represent      : O     O
the            : O     O
first          : O     O
report         : O     O
of             : O     O
a              : O     O
mutation       : O     O
in             : O     O
the            : O     O
human          : O     O
cacna2d4       : O     O
gene           : O     O
and            : O     O
define         : O     O
a              : O     O
novel          : O     O
gene           : O     O
defect         : O     O
that           : O     O
causes         : O     O
autosomal      : O     O
recessive      : O     O
cone           : O     O
dystrophy..    : O     O
Word           ||True ||Pred
==============================
depressed      : O     O
calcium        : O     O
handling       : O     O
by             : O     O
the            : O     O
sarcoplasmic   : O     O
reticulum      : O     O
(sr)           : O     O
ca-atpase      : O     O
and            : O     O
its            : O     O
regulator      : O     O
phospholamban  : O     O
(pln)          : O     O
is             : O     O
a              : O     O
key            : O     O
characteristic : O     O
of             : O     O
human          : O     O
and            : O     O
experimental   : O     O
heart          : O     O
failure.       : O     O
Word           ||True ||Pred
==============================
conclusions:   : O     O
these          : O     O
results        : O     O
support        : O     O
the            : O     O
role           : O     O
of             : O     O
sox2           : O     O
in             : O     O
ocular         : O     O
development.   : O     O
Word           ||True ||Pred
==============================
in             : O     O
cdna           : O     O
derived        : O     O
from           : O     O
patients       : O     O
with           : O     O
ivs16+1g>a,    : O     O
an             : O     O
additional     : O     O
96             : O     O
bp             : O     O
insertion      : O     O
between        : O     O
exons          : O     O
16             : O     O
and            : O     O
17             : O     O
was            : O     O
observed.      : O     O
Word           ||True ||Pred
==============================
identification : O     O
of             : O     O
a              : O     O
gain-of-function: O     O
mutation       : O     O
of             : O     O
the            : O     O
prolactin      : O     O
receptor       : O     O
in             : O     O
women          : O     O
with           : O     O
benign         : O     O
breast         : O     O
tumors.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
brca1          : O     O
tumor          : O     O
suppressor     : O     O
exists         : O     O
as             : O     O
a              : O     O
heterodimeric  : O     O
complex        : O     O
with           : O     O
bard1,         : O     O
and            : O     O
this           : O     O
complex        : O     O
is             : O     O
thought        : O     O
to             : O     O
mediate        : O     O
many           : O     O
of             : O     O
the            : O     O
functions      : O     O
ascribed       : O     O
to             : O     O
brca1,         : O     O
including      : O     O
its            : O     O
role           : O     O
in             : O     O
tumor          : O     O
suppression.   : O     O
Word           ||True ||Pred
==============================
bss            : O     O
is             : O     O
caused         : O     O
by             : O     O
genetic        : O     O
alterations    : O     O
of             : O     O
the            : O     O
glycoprotein   : O     O
(gp)           : O     O
ib/v/ix        : O     O
complex.       : O     O
Word           ||True ||Pred
==============================
findings:      : O     O
similar        : O     O
distribution   : O     O
of             : O     O
the            : O     O
allelic        : O     O
and            : O     O
genotypic      : O     O
frequencies    : O     O
were           : O     O
observed       : O     O
between        : O     O
the            : O     O
groups         : O     O
(p>0.05).      : O     O
Word           ||True ||Pred
==============================
when           : O     O
expressed      : O     O
with           : O     O
the            : O     O
beta1          : O     O
subunit,       : O     O
the            : O     O
mutated        : O     O
channels       : O     O
exhibited      : O     O
a              : O     O
-4.5-mv        : O     O
shift          : O     O
of             : O     O
inactivation   : O     O
with           : O     O
slower         : O     O
recovery       : O     O
leading        : O     O
to             : O     O
a              : O     O
rate-dependent : O     O
na(+)          : O     O
current        : O     O
reduction      : O     O
and            : O     O
a              : O     O
moderate       : O     O
increase       : O     O
in             : O     O
late           : O     O
na(+)          : O     O
current.       : O     O
Word           ||True ||Pred
==============================
the            : O     O
3'             : O     O
insertion/deletion: O     O
(3'utr         : O     O
i/d)           : O     O
variant        : O     O
was            : O     O
associated     : O     O
with           : O     O
body           : O     O
mass           : O     O
index          : O     O
(bmi,          : O     O
p              : O     O
=              : O     O
0.035)         : O     O
among          : O     O
nondiabetic    : O     O
family         : O     O
members.       : O     O
Word           ||True ||Pred
==============================
transient      : O     O
cat            : O     O
assay          : O     O
for            : O     O
transcriptional: O     O
activation     : O     O
revealed       : O     O
that           : O     O
one            : O     O
group,         : O     O
including      : O     O
gly199stop,    : O     O
ser240ile,     : O     O
glu285lys,     : O     O
and            : O     O
lys291asn,     : O     O
abolished      : O     O
the            : O     O
transcriptional: O     O
activity,      : O     O
whereas        : O     O
the            : O     O
other          : O     O
group,         : O     O
including      : O     O
pro250ala,     : O     O
retained       : O     O
stronger       : O     O
transcriptional: O     O
transactivation: O     O
activity       : O     O
than           : O     O
that           : O     O
of             : O     O
wt             : O     O
p53..          : O     O
Word           ||True ||Pred
==============================
results:       : O     O
the            : O     O
clinical       : O     O
features       : O     O
included       : O     O
hearing        : O     O
impairment,    : O     O
ichthyosiform  : O     O
erythroderma   : O     O
with           : O     O
hyperkeratotic : O     O
plaques,       : O     O
palmoplantar   : O     O
keratoderma,   : O     O
alopecia       : O     O
of             : O     O
the            : O     O
scalp          : O     O
and            : O     O
eyelashes,     : O     O
and            : O     O
a              : O     O
thick          : O     O
vernix         : O     O
caseosa-like   : O     O
covering       : O     O
of             : O     O
the            : O     O
scalp.         : O     O
Word           ||True ||Pred
==============================
longer         : O     O
duration       : O     O
of             : O     O
pill           : O     O
use            : O     O
was            : O     O
associated     : O     O
with           : O     O
a              : O     O
significantly  : O     O
greater        : O     O
risk           : O     O
reduction      : O     O
(p             : O     O
for            : O     O
trend          : O     O
=              : O     O
0.015).        : O     O
Word           ||True ||Pred
==============================
6.1            : O     O
+/-            : O     O
0.6            : O     O
nm)            : O     O
and            : O     O
time           : O     O
to             : O     O
nuclear        : O     O
translocation  : O     O
(14.75         : O     O
+/-            : O     O
0.25           : O     O
vs.            : O     O
Word           ||True ||Pred
==============================
matrigel       : O     O
invasion       : O     O
assays         : O     O
showed         : O     O
enhanced       : O     O
invasion       : O     O
with           : O     O
g735s,         : O     O
g796s          : O     O
and            : O     O
e804g          : O     O
mutants.       : O     O
Word           ||True ||Pred
==============================
these          : O     O
results        : O     O
support        : O     O
the            : O     O
hypothesis     : O     O
that           : O     O
subtle         : O     O
variation      : O     O
in             : O     O
dna            : O     O
repair         : O     O
capacity       : O     O
may            : O     O
influence      : O     O
cancer         : O     O
susceptibility : O     O
in             : O     O
the            : O     O
population..   : O     O
Word           ||True ||Pred
==============================
e872q          : O     O
could          : O     O
be             : O     O
abnormally     : O     O
activated      : O     O
by             : O     O
17beta-estradiol,: O     O
progesterone,  : O     O
and            : O     O
cyproterone    : O     O
acetate        : O     O
(cpa).         : O     O
Word           ||True ||Pred
==============================
patients:      : O     O
the            : O     O
five           : O     O
patients       : O     O
derived        : O     O
from           : O     O
four           : O     O
families       : O     O
living         : O     O
in             : O     O
shandong       : O     O
province,      : O     O
china.         : O     O
Word           ||True ||Pred
==============================
results:       : O     O
of             : O     O
the            : O     O
131            : O     O
patients,      : O     O
51             : O     O
possessed      : O     O
atm            : O     O
sequence       : O     O
alterations    : O     O
located        : O     O
within         : O     O
exons          : O     O
or             : O     O
in             : O     O
short          : O     O
intron         : O     O
regions        : O     O
flanking       : O     O
each           : O     O
exon           : O     O
that           : O     O
encompass      : O     O
putative       : O     O
splice         : O     O
site           : O     O
regions.       : O     O
Word           ||True ||Pred
==============================
complete       : O     O
nucleotide     : O     O
sequencing     : O     O
of             : O     O
viral          : O     O
dna            : O     O
showed         : O     O
the            : O     O
major          : O     O
presence       : O     O
of             : O     O
deletions.     : O     O
Word           ||True ||Pred
==============================
objective:     : O     O
to             : O     O
investigate    : O     O
this           : O     O
relationship,  : O     O
the            : O     O
nramp1         : O     O
polymorphisms  : O     O
in             : O     O
patients       : O     O
with           : O     O
tuberculous    : O     O
pleurisy       : O     O
were           : O     O
determined.    : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
genomic        : O     O
dna            : O     O
was            : O     O
prepared       : O     O
from           : O     O
blood          : O     O
leukocytes,    : O     O
genotyping     : O     O
was            : O     O
performed      : O     O
using          : O     O
microsatellite : O     O
markers,       : O     O
and            : O     O
logarithm      : O     O
of             : O     O
the            : O     O
odds           : O     O
(lod)          : O     O
scores         : O     O
were           : O     O
calculated     : O     O
using          : O     O
the            : O     O
linkage        : O     O
programs.      : O     O
Word           ||True ||Pred
==============================
two            : O     O
point          : O     O
and            : O     O
multipoint     : O     O
linkage        : O     O
analyses       : O     O
were           : O     O
performed      : O     O
using          : O     O
the            : O     O
mlink          : O     O
and            : O     O
superlink      : O     O
programs.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
cacna2d4       : O     O
gene           : O     O
encodes        : O     O
an             : O     O
l-type         : O     O
calcium-channel: O     O
auxiliary      : O     O
subunit        : O     O
of             : O     O
the            : O     O
alpha          : O     O
(2)            : O     O
delta          : O     O
type.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
present        : O     O
study          : O     O
found          : O     O
that           : O     O
pp32r1         : O     O
expression     : O     O
levels         : O     O
vary           : O     O
among          : O     O
human          : O     O
tumor          : O     O
cell           : O     O
lines,         : O     O
with           : O     O
the            : O     O
highest        : O     O
levels         : O     O
found          : O     O
in             : O     O
prostatic      : O     O
adenocarcinoma : O     O
cell           : O     O
lines.         : O     O
Word           ||True ||Pred
==============================
hum            : O     O
mutat          : O     O
22:121-128,    : O     O
2003.          : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
the            : O     O
ctsk           : O     O
gene           : O     O
was            : O     O
analyzed       : O     O
from           : O     O
genomic        : O     O
dna            : O     O
in             : O     O
a              : O     O
nonconsanguinity: O     O
mexican        : O     O
family         : O     O
with           : O     O
3              : O     O
affected       : O     O
members        : O     O
with           : O     O
pycnodysostosis: O     O
and            : O     O
100            : O     O
healthy        : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
each           : O     O
family         : O     O
had            : O     O
two            : O     O
to             : O     O
five           : O     O
affected       : O     O
members.       : O     O
Word           ||True ||Pred
==============================
porphyria      : O     O
cutanea        : O     O
tarda          : O     O
(pct)          : O     O
is             : O     O
sometimes      : O     O
precipitated   : O     O
or             : O     O
aggravated     : O     O
by             : O     O
increased      : O     O
exposure       : O     O
to             : O     O
estrogen,      : O     O
estrogen-like  : O     O
compounds,     : O     O
or             : O     O
tamoxifen.     : O     O
Word           ||True ||Pred
==============================
several        : O     O
gene           : O     O
mutations      : O     O
of             : O     O
apoe           : O     O
have           : O     O
been           : O     O
reported       : O     O
to             : O     O
be             : O     O
associated     : O     O
with           : O     O
lpg.           : O     O
Word           ||True ||Pred
==============================
truncal        : O     O
obesity        : O     O
has            : O     O
been           : O     O
described      : O     O
in             : O     O
all            : O     O
patients       : O     O
older          : O     O
than           : O     O
6              : O     O
years          : O     O
(8/8).         : O     O
Word           ||True ||Pred
==============================
it             : O     O
is             : O     O
intriguing     : O     O
that           : O     O
the            : O     O
serum          : O     O
apoe           : O     O
level          : O     O
was            : O     O
within         : O     O
normal         : O     O
limits.        : O     O
Word           ||True ||Pred
==============================
dna            : O     O
samples        : O     O
were           : O     O
genotyped      : O     O
by             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
(pcr).         : O     O
Word           ||True ||Pred
==============================
there          : O     O
are            : O     O
differential   : O     O
effects        : O     O
of             : O     O
age,           : O     O
gender         : O     O
and            : O     O
smoking        : O     O
status         : O     O
on             : O     O
the            : O     O
association    : O     O
of             : O     O
the            : O     O
g-395a         : O     O
polymorphism   : O     O
with           : O     O
eh;            : O     O
the            : O     O
g-395a         : O     O
polymorphism   : O     O
is             : O     O
significantly  : O     O
associated     : O     O
with           : O     O
eh             : O     O
in             : O     O
subjects       : O     O
over           : O     O
60years        : O     O
old,           : O     O
in             : O     O
females        : O     O
and            : O     O
in             : O     O
nonsmokers.    : O     O
Word           ||True ||Pred
==============================
determination  : O     O
of             : O     O
the            : O     O
smn2           : O     O
copy           : O     O
number         : O     O
showed         : O     O
that           : O     O
the            : O     O
presence       : O     O
of             : O     O
two            : O     O
or             : O     O
three          : O     O
copies         : O     O
generally      : O     O
correlated     : O     O
with           : O     O
a              : O     O
better         : O     O
evolution.     : O     O
Word           ||True ||Pred
==============================
osteogenesis   : O     O
imperfecta,    : O     O
or             : O     O
"brittle       : O     O
bone           : O     O
disease,"      : O     O
is             : O     O
a              : O     O
type           : O     O
i              : O     O
collagen-related: O     O
condition      : O     O
associated     : O     O
with           : O     O
osteoporosis   : O     O
and            : O     O
increased      : O     O
risk           : O     O
of             : O     O
bone           : O     O
fractures.     : O     O
Word           ||True ||Pred
==============================
mutations      : O     O
in             : O     O
the            : O     O
serine         : O     O
protease       : O     O
inhibitor      : O     O
kazal          : O     O
type           : O     O
1              : O     O
gene           : O     O
(spink1)       : O     O
encoding       : O     O
pancreatic     : O     O
secretory      : O     O
trypsin        : O     O
inhibitor      : O     O
(psti)         : O     O
have           : O     O
recently       : O     O
been           : O     O
found          : O     O
to             : O     O
be             : O     O
associated     : O     O
with           : O     O
chronic        : O     O
pancreatitis.  : O     O
Word           ||True ||Pred
==============================
high           : O     O
frequency      : O     O
of             : O     O
lamivudine     : O     O
resistance     : O     O
mutations      : O     O
in             : O     O
brazilian      : O     O
patients       : O     O
co-infected    : O     O
with           : O     O
hiv            : O     O
and            : O     O
hepatitis      : O     O
b.             : O     O
Word           ||True ||Pred
==============================
molecular      : O     O
diagnosis      : O     O
of             : O     O
46,xy          : O     O
dsd            : O     O
and            : O     O
identification : O     O
of             : O     O
a              : O     O
novel          : O     O
8              : O     O
nucleotide     : O     O
deletion       : O     O
in             : O     O
exon           : O     O
1              : O     O
of             : O     O
the            : O     O
srd5a2         : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
tumor          : O     O
tissues        : O     O
were           : O     O
obtained       : O     O
from           : O     O
postmenopausal : O     O
women          : O     O
with           : O     O
node-negative  : O     O
and            : O     O
node-positive  : O     O
breast         : O     O
carcinoma      : O     O
with           : O     O
uniform        : O     O
tumor          : O     O
size.          : O     O
Word           ||True ||Pred
==============================
we             : O     O
now            : O     O
describe       : O     O
2              : O     O
sls            : O     O
patients       : O     O
whose          : O     O
disease        : O     O
is             : O     O
caused         : O     O
by             : O     O
large          : O     O
contiguous     : O     O
gene           : O     O
deletions      : O     O
of             : O     O
the            : O     O
aldh3a2        : O     O
locus          : O     O
on             : O     O
17p11.2.       : O     O
Word           ||True ||Pred
==============================
two            : O     O
cases          : O     O
of             : O     O
brca1          : O     O
promoter       : O     O
deletion       : O     O
involving      : O     O
exons          : O     O
1a-2           : O     O
and            : O     O
exons          : O     O
1a-23          : O     O
were           : O     O
detected.      : O     O
Word           ||True ||Pred
==============================
her            : O     O
mother         : O     O
was            : O     O
heterozygous   : O     O
for            : O     O
the            : O     O
asn45ser       : O     O
mutation,      : O     O
and            : O     O
her            : O     O
father,        : O     O
for            : O     O
the            : O     O
nine-nucleotide: O     O
deletion.      : O     O
Word           ||True ||Pred
==============================
results:       : O     O
three          : O     O
generations    : O     O
of             : O     O
family         : O     O
members        : O     O
were           : O     O
positively     : O     O
diagnosed      : O     O
with           : O     O
lattice        : O     O
corneal        : O     O
dystrophy.     : O     O
Word           ||True ||Pred
==============================
background:    : O     O
leukocyte      : O     O
adhesion       : O     O
deficiency     : O     O
type           : O     O
1              : O     O
(lad-1)        : O     O
is             : O     O
a              : O     O
rare,          : O     O
autosomal      : O     O
recessive      : O     O
inherited      : O     O
immunodeficiency: O     O
disease        : O     O
characterized  : O     O
by             : O     O
recurrent      : O     O
severe         : O     O
bacterial      : O     O
infection,     : O     O
impaired       : O     O
pus            : O     O
formation,     : O     O
poor           : O     O
wound          : O     O
healing,       : O     O
associated     : O     O
with           : O     O
the            : O     O
mutation       : O     O
in             : O     O
the            : O     O
cd18           : O     O
gene           : O     O
responsible    : O     O
for            : O     O
the            : O     O
ability        : O     O
of             : O     O
the            : O     O
leucocytes     : O     O
to             : O     O
migrate        : O     O
from           : O     O
the            : O     O
blood          : O     O
stream         : O     O
towards        : O     O
the            : O     O
site           : O     O
of             : O     O
inflammation.  : O     O
Word           ||True ||Pred
==============================
we             : O     O
investigated   : O     O
the            : O     O
association    : O     O
between        : O     O
chronic        : O     O
itp            : O     O
and            : O     O
the            : O     O
frequency      : O     O
of             : O     O
the            : O     O
single-nucleotide: O     O
polymorphism   : O     O
rs763780       : Mut   O
(7488t/c),     : O     O
which          : O     O
causes         : O     O
a              : O     O
his-to-arg     : O     O
substitution   : O     O
at             : O     O
amino          : O     O
acid           : O     O
161.           : O     O
Word           ||True ||Pred
==============================
method:        : O     O
dnas           : O     O
were           : O     O
extracted      : O     O
from           : O     O
31             : O     O
plasma         : O     O
samples        : O     O
from           : O     O
31             : O     O
patients       : O     O
and            : O     O
analyzed       : O     O
by             : O     O
both           : O     O
methods        : O     O
for            : O     O
egfr           : O     O
exon           : O     O
19             : O     O
deletion       : O     O
and            : O     O
egfr           : O     O
l858r          : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
apolipoproteinb: O     O
100            : O     O
(apob-100)     : O     O
is             : O     O
an             : O     O
important      : O     O
component      : O     O
of             : O     O
atherogenic    : O     O
lipoproteins   : O     O
such           : O     O
as             : O     O
ldl            : O     O
and            : O     O
serves         : O     O
as             : O     O
a              : O     O
ligand         : O     O
for            : O     O
the            : O     O
ldl-receptor.  : O     O
Word           ||True ||Pred
==============================
multilocus     : O     O
association    : O     O
of             : O     O
genetic        : O     O
variants       : O     O
in             : O     O
mll,           : O     O
crebbp,        : O     O
ep300,         : O     O
and            : O     O
top2a          : O     O
with           : O     O
childhood      : O     O
acute          : O     O
lymphoblastic  : O     O
leukemia       : O     O
in             : O     O
hispanics      : O     O
from           : O     O
texas.         : O     O
Word           ||True ||Pred
==============================
however,       : O     O
we             : O     O
identified     : O     O
a              : O     O
novel          : O     O
missense       : O     O
mutation,      : O     O
f826y,         : O     O
in             : O     O
three          : O     O
patients       : O     O
in             : O     O
a              : O     O
heterozygous   : O     O
state,         : O     O
in             : O     O
addition       : O     O
to             : O     O
four           : O     O
single         : O     O
nucleotide     : O     O
polymorphisms, : O     O
including      : O     O
one            : O     O
synonymous     : O     O
mutation       : O     O
(l809l).       : O     O
Word           ||True ||Pred
==============================
the            : O     O
disorder       : O     O
is             : O     O
associated     : O     O
with           : O     O
diverse        : O     O
mutations      : O     O
in             : O     O
the            : O     O
thyroid        : O     O
hormone        : O     O
beta           : O     O
receptor       : O     O
(trbeta).      : O     O
Word           ||True ||Pred
==============================
on             : O     O
the            : O     O
contrary,      : O     O
the            : O     O
dbp            : O     O
glu-containing : O     O
genotype       : O     O
was            : O     O
not            : O     O
accompanied    : O     O
by             : O     O
differences    : O     O
in             : O     O
the            : O     O
prevalence     : O     O
of             : O     O
gad65          : O     O
antibodies.    : O     O
Word           ||True ||Pred
==============================
20.3           : O     O
months,        : O     O
p              : O     O
=              : O     O
0.029).        : O     O
Word           ||True ||Pred
==============================
furthermore,   : O     O
because        : O     O
of             : O     O
the            : O     O
high           : O     O
incidence      : O     O
of             : O     O
heterozygosity : O     O
as             : O     O
well           : O     O
as             : O     O
amorphs,       : O     O
accurate       : O     O
knops          : O     O
typing         : O     O
of             : O     O
donors         : O     O
of             : O     O
african        : O     O
descent        : O     O
is             : O     O
best           : O     O
accomplished   : O     O
by             : O     O
a              : O     O
combination    : O     O
of             : O     O
molecular      : O     O
and            : O     O
serologic      : O     O
techniques..   : O     O
Word           ||True ||Pred
==============================
in             : O     O
our            : O     O
study,         : O     O
we             : O     O
examined       : O     O
the            : O     O
presence       : O     O
of             : O     O
alterations    : O     O
in             : O     O
men1           : O     O
gene           : O     O
in             : O     O
a              : O     O
series         : O     O
of             : O     O
39             : O     O
patients       : O     O
who            : O     O
had            : O     O
undergone      : O     O
surgery        : O     O
for            : O     O
sporadic       : O     O
phpt           : O     O
(35            : O     O
with           : O     O
parathyroid    : O     O
adenoma        : O     O
or             : O     O
hyperplasia,   : O     O
4              : O     O
with           : O     O
a              : O     O
carcinoma).    : O     O
Word           ||True ||Pred
==============================
transfection   : O     O
into           : O     O
chinese        : O     O
hamster        : O     O
ovary          : O     O
cells          : O     O
of             : O     O
a              : O     O
cdna           : O     O
representing   : O     O
only           : O     O
the            : O     O
coding         : O     O
region         : O     O
of             : O     O
oprm1,         : O     O
carrying       : O     O
adenosine,     : O     O
guanosine,     : O     O
cytidine,      : O     O
and            : O     O
thymidine      : O     O
in             : O     O
position       : O     O
118,           : O     O
resulted       : O     O
in             : O     O
1.5-fold       : O     O
lower          : O     O
mrna           : O     O
levels         : O     O
only           : O     O
for            : O     O
oprm1-g118,    : O     O
and            : O     O
more           : O     O
than           : O     O
10-fold        : O     O
lower          : O     O
oprm1          : O     O
protein        : O     O
levels,        : O     O
measured       : O     O
by             : O     O
western        : O     O
blotting       : O     O
and            : O     O
receptor       : O     O
binding        : O     O
assay.         : O     O
Word           ||True ||Pred
==============================
tenomodulin    : O     O
is             : O     O
associated     : O     O
with           : O     O
obesity        : O     O
and            : O     O
diabetes       : O     O
risk:          : O     O
the            : O     O
finnish        : O     O
diabetes       : O     O
prevention     : O     O
study.         : O     O
Word           ||True ||Pred
==============================
we             : O     O
identified     : O     O
19             : O     O
sequence       : O     O
variants       : O     O
by             : O     O
direct         : O     O
dna            : O     O
sequencing     : O     O
in             : O     O
24             : O     O
individuals    : O     O
of             : O     O
which          : O     O
four           : O     O
common         : O     O
variants       : O     O
were           : O     O
selected       : O     O
for            : O     O
genotyping     : O     O
in             : O     O
our            : O     O
asthma         : O     O
cohort         : O     O
(1,055         : O     O
asthmatic      : O     O
patients,      : O     O
384            : O     O
normal         : O     O
controls).     : O     O
Word           ||True ||Pred
==============================
all            : O     O
exon           : O     O
7              : O     O
mutations      : O     O
were           : O     O
frameshift     : O     O
mutations      : O     O
and            : O     O
had            : O     O
nras           : O     O
mutation       : O     O
while          : O     O
exon           : O     O
9              : O     O
mutations      : O     O
were           : O     O
base           : O     O
substitutions  : O     O
and            : O     O
had            : O     O
flt3-itd       : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
this           : O     O
confirms       : O     O
the            : O     O
diagnosis      : O     O
of             : O     O
mucopolysaccharidosis: O     O
ix             : O     O
(mps           : O     O
ix)            : O     O
which          : O     O
has            : O     O
only           : O     O
been           : O     O
described      : O     O
in             : O     O
a              : O     O
single         : O     O
patient        : O     O
to             : O     O
date.          : O     O
Word           ||True ||Pred
==============================
rnasel         : O     O
and            : O     O
rnasel-inhibitor: O     O
variation      : O     O
and            : O     O
prostate       : O     O
cancer         : O     O
risk           : O     O
in             : O     O
afro-caribbeans.: O     O
Word           ||True ||Pred
==============================
mutations      : O     O
in             : O     O
rpgr           : O     O
orf15          : O     O
have           : O     O
also           : O     O
been           : O     O
documented     : O     O
to             : O     O
cause          : O     O
x              : O     O
linked         : O     O
cone-rod       : O     O
dystrophy      : O     O
(xlcord)       : O     O
and            : O     O
atrophic       : O     O
macular        : O     O
degeneration   : O     O
at             : O     O
an             : O     O
unknown        : O     O
frequency.     : O     O
Word           ||True ||Pred
==============================
this           : O     O
syndrome       : O     O
has            : O     O
been           : O     O
associated     : O     O
with           : O     O
mutations      : O     O
in             : O     O
polg,          : O     O
the            : O     O
gene           : O     O
encoding       : O     O
the            : O     O
mitochondrial  : O     O
dna            : O     O
polymerase     : O     O
(pol           : O     O
gamma).        : O     O
Word           ||True ||Pred
==============================
prenatal       : O     O
dna            : O     O
diagnosis      : O     O
in             : O     O
the            : O     O
family         : O     O
of             : O     O
patient        : O     O
2              : O     O
was            : O     O
successfully   : O     O
performed,     : O     O
showing        : O     O
a              : O     O
male           : O     O
fetus          : O     O
with           : O     O
the            : O     O
wild-type      : O     O
genotype.      : O     O
Word           ||True ||Pred
==============================
five           : O     O
separate       : O     O
mutant-transfected: O     O
clones         : O     O
were           : O     O
selected       : O     O
and            : O     O
tested         : O     O
in             : O     O
subsequent     : O     O
growth         : O     O
experiments.   : O     O
Word           ||True ||Pred
==============================
ihc            : O     O
revealed       : O     O
one            : O     O
patient        : O     O
with           : O     O
a              : O     O
putative       : O     O
mlh1           : O     O
aberration     : O     O
and            : O     O
sequencing     : O     O
of             : O     O
this           : O     O
sample         : O     O
revealed       : O     O
five           : O     O
sequence       : O     O
variants       : O     O
including      : O     O
two            : O     O
missense       : O     O
variants       : O     O
p434l          : O     O
and            : O     O
i219v.         : O     O
Word           ||True ||Pred
==============================
more           : O     O
than           : O     O
95%            : O     O
of             : O     O
the            : O     O
functional     : O     O
polg           : O     O
mrna           : O     O
was            : O     O
derived        : O     O
from           : O     O
the            : O     O
allele         : O     O
bearing        : O     O
the            : O     O
a467t          : O     O
mutation       : O     O
and            : O     O
less           : O     O
than           : O     O
5%             : O     O
contained      : O     O
the            : O     O
e873stop       : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
given          : O     O
the            : O     O
essential      : O     O
role           : O     O
of             : O     O
this           : O     O
hormonal       : O     O
system         : O     O
in             : O     O
breast         : O     O
physiology,    : O     O
we             : O     O
reasoned       : O     O
that           : O     O
genetic        : O     O
anomalies      : O     O
of             : O     O
prl/prlr       : O     O
genes          : O     O
may            : O     O
be             : O     O
related        : O     O
to             : O     O
the            : O     O
occurrence     : O     O
of             : O     O
breast         : O     O
diseases       : O     O
with           : O     O
high           : O     O
proliferative  : O     O
potential.     : O     O
Word           ||True ||Pred
==============================
considering    : O     O
the            : O     O
relatively     : O     O
high           : O     O
frequency      : O     O
of             : O     O
beta-thalassemia: O     O
(thal)         : O     O
in             : O     O
the            : O     O
large          : O     O
allochthonous  : O     O
population     : O     O
in             : O     O
the            : O     O
netherlands,   : O     O
combinations   : O     O
of             : O     O
hb             : O     O
zoeterwoude    : O     O
and            : O     O
beta-thal      : O     O
traits         : O     O
may            : O     O
lead           : O     O
to             : O     O
hemizygosity,  : O     O
with           : O     O
severe         : O     O
hypoxia        : O     O
and            : O     O
erythrocytosis : O     O
from           : O     O
a              : O     O
few            : O     O
months         : O     O
after          : O     O
birth..        : O     O
Word           ||True ||Pred
==============================
sequence       : O     O
variations     : O     O
may            : O     O
be             : O     O
pseudogene     : O     O
products       : O     O
rather         : O     O
than           : O     O
true           : O     O
polymorphisms, : O     O
so             : O     O
we             : O     O
should         : O     O
always         : O     O
determine      : O     O
if             : O     O
the            : O     O
position       : O     O
where          : O     O
the            : O     O
variation      : O     O
is             : O     O
located        : O     O
differs        : O     O
between        : O     O
kal1           : O     O
and            : O     O
its            : O     O
pseudogene,    : O     O
because        : O     O
it             : O     O
has            : O     O
been           : O     O
suggested      : O     O
that           : O     O
the            : O     O
presence       : O     O
of             : O     O
various        : O     O
polymorphisms  : O     O
in             : O     O
affected       : O     O
individuals    : O     O
could          : O     O
be             : O     O
the            : O     O
cause          : O     O
of             : O     O
ks..           : O     O
Word           ||True ||Pred
==============================
structural     : O     O
and            : O     O
biochemical    : O     O
basis          : O     O
for            : O     O
novel          : O     O
mutations      : O     O
in             : O     O
homozygous     : O     O
israeli        : O     O
maple          : O     O
syrup          : O     O
urine          : O     O
disease        : O     O
patients:      : O     O
a              : O     O
proposed       : O     O
mechanism      : O     O
for            : O     O
the            : O     O
thiamin-responsive: O     O
phenotype.     : O     O
Word           ||True ||Pred
==============================
when           : O     O
present        : O     O
the            : O     O
defect         : O     O
is             : O     O
also           : O     O
found          : O     O
in             : O     O
the            : O     O
salivary       : O     O
glands         : O     O
and            : O     O
gastric        : O     O
mucosa         : O     O
and            : O     O
it             : O     O
has            : O     O
been           : O     O
shown          : O     O
to             : O     O
arise          : O     O
from           : O     O
abnormalities  : O     O
of             : O     O
the            : O     O
sodium/iodide  : O     O
symporter      : O     O
(nis).         : O     O
Word           ||True ||Pred
==============================
somatic        : O     O
mutations      : O     O
in             : O     O
the            : O     O
p53            : O     O
tumor          : O     O
suppressor     : O     O
gene           : O     O
are            : O     O
the            : O     O
most           : O     O
common         : O     O
genetic        : O     O
alterations    : O     O
found          : O     O
in             : O     O
human          : O     O
malignancies.  : O     O
Word           ||True ||Pred
==============================
we             : O     O
also           : O     O
found          : O     O
a              : O     O
similar        : O     O
electrophysiological: O     O
profile        : O     O
for            : O     O
the            : O     O
neighboring    : O     O
v1764m         : O     O
mutant.        : O     O
Word           ||True ||Pred
==============================
regarding      : O     O
host           : O     O
characteristics,: O     O
one            : O     O
patient        : O     O
had            : O     O
hla            : O     O
b2705/b5801;   : O     O
another        : O     O
b1402/b5701;   : O     O
whereas        : O     O
a              : O     O
third          : O     O
showed         : O     O
b3901/b4402    : O     O
and            : O     O
was            : O     O
delta32-ccr5   : O     O
heterozygous.  : O     O
Word           ||True ||Pred
==============================
aims:          : O     O
disrupted-in   : O     O
schizophrenia  : O     O
1              : O     O
(disc1),       : O     O
identified     : O     O
in             : O     O
a              : O     O
pedigree       : O     O
with           : O     O
a              : O     O
familial       : O     O
psychosis      : O     O
with           : O     O
the            : O     O
chromosome     : O     O
translocation  : O     O
(1:11),        : O     O
is             : O     O
a              : O     O
putative       : O     O
susceptibility : O     O
gene           : O     O
for            : O     O
psychoses      : O     O
such           : O     O
as             : O     O
schizophrenia  : O     O
and            : O     O
major          : O     O
depressive     : O     O
disorder       : O     O
(mdd).         : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
genomic        : O     O
dna            : O     O
was            : O     O
isolated       : O     O
from           : O     O
peripheral     : O     O
blood          : O     O
leukocytes     : O     O
of             : O     O
the            : O     O
patient        : O     O
to             : O     O
allow          : O     O
manba          : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
pon1           : O     O
mutations      : O     O
were           : O     O
identified     : O     O
by             : O     O
hierarchical   : O     O
phenotype-targeted: O     O
sequencing     : O     O
in             : O     O
dnas           : O     O
from           : O     O
the            : O     O
100            : O     O
men            : O     O
with           : O     O
the            : O     O
lowest         : O     O
paraoxonase    : O     O
activity       : O     O
in             : O     O
this           : O     O
cohort,        : O     O
and            : O     O
1595           : O     O
men            : O     O
in             : O     O
the            : O     O
cohort         : O     O
were           : O     O
genotyped      : O     O
for            : O     O
pon1           : O     O
mutations      : O     O
by             : O     O
restriction    : O     O
fragment       : O     O
length         : O     O
polymorphism.  : O     O
Word           ||True ||Pred
==============================
mutation       : O     O
screening      : O     O
of             : O     O
the            : O     O
guca1b         : O     O
gene           : O     O
in             : O     O
patients       : O     O
with           : O     O
autosomal      : O     O
dominant       : O     O
cone           : O     O
and            : O     O
cone           : O     O
rod            : O     O
dystrophy.     : O     O
Word           ||True ||Pred
==============================
fifty-one      : O     O
of             : O     O
the            : O     O
66             : O     O
women          : O     O
(77%)          : O     O
who            : O     O
met            : O     O
our            : O     O
inclusion      : O     O
criteria       : O     O
were           : O     O
tested         : O     O
for            : O     O
promoter       : O     O
deletions      : O     O
using          : O     O
linkage        : O     O
disequilibrium : O     O
analysis       : O     O
of             : O     O
two            : O     O
brca1          : O     O
polymorphic    : O     O
sites          : O     O
(c/g1802       : O     O
and            : O     O
pro871leu)     : O     O
and            : O     O
multiplex      : O     O
ligation-dependent: O     O
probe          : O     O
amplification. : O     O
Word           ||True ||Pred
==============================
a              : O     O
novel          : O     O
point          : O     O
mutation       : O     O
in             : O     O
helix          : O     O
11             : O     O
of             : O     O
the            : O     O
ligand-binding : O     O
domain         : O     O
of             : O     O
the            : O     O
human          : O     O
glucocorticoid : O     O
receptor       : O     O
gene           : O     O
causing        : O     O
generalized    : O     O
glucocorticoid : O     O
resistance.    : O     O
Word           ||True ||Pred
==============================
objectives:    : O     O
dystonia       : O     O
is             : O     O
a              : O     O
common         : O     O
movement       : O     O
disorder.      : O     O
Word           ||True ||Pred
==============================
congenital     : O     O
disorder       : O     O
of             : O     O
glycosylation  : O     O
ic             : O     O
due            : O     O
to             : O     O
a              : O     O
de             : O     O
novo           : O     O
deletion       : O     O
and            : O     O
an             : O     O
halg-6         : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
a              : O     O
single         : O     O
nucleotide     : O     O
polymorphism   : O     O
in             : O     O
the            : O     O
5'-            : O     O
untranslated   : O     O
region         : O     O
of             : O     O
rad51          : O     O
(a             : O     O
g              : O     O
to             : O     O
c              : O     O
substitution   : O     O
at             : O     O
position       : O     O
135,           : O     O
the            : O     O
g/c            : O     O
polymorphism)  : O     O
is             : O     O
reported       : O     O
to             : O     O
modulate       : O     O
breast         : O     O
cancer         : O     O
risk.          : O     O
Word           ||True ||Pred
==============================
the            : O     O
screen         : O     O
included       : O     O
303            : O     O
affected       : O     O
men            : O     O
from           : O     O
136            : O     O
caucasian      : O     O
families,      : O     O
of             : O     O
which          : O     O
45             : O     O
met            : O     O
the            : O     O
criteria       : O     O
for            : O     O
hereditary     : O     O
prostate       : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
we             : O     O
show           : O     O
that           : O     O
the            : O     O
corresponding  : O     O
mutations      : O     O
in             : O     O
mouse          : O     O
adam12         : O     O
inhibit        : O     O
the            : O     O
proteolytic    : O     O
processing     : O     O
and            : O     O
activation     : O     O
of             : O     O
adam12         : O     O
in             : O     O
nih3t3,        : O     O
cos-7,         : O     O
cho-k1         : O     O
cells          : O     O
and            : O     O
in             : O     O
mcf-7          : O     O
breast         : O     O
cancer         : O     O
cells.         : O     O
Word           ||True ||Pred
==============================
a              : O     O
novel          : O     O
insertion      : O     O
mutation       : O     O
in             : O     O
the            : O     O
sedl           : O     O
gene           : O     O
results        : O     O
in             : O     O
x-linked       : O     O
spondyloepiphyseal: O     O
dysplasia      : O     O
tarda          : O     O
in             : O     O
a              : O     O
large          : O     O
chinese        : O     O
pedigree.      : O     O
Word           ||True ||Pred
==============================
among          : O     O
nash           : O     O
patients,      : O     O
body           : O     O
mass           : O     O
index          : O     O
was            : O     O
significantly  : O     O
lower          : O     O
(p<0.05),      : O     O
and            : O     O
non-obese      : O     O
patients       : O     O
were           : O     O
significantly  : O     O
more           : O     O
frequent       : O     O
(p<0.001)      : O     O
in             : O     O
carriers       : O     O
of             : O     O
val175met      : O     O
variant        : O     O
than           : O     O
in             : O     O
homozygotes    : O     O
of             : O     O
wild           : O     O
type           : O     O
pemt.          : O     O
Word           ||True ||Pred
==============================
to             : O     O
study          : O     O
the            : O     O
combined       : O     O
effect         : O     O
of             : O     O
ts             : O     O
polymorphisms, : O     O
four           : O     O
categories     : O     O
were           : O     O
defined        : O     O
accordingly    : O     O
to             : O     O
the            : O     O
level          : O     O
of             : O     O
expression     : O     O
attributed     : O     O
to             : O     O
snp            : O     O
and            : O     O
ins/del        : O     O
6              : O     O
bp             : O     O
genotypes:     : O     O
c_allele       : O     O
6-,            : O     O
c_6+/6+,       : O     O
g_allele6-     : O     O
and            : O     O
g_6+/6+.       : O     O
Word           ||True ||Pred
==============================
the            : O     O
novel          : O     O
variant        : O     O
e233g          : O     O
in             : O     O
rad51d         : O     O
is             : O     O
more           : O     O
highly         : O     O
represented    : O     O
in             : O     O
high-risk,     : O     O
site-specific, : O     O
familial       : O     O
breast         : O     O
cancer         : O     O
cases          : O     O
that           : O     O
are            : O     O
not            : O     O
associated     : O     O
with           : O     O
the            : O     O
brca1/2        : O     O
genes,         : O     O
with           : O     O
a              : O     O
frequency      : O     O
of             : O     O
5.74%          : O     O
(n             : O     O
=              : O     O
174)           : O     O
compared       : O     O
to             : O     O
a              : O     O
control        : O     O
population     : O     O
(n             : O     O
=              : O     O
567)           : O     O
and            : O     O
another        : O     O
subset         : O     O
of             : O     O
breast         : O     O
cancer         : O     O
patients       : O     O
(n             : O     O
=              : O     O
765)           : O     O
with           : O     O
a              : O     O
prevalence     : O     O
of             : O     O
around         : O     O
2%             : O     O
only           : O     O
(comparison    : O     O
to             : O     O
controls,      : O     O
or             : O     O
=              : O     O
2.6,           : O     O
95%            : O     O
ci             : O     O
1.12-6.03;     : O     O
p              : O     O
<              : O     O
0.021).        : O     O
Word           ||True ||Pred
==============================
mthfr          : O     O
c677t          : O     O
polymorphism   : O     O
in             : O     O
the            : O     O
3              : O     O
groups         : O     O
was            : O     O
determined     : O     O
by             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
and            : O     O
restriction    : O     O
fragment       : O     O
length         : O     O
polymorphism   : O     O
studies.       : O     O
Word           ||True ||Pred
==============================
our            : O     O
data           : O     O
suggest        : O     O
that           : O     O
stress         : O     O
kinase         : O     O
signaling      : O     O
and            : O     O
nuclear        : O     O
export         : O     O
regulate       : O     O
ar             : O     O
transcriptional: O     O
activity..     : O     O
Word           ||True ||Pred
==============================
in             : O     O
patch          : O     O
clamp          : O     O
experiments    : O     O
the            : O     O
splice         : O     O
mutant         : O     O
did            : O     O
not            : O     O
generate       : O     O
herg           : O     O
current.       : O     O
Word           ||True ||Pred
==============================
genomic        : O     O
alterations    : O     O
of             : O     O
the            : O     O
wilms'         : O     O
tumor          : O     O
1              : O     O
(wt1)          : O     O
gene           : O     O
have           : O     O
been           : O     O
reported       : O     O
to             : O     O
occur          : O     O
in             : O     O
patients       : O     O
with           : O     O
acute          : O     O
myeloid        : O     O
leukemia       : O     O
(aml).         : O     O
Word           ||True ||Pred
==============================
germline       : O     O
mutations      : O     O
in             : O     O
tumour         : O     O
suppressor     : O     O
p16            : O     O
gene           : O     O
have           : O     O
been           : O     O
implicated     : O     O
as             : O     O
disease        : O     O
causing        : O     O
mutations      : O     O
in             : O     O
some           : O     O
of             : O     O
the            : O     O
melanoma       : O     O
families.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
candidate      : O     O
prostate       : O     O
cancer         : O     O
gene           : O     O
elac2          : O     O
encodes        : O     O
trna           : O     O
3'             : O     O
processing     : O     O
endoribonuclease: O     O
(trnase        : O     O
zl).           : O     O
Word           ||True ||Pred
==============================
analysis       : O     O
of             : O     O
cultured       : O     O
fibroblasts    : O     O
revealed       : O     O
minimal        : O     O
residual       : O     O
hprt           : O     O
activity       : O     O
mainly         : O     O
when           : O     O
guanine        : O     O
was            : O     O
the            : O     O
substrate.     : O     O
Word           ||True ||Pred
==============================
quantitative   : O     O
microsatellite : O     O
analysis       : O     O
revealed       : O     O
loh            : O     O
10q            : O     O
in             : O     O
41             : O     O
of             : O     O
59             : O     O
(69%)          : O     O
glioblastomas. : O     O
Word           ||True ||Pred
==============================
a              : O     O
significant    : O     O
association    : O     O
was            : O     O
also           : O     O
observed       : O     O
between        : O     O
subjects       : O     O
carrying       : O     O
the            : O     O
rs8099917      : Mut   O
tt             : O     O
responder      : O     O
genotype       : O     O
and            : O     O
higher         : O     O
levels         : O     O
of             : O     O
apob-100       : O     O
(p             : O     O
=              : O     O
6.4            : O     O
10(-3))        : O     O
and            : O     O
ldl            : O     O
cholesterol    : O     O
(p             : O     O
=              : O     O
4.2            : O     O
10(-3)).       : O     O
Word           ||True ||Pred
==============================
ethnic         : O     O
background     : O     O
is             : O     O
known          : O     O
to             : O     O
determine      : O     O
both           : O     O
the            : O     O
frequency      : O     O
and            : O     O
the            : O     O
nature         : O     O
of             : O     O
germline       : O     O
alterations.   : O     O
Word           ||True ||Pred
==============================
therefore,     : O     O
genotype-phenotype: O     O
relationships  : O     O
in             : O     O
rdeb           : O     O
cannot         : O     O
be             : O     O
explained      : O     O
purely         : O     O
by             : O     O
the            : O     O
position       : O     O
of             : O     O
ptc..          : O     O
Word           ||True ||Pred
==============================
in             : O     O
contrast,      : O     O
the            : O     O
r462q          : O     O
variant,       : O     O
previously     : O     O
implicated     : O     O
in             : O     O
up             : O     O
to             : O     O
13%            : O     O
of             : O     O
unselected     : O     O
prostate       : O     O
cancer         : O     O
cases,         : O     O
bound          : O     O
2-5a           : O     O
at             : O     O
wild-type      : O     O
levels         : O     O
but            : O     O
had            : O     O
a              : O     O
3-fold         : O     O
decrease       : O     O
in             : O     O
rnase          : O     O
activity.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
aim            : O     O
of             : O     O
the            : O     O
present        : O     O
study          : O     O
was            : O     O
to             : O     O
investigate    : O     O
the            : O     O
possible       : O     O
links          : O     O
between        : O     O
-1082(g/a)     : O     O
polymorphism   : O     O
of             : O     O
the            : O     O
il-10          : O     O
gene           : O     O
and            : O     O
the            : O     O
generalized    : O     O
form           : O     O
of             : O     O
aggressive     : O     O
periodontitis. : O     O
Word           ||True ||Pred
==============================
contrary       : O     O
to             : O     O
our            : O     O
initial        : O     O
assumption     : O     O
of             : O     O
a              : O     O
single         : O     O
allele         : O     O
segregating    : O     O
in             : O     O
this           : O     O
small          : O     O
community,     : O     O
three          : O     O
different      : O     O
pathogenic     : O     O
alleles        : O     O
were           : O     O
observed,      : O     O
with           : O     O
a              : O     O
putative       : O     O
founder        : O     O
mutation       : O     O
occurring      : O     O
at             : O     O
the            : O     O
homozygous     : O     O
state          : O     O
but            : O     O
also           : O     O
compounding    : O     O
with,          : O     O
and            : O     O
thus           : O     O
revealing,     : O     O
two            : O     O
other          : O     O
independent    : O     O
mutations.     : O     O
Word           ||True ||Pred
==============================
genotype       : O     O
analysis       : O     O
was            : O     O
conducted      : O     O
by             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
(pcr)          : O     O
and            : O     O
then           : O     O
dna            : O     O
direct         : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
the            : O     O
five           : O     O
single-base    : O     O
substitutions  : O     O
and            : O     O
the            : O     O
ttat           : O     O
insertion      : O     O
were           : O     O
identified     : O     O
only           : O     O
with           : O     O
3'             : O     O
downstream     : O     O
of             : O     O
vwa            : O     O
allele         : O     O
14..           : O     O
Word           ||True ||Pred
==============================
it             : O     O
progresses     : O     O
to             : O     O
profound       : O     O
deafness       : O     O
at             : O     O
all            : O     O
frequencies    : O     O
by             : O     O
the            : O     O
fourth         : O     O
or             : O     O
fifth          : O     O
decade.        : O     O
Word           ||True ||Pred
==============================
background:    : O     O
psoriasis      : O     O
is             : O     O
a              : O     O
common         : O     O
dermatological : O     O
disorder,      : O     O
in             : O     O
which          : O     O
autoimmunity   : O     O
plays          : O     O
an             : O     O
important      : O     O
role.          : O     O
Word           ||True ||Pred
==============================
p434l          : O     O
and            : O     O
v647           : O     O
were           : O     O
both           : O     O
novel,         : O     O
rare           : O     O
variants.      : O     O
Word           ||True ||Pred
==============================
these          : O     O
data           : O     O
indicate       : O     O
the            : O     O
probable       : O     O
molecular      : O     O
mechanism      : O     O
whereby        : O     O
aa             : O     O
causes         : O     O
urothelial     : O     O
malignancy..   : O     O
Word           ||True ||Pred
==============================
the            : O     O
allele         : O     O
ratio          : O     O
in             : O     O
lymphocytes    : O     O
was            : O     O
consistent     : O     O
with           : O     O
a              : O     O
mosaic         : O     O
where          : O     O
about          : O     O
2/3            : O     O
of             : O     O
cells          : O     O
carried        : O     O
two            : O     O
normal         : O     O
alleles        : O     O
and            : O     O
only           : O     O
1/3            : O     O
was            : O     O
heterozygous   : O     O
for            : O     O
the            : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
in             : O     O
silico         : O     O
analysis       : O     O
predicted      : O     O
a              : O     O
new            : O     O
cryptic        : O     O
splice         : O     O
site           : O     O
downstream     : O     O
of             : O     O
the            : O     O
original       : O     O
position       : O     O
generating     : O     O
a              : O     O
10-base        : O     O
deletion       : O     O
from           : O     O
the            : O     O
beginning      : O     O
of             : O     O
exon           : O     O
12;            : O     O
(c.1706-1715del.atctcctcag).: O     O
Word           ||True ||Pred
==============================
two            : O     O
sequence       : O     O
variants       : O     O
were           : O     O
identified     : O     O
in             : O     O
mlh1.          : O     O
Word           ||True ||Pred
==============================
three          : O     O
patients       : O     O
with           : O     O
the            : O     O
triple         : O     O
polymerase     : O     O
substitution   : O     O
pattern        : O     O
(rtv173l       : O     O
+              : O     O
rtl180m        : O     O
+              : O     O
rtm204v)       : O     O
had            : O     O
associated     : O     O
changes        : O     O
in             : O     O
the            : O     O
envelope       : O     O
gene           : O     O
(se164d        : O     O
+              : O     O
si195m).       : O     O
Word           ||True ||Pred
==============================
however,       : O     O
the            : O     O
mutant         : O     O
did            : O     O
not            : O     O
respond        : O     O
specifically   : O     O
to             : O     O
increased      : O     O
levels         : O     O
of             : O     O
fkbp52,        : O     O
suggesting     : O     O
that           : O     O
this           : O     O
chaperone      : O     O
functions      : O     O
at             : O     O
the            : O     O
hormone-dependent: O     O
activation     : O     O
stage          : O     O
in             : O     O
the            : O     O
folding        : O     O
process.       : O     O
Word           ||True ||Pred
==============================
base           : O     O
pair           : O     O
changes        : O     O
in             : O     O
sox2           : O     O
and            : O     O
chx10          : O     O
were           : O     O
confirmed      : O     O
by             : O     O
sequencing     : O     O
bidirectionally: O     O
in             : O     O
patient        : O     O
samples.       : O     O
Word           ||True ||Pred
==============================
furthermore,   : O     O
the            : O     O
number         : O     O
of             : O     O
the            : O     O
casp8          : O     O
-652           : O     O
6n             : O     O
del            : O     O
(but           : O     O
not            : O     O
302h)          : O     O
variant        : O     O
allele         : O     O
tended         : O     O
to             : O     O
correlate      : O     O
with           : O     O
increased      : O     O
levels         : O     O
of             : O     O
camptothecin-induced: O     O
p53-mediated   : O     O
apoptosis      : O     O
in             : O     O
t              : O     O
lymphocytes    : O     O
from           : O     O
170            : O     O
cancer-free    : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
majority       : O     O
of             : O     O
controls       : O     O
were           : O     O
in             : O     O
hardy          : O     O
weinberg       : O     O
equilibrium.   : O     O
Word           ||True ||Pred
==============================
new            : O     O
mutations,     : O     O
hotspots,      : O     O
and            : O     O
founder        : O     O
effects        : O     O
in             : O     O
brazilian      : O     O
patients       : O     O
with           : O     O
steroid        : O     O
5alpha-reductase: O     O
deficiency     : O     O
type           : O     O
2.             : O     O
Word           ||True ||Pred
==============================
the            : O     O
h391r          : O     O
substitution   : O     O
in             : O     O
the            : O     O
e2             : O     O
subunit        : O     O
abolishes      : O     O
the            : O     O
key            : O     O
catalytic      : O     O
residue        : O     O
that           : O     O
functions      : O     O
as             : O     O
a              : O     O
general        : O     O
base           : O     O
in             : O     O
the            : O     O
acyltransfer   : O     O
reaction,      : O     O
resulting      : O     O
in             : O     O
a              : O     O
completely     : O     O
inactive       : O     O
e2             : O     O
component.     : O     O
Word           ||True ||Pred
==============================
the            : O     O
heterozygosity : O     O
of             : O     O
the            : O     O
region         : O     O
was            : O     O
0.897.         : O     O
Word           ||True ||Pred
==============================
using          : O     O
denaturing     : O     O
high-pressure  : O     O
liquid         : O     O
chromatography : O     O
and            : O     O
sequencing,    : O     O
we             : O     O
screened       : O     O
peripheral     : O     O
blood          : O     O
dna            : O     O
from           : O     O
184            : O     O
familial       : O     O
melanoma       : O     O
cases          : O     O
for            : O     O
braf           : O     O
promoter       : O     O
variants.      : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
to             : O     O
begin          : O     O
to             : O     O
determine      : O     O
whether        : O     O
mutations      : O     O
in             : O     O
up             : O     O
genes          : O     O
might          : O     O
play           : O     O
a              : O     O
role           : O     O
in             : O     O
human          : O     O
vur,           : O     O
we             : O     O
genotyped      : O     O
all            : O     O
four           : O     O
up             : O     O
genes          : O     O
in             : O     O
76             : O     O
patients       : O     O
with           : O     O
radiologically : O     O
proven         : O     O
primary        : O     O
vur            : O     O
by             : O     O
polymerase     : O     O
chain          : O     O
reaction       : O     O
(pcr)          : O     O
amplification  : O     O
and            : O     O
sequencing     : O     O
of             : O     O
all            : O     O
their          : O     O
exons          : O     O
plus           : O     O
50             : O     O
to             : O     O
150            : O     O
bp             : O     O
of             : O     O
flanking       : O     O
intronic       : O     O
sequences.     : O     O
Word           ||True ||Pred
==============================
results:       : O     O
we             : O     O
identified     : O     O
the            : O     O
unclassified   : O     O
variant        : O     O
s384f          : O     O
in             : O     O
three          : O     O
of             : O     O
the            : O     O
four           : O     O
breast         : O     O
cancer         : O     O
patients       : O     O
(the           : O     O
three          : O     O
were           : O     O
diagnosed      : O     O
at             : O     O
41,            : O     O
43             : O     O
and            : O     O
57             : O     O
years          : O     O
of             : O     O
age).          : O     O
Word           ||True ||Pred
==============================
introduction:  : O     O
il-17f         : O     O
is             : O     O
a              : O     O
novel          : O     O
inflammatory   : O     O
cytokine       : O     O
and            : O     O
plays          : O     O
an             : O     O
important      : O     O
role           : O     O
in             : O     O
some           : O     O
autoimmune     : O     O
diseases.      : O     O
Word           ||True ||Pred
==============================
its            : O     O
associated     : O     O
nephropathy    : O     O
is             : O     O
an             : O     O
important      : O     O
cause          : O     O
of             : O     O
end-stage      : O     O
renal          : O     O
failure        : O     O
in             : O     O
children       : O     O
and            : O     O
adults.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
slower         : O     O
progression    : O     O
of             : O     O
hearing        : O     O
loss           : O     O
associated     : O     O
with           : O     O
p.d572h,       : O     O
in             : O     O
comparison     : O     O
with           : O     O
that           : O     O
caused         : O     O
by             : O     O
p.d572n,       : O     O
may            : O     O
reflect        : O     O
a              : O     O
correlation    : O     O
of             : O     O
dfna36         : O     O
phenotype      : O     O
with           : O     O
tmc1           : O     O
genotype..     : O     O
Word           ||True ||Pred
==============================
our            : O     O
sixth          : O     O
helical        : O     O
glycine        : O     O
substitution   : O     O
extends        : O     O
the            : O     O
mutational     : O     O
spectrum       : O     O
and            : O     O
genotype/phenotype: O     O
correlations   : O     O
of             : O     O
strudwick-type : O     O
semd..         : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
we             : O     O
analyzed       : O     O
186            : O     O
individuals    : O     O
with           : O     O
spontaneous    : O     O
hcv            : O     O
clearance,     : O     O
501            : O     O
chronically    : O     O
hcv            : O     O
infected       : O     O
patients,      : O     O
and            : O     O
217            : O     O
healthy        : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
six            : O     O
participants   : O     O
demonstrated   : O     O
lcd1           : O     O
in             : O     O
both           : O     O
eyes,          : O     O
most           : O     O
of             : O     O
whom           : O     O
were           : O     O
symmetric.     : O     O
Word           ||True ||Pred
==============================
titration      : O     O
studies        : O     O
showed         : O     O
that           : O     O
the            : O     O
assay          : O     O
could          : O     O
reliably       : O     O
detect         : O     O
one            : O     O
copy           : O     O
of             : O     O
the            : O     O
mutant         : O     O
allele         : O     O
in             : O     O
a              : O     O
mix            : O     O
of             : O     O
100            : O     O
wild-type      : O     O
alleles.       : O     O
Word           ||True ||Pred
==============================
we             : O     O
identified     : O     O
two            : O     O
new            : O     O
sequence       : O     O
variations:    : O     O
(i)            : O     O
a              : O     O
deletion       : O     O
causing        : O     O
a              : O     O
frameshift     : O     O
(c.69delc)     : O     O
and            : O     O
(ii)           : O     O
a              : O     O
nucleotide     : O     O
substitution   : O     O
determining    : O     O
a              : O     O
splice         : O     O
site           : O     O
mutation       : O     O
(c.410+5       : O     O
g/a)           : O     O
by             : O     O
predictive     : O     O
analysis.      : O     O
Word           ||True ||Pred
==============================
molecular      : O     O
study          : O     O
may            : O     O
help           : O     O
differentiating: O     O
these          : O     O
abnormalities  : O     O
with           : O     O
precision.     : O     O
Word           ||True ||Pred
==============================
results:       : O     O
all            : O     O
subjects       : O     O
studied        : O     O
were           : O     O
free           : O     O
from           : O     O
c282y          : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
genotype       : O     O
frequencies    : O     O
of             : O     O
the            : O     O
g472a          : O     O
snp            : O     O
varied         : O     O
significantly  : O     O
(p             : O     O
=              : O     O
0.029)         : O     O
among          : O     O
the            : O     O
three          : O     O
main           : O     O
ethnic/cultural: O     O
groups         : O     O
(caucasians,   : O     O
hispanics,     : O     O
and            : O     O
african        : O     O
americans).    : O     O
Word           ||True ||Pred
==============================
there          : O     O
were           : O     O
no             : O     O
significant    : O     O
differences    : O     O
in             : O     O
positive       : O     O
and            : O     O
negative       : O     O
symptom        : O     O
scale          : O     O
(panss)        : O     O
items          : O     O
and            : O     O
global         : O     O
assessment     : O     O
of             : O     O
functioning    : O     O
(gaf)          : O     O
scores         : O     O
between        : O     O
the            : O     O
patients       : O     O
with           : O     O
c/c            : O     O
and            : O     O
c/t            : O     O
genotypes.     : O     O
Word           ||True ||Pred
==============================
results:       : O     O
compared       : O     O
with           : O     O
the            : O     O
control        : O     O
group,         : O     O
patients       : O     O
with           : O     O
chronic        : O     O
itp            : O     O
had            : O     O
a              : O     O
significantly  : O     O
lower          : O     O
frequency      : O     O
of             : O     O
the            : O     O
il-17f         : O     O
7488cc         : O     O
genotype       : O     O
(0%            : O     O
vs.            : O     O
Word           ||True ||Pred
==============================
single-stranded: O     O
conformational : O     O
polymorphism   : O     O
and            : O     O
sequencing     : O     O
analyses       : O     O
revealed       : O     O
ar             : O     O
missense       : O     O
mutations      : O     O
in             : O     O
29%            : O     O
(4/14)         : O     O
of             : O     O
the            : O     O
primary        : O     O
tumors         : O     O
and            : O     O
in             : O     O
one            : O     O
(14%)          : O     O
metastasis.    : O     O
Word           ||True ||Pred
==============================
a              : O     O
patient        : O     O
of             : O     O
chinese        : O     O
origin         : O     O
with           : O     O
ambiguous      : O     O
genitalia      : O     O
at             : O     O
14             : O     O
months,        : O     O
a              : O     O
46,xy          : O     O
karyotype,     : O     O
and            : O     O
normal         : O     O
t              : O     O
secretion      : O     O
under          : O     O
human          : O     O
chorionic      : O     O
gonadotropin   : O     O
(hcg)          : O     O
stimulation    : O     O
underwent      : O     O
a              : O     O
gonadectomy    : O     O
at             : O     O
20             : O     O
months.        : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
this           : O     O
study          : O     O
included       : O     O
133            : O     O
patients       : O     O
with           : O     O
avsd           : O     O
and            : O     O
200            : O     O
healthy        : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
statistical    : O     O
analysis       : O     O
was            : O     O
performed      : O     O
for            : O     O
the            : O     O
combined       : O     O
g1359a         : O     O
and            : O     O
a1359a         : O     O
as             : O     O
a              : O     O
group          : O     O
and            : O     O
wild           : O     O
type           : O     O
g1359g         : O     O
as             : O     O
second         : O     O
group,         : O     O
with           : O     O
a              : O     O
dominant       : O     O
model.         : O     O
Word           ||True ||Pred
==============================
to             : O     O
prepare        : O     O
a              : O     O
vaccine        : O     O
candidate,     : O     O
a              : O     O
previously     : O     O
described      : O     O
30             : O     O
nucleotide     : O     O
deletion       : O     O
(delta30)      : O     O
in             : O     O
the            : O     O
3'             : O     O
untranslated   : O     O
region         : O     O
of             : O     O
den-4          : O     O
has            : O     O
been           : O     O
engineered     : O     O
into           : O     O
the            : O     O
den-2          : O     O
isolate.       : O     O
Word           ||True ||Pred
==============================
these          : O     O
studies        : O     O
suggest        : O     O
that           : O     O
large          : O     O
gene           : O     O
deletions      : O     O
may            : O     O
account        : O     O
for            : O     O
up             : O     O
to             : O     O
5%             : O     O
of             : O     O
the            : O     O
mutant         : O     O
alleles        : O     O
in             : O     O
sls.           : O     O
Word           ||True ||Pred
==============================
a              : O     O
3-year-old     : O     O
chinese        : O     O
boy            : O     O
presented      : O     O
with           : O     O
prominent      : O     O
clinical       : O     O
features       : O     O
of             : O     O
malonic        : O     O
aciduria,      : O     O
including      : O     O
developmental  : O     O
delay,         : O     O
short          : O     O
stature,       : O     O
brain          : O     O
abnormalities  : O     O
and            : O     O
massive        : O     O
excretion      : O     O
of             : O     O
malonic        : O     O
acid           : O     O
and            : O     O
methylmalonic  : O     O
acid.          : O     O
Word           ||True ||Pred
==============================
mono-allelic   : O     O
polg           : O     O
expression     : O     O
resulting      : O     O
from           : O     O
nonsense-mediated: O     O
decay          : O     O
and            : O     O
alternative    : O     O
splicing       : O     O
in             : O     O
a              : O     O
patient        : O     O
with           : O     O
alpers         : O     O
syndrome.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
third          : O     O
mutation,      : O     O
a              : O     O
previously     : O     O
identified     : O     O
15-bp          : O     O
deletion       : O     O
that           : O     O
included       : O     O
the            : O     O
3'             : O     O
splice         : O     O
site           : O     O
for            : O     O
exon           : O     O
7,             : O     O
was            : O     O
found          : O     O
in             : O     O
all            : O     O
nine           : O     O
patients,      : O     O
with           : O     O
six            : O     O
patients       : O     O
carrying       : O     O
the            : O     O
deletion       : O     O
in             : O     O
the            : O     O
homozygous     : O     O
state.         : O     O
Word           ||True ||Pred
==============================
resistance     : O     O
of             : O     O
mcf7           : O     O
human          : O     O
breast         : O     O
carcinoma      : O     O
cells          : O     O
to             : O     O
tnf-induced    : O     O
cell           : O     O
death          : O     O
is             : O     O
associated     : O     O
with           : O     O
loss           : O     O
of             : O     O
p53            : O     O
function.      : O     O
Word           ||True ||Pred
==============================
the            : O     O
development    : O     O
of             : O     O
antibodies     : O     O
reflects       : O     O
a              : O     O
loss           : O     O
of             : O     O
tolerance      : O     O
to             : O     O
intestinal     : O     O
bacteria       : O     O
that           : O     O
underlies      : O     O
crohn's        : O     O
disease,       : O     O
resulting      : O     O
in             : O     O
an             : O     O
exaggerated    : O     O
adaptive       : O     O
immune         : O     O
response       : O     O
to             : O     O
these          : O     O
bacteria.      : O     O
Word           ||True ||Pred
==============================
furthermore,   : O     O
patients       : O     O
with           : O     O
the            : O     O
il-17f         : O     O
7488tt         : O     O
genotype       : O     O
showed         : O     O
a              : O     O
severe         : O     O
thrombocytopenic: O     O
state          : O     O
(platelet      : O     O
count<10       : O     O
10(9)          : O     O
/l)            : O     O
at             : O     O
diagnosis      : O     O
than           : O     O
those          : O     O
with           : O     O
the            : O     O
il-17f         : O     O
7488tc         : O     O
genotype       : O     O
(20.9%         : O     O
vs.            : O     O
Word           ||True ||Pred
==============================
up             : O     O
to             : O     O
date,          : O     O
a              : O     O
total          : O     O
of             : O     O
four           : O     O
mutations      : O     O
in             : O     O
dfna5          : O     O
have           : O     O
been           : O     O
reported       : O     O
to             : O     O
lead           : O     O
to             : O     O
hearing        : O     O
impairment,    : O     O
all            : O     O
of             : O     O
them           : O     O
result         : O     O
in             : O     O
skipping       : O     O
of             : O     O
exon           : O     O
8              : O     O
at             : O     O
the            : O     O
mrna           : O     O
level.         : O     O
Word           ||True ||Pred
==============================
desmin-related : O     O
myopathies     : O     O
(drms)         : O     O
are            : O     O
a              : O     O
heterogeneous  : O     O
group          : O     O
of             : O     O
muscle         : O     O
disorders,     : O     O
morphologically: O     O
defined        : O     O
by             : O     O
intrasarcoplasmic: O     O
aggregates     : O     O
of             : O     O
desmin.        : O     O
Word           ||True ||Pred
==============================
this           : O     O
resulted       : O     O
in             : O     O
a              : O     O
silent         : O     O
change         : O     O
at             : O     O
codon          : O     O
34             : O     O
of             : O     O
the            : O     O
mature         : O     O
protein.       : O     O
Word           ||True ||Pred
==============================
as             : O     O
all            : O     O
three          : O     O
mutations      : O     O
predict        : O     O
truncation     : O     O
of             : O     O
the            : O     O
dll3           : O     O
protein        : O     O
and            : O     O
loss           : O     O
of             : O     O
the            : O     O
membrane-attaching: O     O
domain,        : O     O
the            : O     O
results        : O     O
confirm        : O     O
that           : O     O
autosomal      : O     O
recessive      : O     O
spondylocostal : O     O
dysostosis     : O     O
represents     : O     O
the            : O     O
null           : O     O
phenotype      : O     O
of             : O     O
dll3,          : O     O
with           : O     O
remarkable     : O     O
phenotypic     : O     O
consistency    : O     O
across         : O     O
families..     : O     O
Word           ||True ||Pred
==============================
inner          : O     O
medullar       : O     O
collecting     : O     O
duct           : O     O
(imcd)         : O     O
cells          : O     O
transfected    : O     O
with           : O     O
the            : O     O
mutant         : O     O
pkd2           : O     O
mouse          : O     O
gene           : O     O
presented      : O     O
a              : O     O
perinuclear    : O     O
and            : O     O
diffuse        : O     O
cytoplasmic    : O     O
localization   : O     O
compared       : O     O
with           : O     O
the            : O     O
wild           : O     O
type           : O     O
er             : O     O
localization.  : O     O
Word           ||True ||Pred
==============================
the            : O     O
frequency      : O     O
of             : O     O
this           : O     O
haplotype      : O     O
in             : O     O
the            : O     O
general        : O     O
african        : O     O
american       : O     O
population     : O     O
is             : O     O
<0.003.        : O     O
Word           ||True ||Pred
==============================
microsatellite : O     O
dna            : O     O
markers        : O     O
flanking       : O     O
the            : O     O
sma            : O     O
locus          : O     O
revealed       : O     O
the            : O     O
occurrence     : O     O
of             : O     O
the            : O     O
4-bp           : O     O
deletion       : O     O
in             : O     O
the            : O     O
background     : O     O
of             : O     O
the            : O     O
same           : O     O
haplotype,     : O     O
suggesting     : O     O
that           : O     O
a              : O     O
single         : O     O
mutational     : O     O
event          : O     O
was            : O     O
involved       : O     O
in             : O     O
the            : O     O
10             : O     O
families.      : O     O
Word           ||True ||Pred
==============================
in             : O     O
1982,          : O     O
one            : O     O
of             : O     O
us             : O     O
reported       : O     O
a              : O     O
cluster        : O     O
of             : O     O
eight          : O     O
individuals    : O     O
affected       : O     O
by             : O     O
spondylocostal : O     O
dysostosis     : O     O
(sd,           : O     O
mim            : O     O
277300)        : O     O
in             : O     O
four           : O     O
nuclear        : O     O
families       : O     O
indigenous     : O     O
to             : O     O
a              : O     O
village        : O     O
from           : O     O
eastern        : O     O
switzerland.   : O     O
Word           ||True ||Pred
==============================
the            : O     O
relationship   : O     O
between        : O     O
the            : O     O
nucleotide     : O     O
change         : O     O
and            : O     O
the            : O     O
protein        : O     O
function       : O     O
is             : O     O
indeterminate. : O     O
Word           ||True ||Pred
==============================
this           : O     O
mutation       : O     O
was            : O     O
responsible    : O     O
for            : O     O
the            : O     O
familial       : O     O
disorder       : O     O
through        : O     O
the            : O     O
substitution   : O     O
of             : O     O
a              : O     O
highly         : O     O
conserved      : O     O
arginine       : O     O
to             : O     O
tryptophan     : O     O
at             : O     O
codon          : O     O
198            : O     O
(p.r198w).     : O     O
Word           ||True ||Pred
==============================
given          : O     O
the            : O     O
geographical   : O     O
conformation   : O     O
of             : O     O
this           : O     O
region,        : O     O
which          : O     O
is             : O     O
neither        : O     O
geographically : O     O
or             : O     O
culturally     : O     O
isolated,      : O     O
a              : O     O
recent         : O     O
origin         : O     O
of             : O     O
the            : O     O
mutation       : O     O
could          : O     O
be             : O     O
hypothesized.. : O     O
Word           ||True ||Pred
==============================
we             : O     O
progressively  : O     O
screened       : O     O
dna            : O     O
samples        : O     O
from           : O     O
613            : O     O
individuals    : O     O
with           : O     O
id             : O     O
initially      : O     O
for            : O     O
the            : O     O
most           : O     O
frequent       : O     O
arx            : O     O
mutations      : O     O
(c.304ins(gcg)(7)'expansion': O     O
of             : O     O
pa1            : O     O
and            : O     O
c.429_452dup   : Mut   O
'dup24bp'      : O     O
of             : O     O
pa2).          : O     O
Word           ||True ||Pred
==============================
individuals    : O     O
homozygous     : O     O
for            : O     O
the            : O     O
-866           : O     O
a              : O     O
allele         : O     O
had            : O     O
decreased      : O     O
adipose        : O     O
mrna           : O     O
levels         : O     O
relative       : O     O
to             : O     O
gg             : O     O
homozygous     : O     O
individuals    : O     O
(p             : O     O
=              : O     O
0.009),        : O     O
but            : O     O
the            : O     O
3'utr          : O     O
i/d            : O     O
variant        : O     O
had            : O     O
no             : O     O
impact         : O     O
on             : O     O
mrna           : O     O
levels.        : O     O
Word           ||True ||Pred
==============================
background/objectives:: O     O
histamine      : O     O
has            : O     O
been           : O     O
implicated     : O     O
in             : O     O
the            : O     O
pathogenesis   : O     O
of             : O     O
migraine.      : O     O
Word           ||True ||Pred
==============================
comparison     : O     O
of             : O     O
the            : O     O
two            : O     O
case           : O     O
subgroups      : O     O
supported      : O     O
this           : O     O
finding        : O     O
(or            : O     O
=              : O     O
2.65,          : O     O
95%            : O     O
ci             : O     O
=              : O     O
1.15           : O     O
to             : O     O
6.09).         : O     O
Word           ||True ||Pred
==============================
in             : O     O
an             : O     O
earlier        : O     O
study          : O     O
we             : O     O
showed         : O     O
that           : O     O
c10orf97       : O     O
(chromosome-10,: O     O
open           : O     O
reading        : O     O
frame-97)      : O     O
was            : O     O
expressed      : O     O
in             : O     O
almost         : O     O
all            : O     O
of             : O     O
the            : O     O
tissues        : O     O
and            : O     O
cell           : O     O
lines          : O     O
tested,        : O     O
and            : O     O
that           : O     O
it             : O     O
inhibited      : O     O
the            : O     O
growth         : O     O
of             : O     O
seven          : O     O
tumor          : O     O
cell           : O     O
lines,         : O     O
including      : O     O
two            : O     O
lung           : O     O
carcinoma      : O     O
cell           : O     O
lines          : O     O
(a549          : O     O
and            : O     O
pg).           : O     O
Word           ||True ||Pred
==============================
furthermore,   : O     O
the            : O     O
g.203a>c       : O     O
substitution   : O     O
altered        : O     O
the            : O     O
specific       : O     O
sequence       : O     O
of             : O     O
the            : O     O
steroid        : O     O
receptor       : O     O
for            : O     O
the            : O     O
glucocorticoid : O     O
nuclear        : O     O
receptor       : O     O
(gr)/transcription: O     O
factor         : O     O
in             : O     O
the            : O     O
pln            : O     O
promoter,      : O     O
resulting      : O     O
in             : O     O
enhanced       : O     O
binding        : O     O
to             : O     O
the            : O     O
mutated        : O     O
dna            : O     O
site.          : O     O
Word           ||True ||Pred
==============================
this           : O     O
mutation       : O     O
was            : O     O
also           : O     O
present        : O     O
in             : O     O
two            : O     O
family         : O     O
members        : O     O
but            : O     O
absent         : O     O
in             : O     O
the            : O     O
other,         : O     O
unaffected     : O     O
family         : O     O
members        : O     O
and            : O     O
the            : O     O
170            : O     O
healthy        : O     O
chinese        : O     O
individuals.   : O     O
Word           ||True ||Pred
==============================
the            : O     O
analysis       : O     O
of             : O     O
the            : O     O
coding         : O     O
sequence       : O     O
of             : O     O
lce3b          : O     O
and            : O     O
lce3c          : O     O
in             : O     O
the            : O     O
patients       : O     O
who            : O     O
had            : O     O
at             : O     O
least          : O     O
one            : O     O
copy           : O     O
of             : O     O
this           : O     O
showed         : O     O
that           : O     O
only           : O     O
one            : O     O
patient        : O     O
has            : O     O
a              : O     O
no             : O     O
previously     : O     O
reported       : O     O
lce3b          : O     O
variant        : O     O
(r68c).        : O     O
Word           ||True ||Pred
==============================
as             : O     O
for            : O     O
piod,          : O     O
the            : O     O
majority       : O     O
of             : O     O
the            : O     O
studied        : O     O
kindreds       : O     O
had            : O     O
only           : O     O
heterozygous   : O     O
mutations      : O     O
and/or         : O     O
polymorphisms. : O     O
Word           ||True ||Pred
==============================
background:    : O     O
mice           : O     O
with           : O     O
defects        : O     O
in             : O     O
the            : O     O
klotho         : O     O
gene           : O     O
exhibit        : O     O
multiple       : O     O
aging          : O     O
phenotypes     : O     O
including      : O     O
arteriosclerosis.: O     O
Word           ||True ||Pred
==============================
the            : O     O
p53            : O     O
protein        : O     O
has            : O     O
become         : O     O
a              : O     O
subject        : O     O
of             : O     O
intense        : O     O
interest       : O     O
since          : O     O
the            : O     O
discovery      : O     O
that           : O     O
about          : O     O
50%            : O     O
of             : O     O
human          : O     O
cancers        : O     O
carry          : O     O
p53            : O     O
mutations.     : O     O
Word           ||True ||Pred
==============================
we             : O     O
performed      : O     O
mutation       : O     O
analysis       : O     O
of             : O     O
the            : O     O
complete       : O     O
coding         : O     O
sequence       : O     O
of             : O     O
the            : O     O
gldc           : O     O
gene           : O     O
in             : O     O
28             : O     O
unrelated      : O     O
patients       : O     O
with           : O     O
neonatal       : O     O
nkh            : O     O
using          : O     O
denaturing     : O     O
high-performance: O     O
liquid         : O     O
chromatography : O     O
(dhplc)        : O     O
and            : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
these          : O     O
data           : O     O
indicate       : O     O
that           : O     O
the            : O     O
cardiac        : O     O
i(f)           : O     O
channels       : O     O
are            : O     O
functionally   : O     O
expressed      : O     O
but            : O     O
with           : O     O
altered        : O     O
biophysical    : O     O
properties.    : O     O
Word           ||True ||Pred
==============================
the            : O     O
v89l           : O     O
polymorphism   : O     O
was            : O     O
found          : O     O
in             : O     O
heterozygosis  : O     O
in             : O     O
one            : O     O
of             : O     O
them           : O     O
(with          : O     O
a207d)         : O     O
and            : O     O
in             : O     O
one            : O     O
case           : O     O
with           : O     O
an             : O     O
otherwise      : O     O
normal         : O     O
gene           : O     O
sequence.      : O     O
Word           ||True ||Pred
==============================
effects        : O     O
of             : O     O
rnase          : O     O
l              : O     O
mutations      : O     O
associated     : O     O
with           : O     O
prostate       : O     O
cancer         : O     O
on             : O     O
apoptosis      : O     O
induced        : O     O
by             : O     O
2',5'-oligoadenylates.: O     O
Word           ||True ||Pred
==============================
nine           : O     O
were           : O     O
index          : O     O
mtc            : O     O
cases,         : O     O
5              : O     O
phaeochromocytoma,: O     O
3              : O     O
hirschsprung's : O     O
disease-men    : O     O
associations   : O     O
and            : O     O
2              : O     O
miscellaneous  : O     O
(1             : O     O
neuroblastoma, : O     O
1              : O     O
intestinal     : O     O
neuronal       : O     O
dysplasia),    : O     O
while          : O     O
1              : O     O
fell           : O     O
into           : O     O
the            : O     O
men2b          : O     O
category.      : O     O
Word           ||True ||Pred
==============================
two            : O     O
of             : O     O
the            : O     O
missense       : O     O
alterations    : O     O
identified     : O     O
(cys557ser     : O     O
and            : O     O
val507met)     : O     O
were           : O     O
recently       : O     O
suggested      : O     O
to             : O     O
associate      : O     O
with           : O     O
an             : O     O
increased      : O     O
breast         : O     O
cancer         : O     O
risk.          : O     O
Word           ||True ||Pred
==============================
somatic        : O     O
truncating     : O     O
gen1           : O     O
mutations      : O     O
have           : O     O
been           : O     O
reported       : O     O
in             : O     O
two            : O     O
breast         : O     O
cancers.       : O     O
Word           ||True ||Pred
==============================
wfs1           : O     O
encoding       : O     O
a              : O     O
transmembrane  : O     O
protein        : O     O
was            : O     O
identified     : O     O
as             : O     O
the            : O     O
gene           : O     O
responsible    : O     O
for            : O     O
wfs.           : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
the            : O     O
single         : O     O
nucleotide     : O     O
polymorphisms  : O     O
(snp)          : O     O
at             : O     O
positions      : O     O
-1123          : O     O
(rs2488457),   : O     O
+1858          : O     O
(rs2476601,    : O     O
the            : O     O
r620w          : O     O
substitution), : O     O
and            : O     O
+2740          : O     O
(rs1217412)    : O     O
were           : O     O
genotyped      : O     O
using          : O     O
taqman         : O     O
assays         : O     O
in             : O     O
372            : O     O
subjects       : O     O
with           : O     O
childhood-onset: O     O
t1d,           : O     O
130            : O     O
subjects       : O     O
with           : O     O
jia,           : O     O
and            : O     O
400            : O     O
control        : O     O
subjects       : O     O
of             : O     O
czech          : O     O
origin,        : O     O
and            : O     O
in             : O     O
160            : O     O
subjects       : O     O
with           : O     O
t1d            : O     O
and            : O     O
271            : O     O
healthy        : O     O
controls       : O     O
of             : O     O
azeri          : O     O
origin.        : O     O
Word           ||True ||Pred
==============================
we             : O     O
report         : O     O
a              : O     O
novel          : O     O
mutation       : O     O
of             : O     O
the            : O     O
irf6           : O     O
gene           : O     O
in             : O     O
a              : O     O
german         : O     O
family.        : O     O
Word           ||True ||Pred
==============================
ectodermal     : O     O
dysplasia-skin : O     O
fragility      : O     O
syndrome       : O     O
resulting      : O     O
from           : O     O
a              : O     O
new            : O     O
homozygous     : O     O
mutation,      : O     O
888delc,       : O     O
in             : O     O
the            : O     O
desmosomal     : O     O
protein        : O     O
plakophilin    : O     O
1.             : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
sequencing     : O     O
of             : O     O
genomic        : O     O
dna            : O     O
from           : O     O
the            : O     O
affected       : O     O
individual     : O     O
and            : O     O
both           : O     O
parents        : O     O
to             : O     O
search         : O     O
for            : O     O
pathogenic     : O     O
mutations      : O     O
in             : O     O
porcn          : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
in             : O     O
conclusion,    : O     O
the            : O     O
beta-thalassaemia: O     O
gene           : O     O
(ivs1-1g       : O     O
>              : O     O
c)             : O     O
was            : O     O
expressed      : O     O
in             : O     O
transfected    : O     O
cells,         : O     O
but            : O     O
showed         : O     O
aberrant       : O     O
rna            : O     O
splicing.      : O     O
Word           ||True ||Pred
==============================
none           : O     O
of             : O     O
the            : O     O
ar             : O     O
mutants        : O     O
differed       : O     O
from           : O     O
wild-type      : O     O
ar             : O     O
(wtar)         : O     O
in             : O     O
their          : O     O
abilities      : O     O
to             : O     O
bind           : O     O
the            : O     O
synthetic      : O     O
androgen       : O     O
methyltrienolone.: O     O
Word           ||True ||Pred
==============================
this           : O     O
pattern        : O     O
and            : O     O
an             : O     O
accompanying   : O     O
rtv173l        : O     O
mutation       : O     O
was            : O     O
found          : O     O
in             : O     O
four           : O     O
patients.      : O     O
Word           ||True ||Pred
==============================
background:    : O     O
vitamin        : O     O
d-binding      : O     O
protein        : O     O
(dbp)          : O     O
is             : O     O
the            : O     O
main           : O     O
systemic       : O     O
transporter    : O     O
of             : O     O
1.25(oh)2d3    : O     O
and            : O     O
is             : O     O
essential      : O     O
for            : O     O
its            : O     O
cellular       : O     O
endocytosis.   : O     O
Word           ||True ||Pred
==============================
brca1          : O     O
is             : O     O
organized      : O     O
in             : O     O
an             : O     O
n-terminal     : O     O
ring-finger    : O     O
domain         : O     O
and            : O     O
two            : O     O
brct           : O     O
(breast        : O     O
cancer         : O     O
c-terminus)    : O     O
domains,       : O     O
involved       : O     O
in             : O     O
protein-protein: O     O
interaction.   : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
the            : O     O
atm            : O     O
gene           : O     O
product        : O     O
is             : O     O
a              : O     O
central        : O     O
component      : O     O
of             : O     O
cell           : O     O
cycle          : O     O
regulation     : O     O
and            : O     O
genomic        : O     O
surveillance.  : O     O
Word           ||True ||Pred
==============================
results:       : O     O
the            : O     O
comparative    : O     O
analysis       : O     O
of             : O     O
the            : O     O
three          : O     O
groups         : O     O
revealed       : O     O
significant    : O     O
differences    : O     O
for            : O     O
allele         : O     O
frequencies    : O     O
in             : O     O
the            : O     O
two            : O     O
genes          : O     O
in             : O     O
patients       : O     O
groups         : O     O
(prostate      : O     O
cancer         : O     O
and            : O     O
benign         : O     O
prostatic      : O     O
hyperplasia)   : O     O
versus         : O     O
the            : O     O
general        : O     O
population.    : O     O
Word           ||True ||Pred
==============================
one            : O     O
breast         : O     O
cancer         : O     O
sample         : O     O
also           : O     O
contained      : O     O
a              : O     O
g              : O     O
-->            : O     O
t              : O     O
transversion   : O     O
(q253h).       : O     O
Word           ||True ||Pred
==============================
these          : O     O
studies        : O     O
indicate       : O     O
that           : O     O
disruption     : O     O
of             : O     O
the            : O     O
normal         : O     O
activity       : O     O
of             : O     O
the            : O     O
pten           : O     O
phosphatase    : O     O
can            : O     O
have           : O     O
dramatic       : O     O
effects        : O     O
on             : O     O
the            : O     O
therapeutic    : O     O
sensitivity    : O     O
of             : O     O
breast         : O     O
cancer         : O     O
cells.         : O     O
Word           ||True ||Pred
==============================
mutations      : O     O
in             : O     O
atm            : O     O
are            : O     O
responsible    : O     O
for            : O     O
the            : O     O
autosomal      : O     O
recessive      : O     O
disorder       : O     O
ataxia         : O     O
telangiectasia.: O     O
Word           ||True ||Pred
==============================
when           : O     O
the            : O     O
ratios         : O     O
of             : O     O
the            : O     O
three          : O     O
genotypes      : O     O
were           : O     O
compared       : O     O
between        : O     O
the            : O     O
two            : O     O
groups,        : O     O
the            : O     O
aa             : O     O
genotype       : O     O
was            : O     O
found          : O     O
to             : O     O
be             : O     O
more           : O     O
significantly  : O     O
associated     : O     O
with           : O     O
tb.            : O     O
Word           ||True ||Pred
==============================
achondroplasia : O     O
is             : O     O
the            : O     O
most           : O     O
common         : O     O
form           : O     O
of             : O     O
dwarfism       : O     O
and            : O     O
has            : O     O
an             : O     O
incidence      : O     O
of             : O     O
approximately  : O     O
1/7500.        : O     O
Word           ||True ||Pred
==============================
hereditary     : O     O
scot           : O     O
deficiency     : O     O
(mim           : O     O
245050)        : O     O
causes         : O     O
episodes       : O     O
of             : O     O
severe         : O     O
ketoacidosis.  : O     O
Word           ||True ||Pred
==============================
both           : O     O
p38alpha       : O     O
and            : O     O
jnk1           : O     O
phosphorylated : O     O
ser            : O     O
650            : O     O
in             : O     O
vitro.         : O     O
Word           ||True ||Pred
==============================
four           : O     O
novel          : O     O
mutations      : O     O
in             : O     O
the            : O     O
thiazide-sensitive: O     O
na-cl          : O     O
co-transporter : O     O
gene           : O     O
in             : O     O
japanese       : O     O
patients       : O     O
with           : O     O
gitelman's     : O     O
syndrome.      : O     O
Word           ||True ||Pred
==============================
subsequently,  : O     O
genome-wide    : O     O
homozygosity   : O     O
mapping        : O     O
was            : O     O
performed      : O     O
in             : O     O
dna            : O     O
samples        : O     O
from           : O     O
available      : O     O
family         : O     O
members        : O     O
using          : O     O
a              : O     O
700k           : O     O
single         : O     O
nucleotide     : O     O
polymorphism   : O     O
(snp)          : O     O
microarray.    : O     O
Word           ||True ||Pred
==============================
apoe           : O     O
genotype-function: O     O
relationship:  : O     O
evidence       : O     O
of             : O     O
-491           : O     O
a/t            : O     O
promoter       : O     O
polymorphism   : O     O
modifying      : O     O
transcription  : O     O
control        : O     O
but            : O     O
not            : O     O
type           : O     O
2              : O     O
diabetes       : O     O
risk.          : O     O
Word           ||True ||Pred
==============================
mutation       : O     O
analysis       : O     O
of             : O     O
foxf2          : O     O
in             : O     O
patients       : O     O
with           : O     O
disorders      : O     O
of             : O     O
sex            : O     O
development    : O     O
(dsd)          : O     O
in             : O     O
combination    : O     O
with           : O     O
cleft          : O     O
palate.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
gene           : O     O
mutated        : O     O
in             : O     O
ataxia-telangiectasia: O     O
(a-t),         : O     O
atm,           : O     O
is             : O     O
a              : O     O
proximal       : O     O
component      : O     O
in             : O     O
performing     : O     O
such           : O     O
tasks.         : O     O
Word           ||True ||Pred
==============================
association    : O     O
of             : O     O
microsomal     : O     O
epoxide        : O     O
hydrolase      : O     O
polymorphisms  : O     O
and            : O     O
lung           : O     O
cancer         : O     O
risk.          : O     O
Word           ||True ||Pred
==============================
background:    : O     O
recessive      : O     O
dystrophic     : O     O
epidermolysis  : O     O
bullosa        : O     O
(rdeb)         : O     O
is             : O     O
an             : O     O
inherited      : O     O
blistering     : O     O
skin           : O     O
disorder       : O     O
caused         : O     O
by             : O     O
mutations      : O     O
in             : O     O
col7a1         : O     O
gene           : O     O
encoding       : O     O
type           : O     O
vii            : O     O
collagen,      : O     O
the            : O     O
major          : O     O
component      : O     O
of             : O     O
anchoring      : O     O
fibrils        : O     O
in             : O     O
the            : O     O
dermo-epidermal: O     O
junction.      : O     O
Word           ||True ||Pred
==============================
these          : O     O
included       : O     O
missense       : O     O
(p.t286m)      : O     O
and            : O     O
nonsense       : O     O
(p.w111x)      : O     O
mutations      : O     O
and            : O     O
a              : O     O
transition     : O     O
in             : O     O
the            : O     O
obligate       : O     O
ag-dinucleotide: O     O
of             : O     O
the            : O     O
intron         : O     O
8              : O     O
acceptor       : O     O
splice         : O     O
site           : O     O
(c.610-2a>g).  : O     O
Word           ||True ||Pred
==============================
h2             : O     O
relaxin        : O     O
is             : O     O
overexpressed  : O     O
in             : O     O
the            : O     O
lncap-r273h    : O     O
subline.       : O     O
Word           ||True ||Pred
==============================
the            : O     O
novel          : O     O
ttat           : O     O
tetranucleotide: O     O
was            : O     O
inserted       : O     O
between        : O     O
nt             : O     O
2057           : O     O
and            : O     O
2058.          : O     O
Word           ||True ||Pred
==============================
while          : O     O
data           : O     O
pooling        : O     O
strategies     : O     O
may            : O     O
provide        : O     O
more           : O     O
information    : O     O
for            : O     O
multifactorial : O     O
analysis       : O     O
to             : O     O
improve        : O     O
the            : O     O
interpretation : O     O
of             : O     O
the            : O     O
clinical       : O     O
significance   : O     O
of             : O     O
these          : O     O
variants,      : O     O
it             : O     O
is             : O     O
likely         : O     O
that           : O     O
the            : O     O
development    : O     O
of             : O     O
current        : O     O
multifactorial : O     O
likelihood     : O     O
approaches     : O     O
and            : O     O
the            : O     O
consideration  : O     O
of             : O     O
alternative    : O     O
statistical    : O     O
approaches     : O     O
will           : O     O
be             : O     O
needed         : O     O
to             : O     O
determine      : O     O
whether        : O     O
these          : O     O
individually   : O     O
rare           : O     O
variants       : O     O
do             : O     O
confer         : O     O
a              : O     O
low            : O     O
or             : O     O
moderate       : O     O
risk           : O     O
of             : O     O
breast         : O     O
cancer..       : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
to             : O     O
report         : O     O
three          : O     O
types          : O     O
of             : O     O
heterozygous   : O     O
mutations      : O     O
in             : O     O
the            : O     O
opa1           : O     O
gene           : O     O
in             : O     O
five           : O     O
patients       : O     O
from           : O     O
three          : O     O
families       : O     O
with           : O     O
autosomal      : O     O
dominant       : O     O
optic          : O     O
atrophy        : O     O
(adoa,         : O     O
mim#165500).   : O     O
Word           ||True ||Pred
==============================
conclusion:    : O     O
two            : O     O
novel          : O     O
mutations      : O     O
within         : O     O
the            : O     O
coding         : O     O
region         : O     O
of             : O     O
the            : O     O
ndp            : O     O
gene           : O     O
were           : O     O
found,         : O     O
one            : O     O
associated     : O     O
with           : O     O
a              : O     O
severe         : O     O
disease        : O     O
phenotypes     : O     O
of             : O     O
norrie         : O     O
disease        : O     O
and            : O     O
the            : O     O
other          : O     O
with           : O     O
fevr.          : O     O
Word           ||True ||Pred
==============================
we             : O     O
propose        : O     O
that           : O     O
the            : O     O
tyr1306cys     : O     O
substitution   : O     O
in             : O     O
larg,          : O     O
through        : O     O
its            : O     O
differential   : O     O
activation     : O     O
of             : O     O
rhoa,          : O     O
increases      : O     O
insulin        : O     O
sensitivity    : O     O
in             : O     O
nondiabetic    : O     O
pima           : O     O
indians..      : O     O
Word           ||True ||Pred
==============================
eight          : O     O
snps           : O     O
were           : O     O
found          : O     O
on             : O     O
the            : O     O
exon3,         : O     O
10             : O     O
and            : O     O
11             : O     O
of             : O     O
brca2,         : O     O
among          : O     O
which          : O     O
5              : O     O
were           : O     O
silent         : O     O
changes        : O     O
and            : O     O
3              : O     O
were           : O     O
polymorphic    : O     O
amino          : O     O
acid           : O     O
alterations.   : O     O
Word           ||True ||Pred
==============================
the            : O     O
primary        : O     O
tumor,         : O     O
lymph          : O     O
node           : O     O
metastasis,    : O     O
and            : O     O
xenograft      : O     O
were           : O     O
hypodiploid    : O     O
by             : O     O
dna            : O     O
flow           : O     O
cytometry,     : O     O
whereas        : O     O
the            : O     O
cell           : O     O
line           : O     O
displayed      : O     O
an             : O     O
aneuploidy     : O     O
apparently     : O     O
developed      : O     O
via            : O     O
polyploidization.: O     O
Word           ||True ||Pred
==============================
homozygous     : O     O
familial       : O     O
hypobetalipoproteinaemia: O     O
(ho-fhbl)      : O     O
is             : O     O
a              : O     O
rare           : O     O
co-dominant    : O     O
disorder       : O     O
characterized  : O     O
by             : O     O
extremely      : O     O
low            : O     O
levels         : O     O
of             : O     O
low-density    : O     O
lipoprotein    : O     O
cholesterol    : O     O
(ldl-c)        : O     O
and            : O     O
apolipoprotein : O     O
b              : O     O
(apob).        : O     O
Word           ||True ||Pred
==============================
eight          : O     O
female         : O     O
carriers       : O     O
had            : O     O
the            : O     O
typical        : O     O
sequencing     : O     O
chromatograms  : O     O
of             : O     O
heterozygotes. : O     O
Word           ||True ||Pred
==============================
therefore,     : O     O
we             : O     O
suggest        : O     O
pax2           : O     O
molecular      : O     O
analysis       : O     O
to             : O     O
be             : O     O
extended       : O     O
to             : O     O
all            : O     O
patients       : O     O
with           : O     O
congenital     : O     O
malformations  : O     O
of             : O     O
kidney         : O     O
and            : O     O
urinary        : O     O
tract          : O     O
(cakut)..      : O     O
Word           ||True ||Pred
==============================
conclusions:   : O     O
the            : O     O
data           : O     O
presented      : O     O
here           : O     O
demonstrate    : O     O
that           : O     O
ar             : O     O
mutants        : O     O
found          : O     O
in             : O     O
prostate       : O     O
cancer         : O     O
had            : O     O
different      : O     O
functional     : O     O
alterations,   : O     O
which          : O     O
might          : O     O
play           : O     O
an             : O     O
important      : O     O
role           : O     O
in             : O     O
the            : O     O
progression    : O     O
of             : O     O
prostate       : O     O
cancer..       : O     O
Word           ||True ||Pred
==============================
the            : O     O
dopamine       : O     O
b-hydroxylase  : O     O
-1021c/t       : O     O
polymorphism   : O     O
is             : O     O
associated     : O     O
with           : O     O
the            : O     O
risk           : O     O
of             : O     O
alzheimer's    : O     O
disease        : O     O
in             : O     O
the            : O     O
epistasis      : O     O
project.       : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
four           : O     O
irf5           : O     O
polymorphisms  : O     O
were           : O     O
genotyped      : O     O
in             : O     O
1488           : O     O
sle            : O     O
patients       : O     O
and            : O     O
1466           : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
structure-function: O     O
studies        : O     O
and            : O     O
in             : O     O
silico         : O     O
analyses       : O     O
provided       : O     O
the            : O     O
first          : O     O
experimental   : O     O
evidence       : O     O
of             : O     O
an             : O     O
indel          : O     O
of             : O     O
a              : O     O
stop           : O     O
codon          : O     O
by             : O     O
alternative    : O     O
splicing       : O     O
at             : O     O
a              : O     O
nagnag         : O     O
acceptor       : O     O
site.          : O     O
Word           ||True ||Pred
==============================
materials      : O     O
and            : O     O
methods:       : O     O
we             : O     O
screened       : O     O
greek          : O     O
adpkd          : O     O
patients       : O     O
with           : O     O
the            : O     O
denaturing     : O     O
gradient       : O     O
gel            : O     O
electrophoresis: O     O
(dgge)         : O     O
assay          : O     O
and            : O     O
direct         : O     O
sequencing.    : O     O
Word           ||True ||Pred
==============================
phenotypic     : O     O
presentation   : O     O
of             : O     O
46,xy          : O     O
dsd            : O     O
depends        : O     O
on             : O     O
the            : O     O
underlying     : O     O
defects.       : O     O
Word           ||True ||Pred
==============================
we             : O     O
have           : O     O
described      : O     O
a              : O     O
patient        : O     O
with           : O     O
a              : O     O
clear          : O     O
tiod           : O     O
causing        : O     O
severe         : O     O
goitrous       : O     O
ch             : O     O
due            : O     O
to             : O     O
a              : O     O
monoallelic    : O     O
tpo            : O     O
mutation.      : O     O
Word           ||True ||Pred
==============================
introduction   : O     O
and            : O     O
hypothesis:    : O     O
a              : O     O
familial       : O     O
tendency       : O     O
has            : O     O
been           : O     O
demonstrated   : O     O
in             : O     O
the            : O     O
etiology       : O     O
of             : O     O
pelvic         : O     O
organ          : O     O
prolapse       : O     O
(pop),         : O     O
but            : O     O
the            : O     O
specific       : O     O
genetic        : O     O
defects        : O     O
have           : O     O
not            : O     O
been           : O     O
identified.    : O     O
Word           ||True ||Pred
==============================
published      : O     O
studies        : O     O
were           : O     O
searched       : O     O
using          : O     O
appropriate    : O     O
keywords.      : O     O
Word           ||True ||Pred
==============================
rt-pcr         : O     O
analysis       : O     O
in             : O     O
the            : O     O
mildest        : O     O
affected       : O     O
patient        : O     O
with           : O     O
a              : O     O
heterozygous   : O     O
c.360+1g>c     : O     O
mutation,      : O     O
demonstrated   : O     O
expression     : O     O
of             : O     O
a              : O     O
short          : O     O
in-frame       : O     O
mutant         : O     O
transcript     : O     O
with           : O     O
exon           : O     O
5              : O     O
skipping,      : O     O
which          : O     O
may            : O     O
account        : O     O
for            : O     O
the            : O     O
mild           : O     O
phenotype.     : O     O
Word           ||True ||Pred
==============================
methods:       : O     O
all            : O     O
individuals    : O     O
in             : O     O
the            : O     O
study          : O     O
underwent      : O     O
a              : O     O
full           : O     O
clinical       : O     O
examination    : O     O
and            : O     O
the            : O     O
details        : O     O
of             : O     O
history        : O     O
were           : O     O
collected.     : O     O
Word           ||True ||Pred
==============================
the            : O     O
results        : O     O
indicated      : O     O
that           : O     O
dds-wt1        : O     O
is             : O     O
unable         : O     O
to             : O     O
regulate       : O     O
vegf           : O     O
transcription  : O     O
or             : O     O
stabilize      : O     O
vegf           : O     O
mrna           : O     O
in             : O     O
lncap          : O     O
prostate       : O     O
cancer         : O     O
cells.         : O     O
Word           ||True ||Pred
==============================
we             : O     O
evaluated      : O     O
this           : O     O
hypothesis     : O     O
among          : O     O
186            : O     O
breast         : O     O
cancer         : O     O
cases          : O     O
and            : O     O
200            : O     O
age-matched    : O     O
controls       : O     O
as             : O     O
part           : O     O
of             : O     O
a              : O     O
large          : O     O
population-based: O     O
case-control   : O     O
study          : O     O
conducted      : O     O
in             : O     O
urban          : O     O
shanghai       : O     O
during         : O     O
1996           : O     O
to             : O     O
1998.          : O     O
Word           ||True ||Pred
==============================
expression     : O     O
of             : O     O
this           : O     O
mutant         : O     O
channel        : O     O
in             : O     O
tsa201         : O     O
mammalian      : O     O
cells          : O     O
by             : O     O
site-directed  : O     O
mutagenesis    : O     O
revealed       : O     O
a              : O     O
persistent     : O     O
tetrodotoxin-sensitive: O     O
but            : O     O
lidocaine-resistant: O     O
current        : O     O
that           : O     O
was            : O     O
associated     : O     O
with           : O     O
a              : O     O
positive       : O     O
shift          : O     O
of             : O     O
the            : O     O
steady-state   : O     O
inactivation   : O     O
curve,         : O     O
steeper        : O     O
activation     : O     O
curve          : O     O
and            : O     O
faster         : O     O
recovery       : O     O
from           : O     O
inactivation.  : O     O
Word           ||True ||Pred
==============================
this           : O     O
report         : O     O
presents       : O     O
clinical,      : O     O
neuropathological: O     O
and            : O     O
molecular      : O     O
genetic        : O     O
data           : O     O
from           : O     O
2              : O     O
families       : O     O
in             : O     O
france         : O     O
with           : O     O
an             : O     O
identical      : O     O
p53            : O     O
germline       : O     O
mutation       : O     O
in             : O     O
codon          : O     O
248            : O     O
(cgg->tgg;     : O     O
arg->trp)      : O     O
and            : O     O
a              : O     O
clustering     : O     O
of             : O     O
cns            : O     O
tumors.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
hs-111         : O     O
(-21           : O     O
a)             : O     O
variation      : O     O
also           : O     O
showed         : O     O
association    : O     O
with           : O     O
beta-ti        : O     O
patients       : O     O
who            : O     O
had            : O     O
high           : O     O
levels         : O     O
of             : O     O
hb             : O     O
f.             : O     O
Word           ||True ||Pred
==============================
we             : O     O
report         : O     O
on             : O     O
monozygotic    : O     O
twins          : O     O
with           : O     O
short          : O     O
stature        : O     O
and            : O     O
severe         : O     O
spondyloepimetaphyseal: O     O
dysplasia      : O     O
congenita      : O     O
(semdc)        : O     O
from           : O     O
the            : O     O
polish         : O     O
population.    : O     O
Word           ||True ||Pred
==============================
this           : O     O
snp            : O     O
has            : O     O
also           : O     O
been           : O     O
shown          : O     O
to             : O     O
have           : O     O
an             : O     O
association    : O     O
with           : O     O
decreased      : O     O
risk           : O     O
in             : O     O
breast         : O     O
cancer.        : O     O
Word           ||True ||Pred
==============================
altogether,    : O     O
base           : O     O
changes        : O     O
were           : O     O
detected       : O     O
in             : O     O
four           : O     O
tumors         : O     O
(36%).         : O     O
Word           ||True ||Pred
==============================
introduction:  : O     O
unclassified   : O     O
variants       : O     O
(uvs)          : O     O
of             : O     O
unknown        : O     O
clinical       : O     O
significance   : O     O
are            : O     O
frequently     : O     O
detected       : O     O
in             : O     O
the            : O     O
brca2          : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
thus,          : O     O
the            : O     O
-1021t         : O     O
allele         : O     O
with           : O     O
presumed       : O     O
low            : O     O
activity       : O     O
may            : O     O
be             : O     O
associated     : O     O
with           : O     O
misregulation  : O     O
of             : O     O
inflammation,  : O     O
which          : O     O
could          : O     O
contribute     : O     O
to             : O     O
the            : O     O
onset          : O     O
of             : O     O
ad.            : O     O
Word           ||True ||Pred
==============================
inactivating   : O     O
mutations      : O     O
in             : O     O
the            : O     O
lh             : O     O
receptor       : O     O
are            : O     O
the            : O     O
predominant    : O     O
cause          : O     O
for            : O     O
male           : O     O
pseudohermaphroditism: O     O
in             : O     O
subjects       : O     O
with           : O     O
leydig         : O     O
cell           : O     O
hypoplasia     : O     O
(lch).         : O     O
Word           ||True ||Pred
==============================
there          : O     O
is             : O     O
also           : O     O
reduced        : O     O
14-3-3         : O     O
binding        : O     O
to             : O     O
t135e          : O     O
rnf11.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
odd            : O     O
ratios         : O     O
(or)           : O     O
and            : O     O
95%            : O     O
confidence     : O     O
intervals      : O     O
(ci)           : O     O
were           : O     O
calculated     : O     O
by             : O     O
unconditional  : O     O
logistic       : O     O
regression     : O     O
model.         : O     O
Word           ||True ||Pred
==============================
background:    : O     O
hispanic       : O     O
children       : O     O
have           : O     O
both           : O     O
a              : O     O
higher         : O     O
incidence      : O     O
and            : O     O
a              : O     O
poorer         : O     O
outcome        : O     O
in             : O     O
acute          : O     O
lymphoblastic  : O     O
leukemia       : O     O
(all).         : O     O
Word           ||True ||Pred
==============================
in             : O     O
this           : O     O
study          : O     O
we             : O     O
investigated   : O     O
the            : O     O
polymorphism   : O     O
rs2234671      : Mut   O
in             : O     O
395            : O     O
brazilian      : O     O
subjects       : O     O
with           : O     O
and            : O     O
without        : O     O
chronic        : O     O
periodontitis. : O     O
Word           ||True ||Pred
==============================
our            : O     O
results        : O     O
suggest        : O     O
the            : O     O
importance     : O     O
of             : O     O
routine        : O     O
screening      : O     O
for            : O     O
the            : O     O
rather         : O     O
frequent       : O     O
-3170g>a       : O     O
mutation       : O     O
(in            : O     O
addition       : O     O
to             : O     O
c.35delg)      : O     O
in             : O     O
patients       : O     O
with           : O     O
hearing        : O     O
impairment..   : O     O
Word           ||True ||Pred
==============================
these          : O     O
results        : O     O
present        : O     O
a              : O     O
novel          : O     O
approach       : O     O
to             : O     O
high-throughput: O     O
mutation       : O     O
screening      : O     O
using          : O     O
small          : O     O
amounts        : O     O
of             : O     O
starting       : O     O
material       : O     O
and            : O     O
reveal         : O     O
a              : O     O
mutation       : O     O
spectrum       : O     O
across         : O     O
30             : O     O
genes          : O     O
in             : O     O
a              : O     O
large          : O     O
cohort         : O     O
of             : O     O
breast         : O     O
and            : O     O
colorectal     : O     O
cancers..      : O     O
Word           ||True ||Pred
==============================
however,       : O     O
only           : O     O
full-length    : O     O
pol            : O     O
gamma          : O     O
protein        : O     O
was            : O     O
detected       : O     O
by             : O     O
western        : O     O
blot           : O     O
analysis.      : O     O
Word           ||True ||Pred
==============================
in             : O     O
conclusion,    : O     O
we             : O     O
report         : O     O
a              : O     O
new            : O     O
dguok          : O     O
splice         : O     O
site           : O     O
mutation       : O     O
that           : O     O
provide        : O     O
insight        : O     O
into           : O     O
a              : O     O
critical       : O     O
protein        : O     O
domain         : O     O
(dgk           : O     O
kinase         : O     O
domain)        : O     O
and            : O     O
the            : O     O
first          : O     O
founder        : O     O
mutation       : O     O
in             : O     O
a              : O     O
north-african  : O     O
population..   : O     O
Word           ||True ||Pred
==============================
no             : O     O
statistically  : O     O
significant    : O     O
association    : O     O
of             : O     O
the            : O     O
cys557ser      : O     O
or             : O     O
val507met      : O     O
variants       : O     O
with           : O     O
any            : O     O
clinicopathologic: O     O
parameters     : O     O
was            : O     O
observed.      : O     O
Word           ||True ||Pred
==============================
we             : O     O
found          : O     O
a              : O     O
repressive     : O     O
effect         : O     O
of             : O     O
the            : O     O
rs12203592     : Mut   O
wildtype       : O     O
allele         : O     O
c              : O     O
on             : O     O
irf4           : O     O
promoter       : O     O
activity       : O     O
(p<0.001)      : O     O
but            : O     O
no             : O     O
repression     : O     O
by             : O     O
the            : O     O
variant        : O     O
allele         : O     O
in             : O     O
any            : O     O
cell           : O     O
line           : O     O
tested.        : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
mutations      : O     O
in             : O     O
the            : O     O
sox2           : O     O
and            : O     O
chx10          : O     O
genes          : O     O
have           : O     O
been           : O     O
reported       : O     O
in             : O     O
patients       : O     O
with           : O     O
anophthalmia   : O     O
and/or         : O     O
microphthalmia.: O     O
Word           ||True ||Pred
==============================
the            : O     O
allele         : O     O
frequency      : O     O
and            : O     O
genotype       : O     O
distribution   : O     O
were           : O     O
compared       : O     O
in             : O     O
90             : O     O
patients       : O     O
with           : O     O
interstitial   : O     O
nephritis      : O     O
and            : O     O
200            : O     O
healthy        : O     O
controls.      : O     O
Word           ||True ||Pred
==============================
a              : O     O
novel          : O     O
mutation       : O     O
(e333d)        : O     O
in             : O     O
the            : O     O
thyroid        : O     O
hormone        : O     O
beta           : O     O
receptor       : O     O
causing        : O     O
resistance     : O     O
to             : O     O
thyroid        : O     O
hormone        : O     O
syndrome.      : O     O
Word           ||True ||Pred
==============================
identification : O     O
of             : O     O
novel          : O     O
type           : O     O
vii            : O     O
collagen       : O     O
gene           : O     O
mutations      : O     O
resulting      : O     O
in             : O     O
severe         : O     O
recessive      : O     O
dystrophic     : O     O
epidermolysis  : O     O
bullosa.       : O     O
Word           ||True ||Pred
==============================
moreover,      : O     O
the            : O     O
same           : O     O
p53            : O     O
gene           : O     O
mutation,      : O     O
arg273cys,     : O     O
was            : O     O
detected       : O     O
in             : O     O
all            : O     O
tumour         : O     O
samples.       : O     O
Word           ||True ||Pred
==============================
in             : O     O
total,         : O     O
four           : O     O
novel          : O     O
mutations      : O     O
were           : O     O
identified;    : O     O
e137d          : O     O
(n=1),         : O     O
r32q           : O     O
(n=1),         : O     O
e101k          : O     O
(n=1)          : O     O
and            : O     O
y156h          : O     O
(n=1)          : O     O
and            : O     O
one            : O     O
mutation       : O     O
deletion;      : O     O
366delt        : O     O
(n=1).         : O     O
Word           ||True ||Pred
==============================
a              : O     O
haplotype      : O     O
containing     : O     O
these          : O     O
four           : O     O
snps           : O     O
(cata)         : O     O
significantly  : O     O
increased      : O     O
protection     : O     O
of             : O     O
wet            : O     O
amd            : O     O
with           : O     O
a              : O     O
p              : O     O
value          : O     O
of             : O     O
0.0005         : O     O
and            : O     O
an             : O     O
odds           : O     O
ratio          : O     O
of             : O     O
0.29           : O     O
(95%           : O     O
confidence     : O     O
interval:      : O     O
0.15-0.60).    : O     O
Word           ||True ||Pred
==============================
in             : O     O
md,            : O     O
a              : O     O
recurrent      : O     O
p799l          : O     O
mutation       : O     O
was            : O     O
identified     : O     O
in             : O     O
nine           : O     O
subjects,      : O     O
as             : O     O
well           : O     O
as             : O     O
10             : O     O
novel          : O     O
mutations      : O     O
including      : O     O
f471del,       : O     O
the            : O     O
first          : O     O
deletion       : O     O
mutation       : O     O
of             : O     O
trpv4.         : O     O
Word           ||True ||Pred
==============================
tr             : O     O
benbach        : O     O
and            : O     O
colleagues     : O     O
described      : O     O
a              : O     O
patient        : O     O
with           : O     O
two            : O     O
heterozygotic  : O     O
nucleotide     : O     O
transversions  : O     O
in             : O     O
exon           : O     O
4              : O     O
of             : O     O
tnfrsf1a       : O     O
gene:          : O     O
the            : O     O
first          : O     O
is             : O     O
a              : O     O
substitution   : O     O
from           : O     O
guanine        : O     O
to             : O     O
cytosine       : O     O
at             : O     O
position       : O     O
263            : O     O
of             : O     O
the            : O     O
nucleotide     : O     O
sequence       : O     O
(c.263         : O     O
g>c);          : O     O
the            : O     O
second         : O     O
is             : O     O
a              : O     O
substitution   : O     O
from           : O     O
cytosine       : O     O
to             : O     O
adenine        : O     O
at             : O     O
position       : O     O
264            : O     O
(c.264         : O     O
c>a);          : O     O
the            : O     O
two            : O     O
mutations      : O     O
affect         : O     O
the            : O     O
amino          : O     O
acid           : O     O
number         : O     O
88             : O     O
of             : O     O
the            : O     O
protein.       : O     O
Word           ||True ||Pred
==============================
this           : O     O
causes         : O     O
conversion     : O     O
of             : O     O
a              : O     O
tyrosine       : O     O
codon          : O     O
into           : O     O
a              : O     O
stop           : O     O
codon          : O     O
at             : O     O
codon          : O     O
612            : O     O
in             : O     O
the            : O     O
seventh        : O     O
transmembrane  : O     O
domain,        : O     O
resulting      : O     O
in             : O     O
a              : O     O
truncated      : O     O
receptor       : O     O
that           : O     O
lacks          : O     O
a              : O     O
cytoplasmic    : O     O
tail.          : O     O
Word           ||True ||Pred
==============================
we             : O     O
describe       : O     O
a              : O     O
patient        : O     O
who            : O     O
had            : O     O
nine           : O     O
primary        : O     O
malignant      : O     O
tumors         : O     O
and            : O     O
a              : O     O
germline       : O     O
mutation       : O     O
in             : O     O
the            : O     O
p53            : O     O
tumor-suppressor: O     O
gene,          : O     O
characteristically: O     O
found          : O     O
in             : O     O
the            : O     O
li-fraumeni    : O     O
syndrome       : O     O
(lfs).         : O     O
Word           ||True ||Pred
==============================
however,       : O     O
evidence       : O     O
for            : O     O
reduced        : O     O
prostate       : O     O
cancer-specific: O     O
survival       : O     O
was            : O     O
apparent       : O     O
in             : O     O
those          : O     O
cases          : O     O
whose          : O     O
tumor          : O     O
had            : O     O
multiple       : O     O
copies         : O     O
of             : O     O
the            : O     O
fusion.        : O     O
Word           ||True ||Pred
==============================
the            : O     O
other          : O     O
5              : O     O
snps           : O     O
in             : O     O
brca2,         : O     O
cdkn2a,        : O     O
srd5a2,        : O     O
casp8          : O     O
and            : O     O
tgfb1          : O     O
showed         : O     O
no             : O     O
association    : O     O
with           : O     O
ovarian        : O     O
cancer         : O     O
risk;          : O     O
given          : O     O
the            : O     O
large          : O     O
sample         : O     O
size,          : O     O
these          : O     O
results        : O     O
can            : O     O
also           : O     O
be             : O     O
considered     : O     O
to             : O     O
be             : O     O
informative.   : O     O
Word           ||True ||Pred
==============================
no             : O     O
significant    : O     O
association    : O     O
of             : O     O
polymorphisms  : O     O
(i97l,         : O     O
r462q          : O     O
and            : O     O
d541e)         : O     O
was            : O     O
observed,      : O     O
neither        : O     O
in             : O     O
case-control   : O     O
analyses       : O     O
nor            : O     O
by             : O     O
family-based   : O     O
association    : O     O
tests.         : O     O
Word           ||True ||Pred
==============================
the            : O     O
d2267          : O     O
residue        : O     O
is             : O     O
predicted      : O     O
to             : O     O
coordinate     : O     O
binding        : O     O
of             : O     O
a              : O     O
calcium        : O     O
ion,           : O     O
which          : O     O
influences     : O     O
the            : O     O
conformational : O     O
binding        : O     O
loops          : O     O
of             : O     O
the            : O     O
c-type         : O     O
lectin         : O     O
domain         : O     O
that           : O     O
mediate        : O     O
interactions   : O     O
with           : O     O
tenascins      : O     O
and            : O     O
other          : O     O
extracellular-matrix: O     O
proteins.      : O     O
Word           ||True ||Pred
==============================
this           : O     O
is             : O     O
the            : O     O
second         : O     O
highest        : O     O
number         : O     O
of             : O     O
types          : O     O
of             : O     O
primary        : O     O
malignant      : O     O
tumors         : O     O
to             : O     O
be             : O     O
reported       : O     O
in             : O     O
lfs.           : O     O
Word           ||True ||Pred
==============================
two            : O     O
heterozygous   : O     O
dna            : O     O
sequence       : O     O
variations     : O     O
were           : O     O
solely         : O     O
present        : O     O
in             : O     O
one            : O     O
single         : O     O
patient        : O     O
each           : O     O
but            : O     O
in             : O     O
none           : O     O
of             : O     O
the            : O     O
20             : O     O
normal         : O     O
controls:      : O     O
a              : O     O
duplication    : O     O
of             : O     O
gcc            : O     O
(c.97gcc[9]+[10]): O     O
resulting      : O     O
in             : O     O
an             : O     O
extra          : O     O
alanine        : O     O
within         : O     O
exon           : O     O
1              : O     O
and            : O     O
a              : O     O
25*g>a         : O     O
substitution   : O     O
in             : O     O
the            : O     O
3'-untranslated: O     O
region.        : O     O
Word           ||True ||Pred
==============================
translocation) : O     O
and            : O     O
the            : O     O
number         : O     O
of             : O     O
fusion         : O     O
copies         : O     O
(single        : O     O
vs.            : O     O
Word           ||True ||Pred
==============================
functional     : O     O
and            : O     O
genomic        : O     O
approaches     : O     O
reveal         : O     O
an             : O     O
ancient        : O     O
chek2          : O     O
allele         : O     O
associated     : O     O
with           : O     O
breast         : O     O
cancer         : O     O
in             : O     O
the            : O     O
ashkenazi      : O     O
jewish         : O     O
population.    : O     O
Word           ||True ||Pred
==============================
we             : O     O
demonstrated   : O     O
that           : O     O
the            : O     O
molecular      : O     O
mechanisms     : O     O
of             : O     O
glucocorticoid : O     O
signaling      : O     O
dysfunction    : O     O
involved       : O     O
gr             : O     O
haploinsufficiency: O     O
due            : O     O
to             : O     O
the            : O     O
selective      : O     O
degradation    : O     O
of             : O     O
the            : O     O
mutated        : O     O
gr             : O     O
transcript     : O     O
through        : O     O
a              : O     O
nonsense-mediated: O     O
mrna           : O     O
decay          : O     O
that           : O     O
was            : O     O
experimentally : O     O
validated      : O     O
on             : O     O
emetine-treated: O     O
propositus'    : O     O
fibroblasts.   : O     O
Word           ||True ||Pred
==============================
mutations      : O     O
in             : O     O
the            : O     O
ndp            : O     O
gene:          : O     O
contribution   : O     O
to             : O     O
norrie         : O     O
disease,       : O     O
familial       : O     O
exudative      : O     O
vitreoretinopathy: O     O
and            : O     O
retinopathy    : O     O
of             : O     O
prematurity.   : O     O
Word           ||True ||Pred
==============================
it             : O     O
also           : O     O
shows          : O     O
the            : O     O
independent    : O     O
segregation    : O     O
of             : O     O
familial       : O     O
cavernomatosis : O     O
and            : O     O
gs..           : O     O
Word           ||True ||Pred
==============================
these          : O     O
patients       : O     O
have           : O     O
presented      : O     O
neisseria      : O     O
meningitidis   : O     O
infection      : O     O
(four          : O     O
cases),        : O     O
focal          : O     O
and            : O     O
segmental      : O     O
glomerulosclerosis: O     O
with           : O     O
hyalinosis     : O     O
(one           : O     O
case),         : O     O
systemic       : O     O
lupus          : O     O
erythematosus  : O     O
(one           : O     O
case)          : O     O
or             : O     O
still's        : O     O
disease        : O     O
(one           : O     O
case).         : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
aniridia       : O     O
(an)           : O     O
is             : O     O
a              : O     O
rare           : O     O
congenital     : O     O
panocular      : O     O
disorder       : O     O
caused         : O     O
by             : O     O
the            : O     O
mutations      : O     O
of             : O     O
the            : O     O
paired         : O     O
box            : O     O
homeotic       : O     O
gene           : O     O
6(pax6)        : O     O
gene.          : O     O
Word           ||True ||Pred
==============================
purpose:       : O     O
to             : O     O
identify       : O     O
the            : O     O
underlying     : O     O
genetic        : O     O
defect         : O     O
in             : O     O
a              : O     O
four-generation: O     O
family         : O     O
of             : O     O
chinese        : O     O
origin         : O     O
with           : O     O
autosomal      : O     O
dominant       : O     O
congenital     : O     O
cataract-microcornea: O     O
syndrome       : O     O
(ccmc).        : O     O
Word           ||True ||Pred
==============================
this           : O     O
method         : O     O
is             : O     O
useful         : O     O
in             : O     O
evaluating     : O     O
known          : O     O
disease        : O     O
genes          : O     O
for            : O     O
common         : O     O
disease        : O     O
phenotypes,    : O     O
such           : O     O
as             : O     O
breast         : O     O
cancer         : O     O
or             : O     O
colorectal     : O     O
cancer.        : O     O
